EurekaMag PDF full texts Chapter 67,074

Hreinsson, J.P.; Palsdottir, S.; Bjornsson, E. 2014: The Association of Drugs and Specific Causes of Acute Lower Gastrointestinal Bleeding: a Prospective Study. Gastroenterology 146(5): S-46

Lin, E.C.; Massey, B.T. 2014: The Positive Glucose Breath Test: Small Bowel Bacterial Overgrowth or Colonic Fermentation?. Gastroenterology 146(5): S-46

Noto, J.M.; Piazuelo, M.B.; Delgado, A.G.; Correa, P.; Peek, R.M. 2014: Helicobacter pylori Suppresses Hepcidin, a Master Regulator of Iron Homeostasis, in a cag -Dependent Manner. Gastroenterology 146(5): S-46-S-47

Sun, X.; Zhang, M.; El-Zaatari, M.; Chang, Y.-M.; Huffnagle, G.B.; Kao, J.Y. 2014: Ccr2 Is Essential for H. pylori Induced Immune Tolerance in Mice. Gastroenterology 146(5): S-47

Varga, M.G.; Peek, R.M. 2014: Helicobacter pylori cag Secretion System-Mediated Up-Regulation of the Innate Immune Receptor Tlr9. Gastroenterology 146(5): S-47

Wei, J.; Noto, J.M.; Zaika, E.; Romero-Gallo, J.; Piazuelo, M.B.; Schneider, B.G.; Correa, P.; El-Rifai, W.; Peek, R.M.; Zaika, A. 2014: H. pylori Compromises Cellular Response to Oncogenic Stress. Gastroenterology 146(5): S-47

Marcus, E.A.; Sachs, G.; Wen, Y.; Scott, D.R. 2014: Helicobacter pylori ArsR Phosphorylation Regulates Expression of the Urease Gene Cluster and Impacts Acid Acclimation. Gastroenterology 146(5): S-47

Fushiya, J.; Asano, N.; Imatani, A.; Kondo, Y.; Jin, X.; Iijima, K.; Koike, T.; Shimosegawa, T. 2014: Impaired Nod1 Function Induce Dysplasia in Helicobacter pylori Infected Stomach Through Wnt/-Catenin Signaling. Gastroenterology 146(5): S-47-S-48

Corridoni, D.; Pietropaoli, D.; DiStefano, G.; Rodriguez-Palacios, A.; Guanzon, M.; Menghini, P.; Xin, W.; Pizarro, T.T.; Cominelli, F. 2014: Nod2 Plays a Pro-Inflammatory Role in the Chronic Phase of Crohn's-Like Ileitis by a Mechanism Involving Th2 Cytokines. Gastroenterology 146(5): S-48

Reich, K.; Madsen, K.; Foshaug, R.R.; Fedorak, R.N.; Kroeker, K.I. 2014: High Dose Vitamin D Supplementation Stimulates Innate Cytokine Responses in Patients With Inflammatory Bowel Disease on Infliximab. Gastroenterology 146(5): S-48

Aden, K.; Rehman, A.; Haesler, R.; Tran, F.; Pfeuffer, S.; Billmann, S.; Paulsen, M.; Lipinski, S.; Kaser, A.; Schreiber, S.; Rosenstiel, P.C. 2014: The Epithelial Il-23R Mediates Intestinal Immune Defense and Epithelial Regeneration. Gastroenterology 146(5): S-48-S-49

Leal, R.F.; Planell, N.; Kajekar, R.; Lozano, J.J.; Ordás, I.; Dotti, I.; Esteller, M.; Masamunt, M.C.; Parmar, H.; Ricart, E.; Panes, J.; Salas, A. 2014: Identification of Inflammatory Mediators in Crohn's Disease Patients Who Are Unresponsive to Anti-Tnf Therapy -A Transcriptional Analysis of Intestinal Mucosa. Gastroenterology 146(5): S-49

Pickert, G.; Gore, E.; Brombacher, F.; Schuppan, D. 2014: Deletion of Il-4Ra on Macrophages Renders Mice Resistant to Intestinal Inflammation. Gastroenterology 146(5): S-49

Galien, R.; Merciris, D.; Vanhoutte, F.P.; Delachaume, C.; Namour, F.S.; Vayssière, B.; Van der Aa, A.; Brys, R.; van't Klooster, G.A. 2014: Exploration of Glpg0634, the First Selective Jak1 Inhibitor, in Inflammatory Bowel Disease Is Supported by Early Clinical Results and Mouse Dss-Colitis Data. Gastroenterology 146(5): S-49

Singh, V.; Yang, J.; Sarker, R.; Chen, T.; Cha, B.; Zachos, N.C.; Donowitz, M. 2014: Basal and Stimulated Bb Nhe3 Activity Requires Intracellular Snx27, a Pdzdomain Containing Binding Partner of Nhe3 That Regulates Endosome to Plasma Membrane Trafficking. Gastroenterology 146(5): S-50

Foulke-Abel, J.; In, J.; Zachos, N.C.; Kovbasnjuk, O.; Ettayebi, K.; de Jonge, H.; Estes, M.K.; Donowitz, M. 2014: Human Small Intestinal Enteroids Enable Mechanistic Studies of cAmpinduced Changes in Intracellular pH. Gastroenterology 146(5): S-50

No, Y.R.; Yoo, B.K.; He, P.; Yun, C. 2014: Nedd4-2 Uniquely Regulates Human Na+/H+ Exchanger Nhe3 by Ubiquitination. Gastroenterology 146(5): S-50

Walker, N.M.; Stein, S.R.; Williams, A.M.; Liu, J.; Clarke, L.L. 2014: Increased Functional Ae2 Activity Does Not Compensate for Increased pHi in Cftr Knockout Enteroids. Gastroenterology 146(5): S-50

Patel, A.; Yang, J.; Potru, R.; Dolinger, M.; Conti, D.; Jones, D.M.; Huang, Y.; Zhu, X. 2014: Autophagic Down-Regulation and Transient Traffic Perturbation of Nhe3 by Rapamycin: Implication in Non-Infectious Diarrhea in Organ Transplantation. Gastroenterology 146(5): S-50-S-51

Muthusamy, S.; Malhotra, P.; Hosameddin, M.; Dudeja, A.K.; Borthakur, S.; Saksena, S.; Gill, R.K.; Dudeja, P.K.; Alrefai, W.A. 2014: N-Glycosylation Is Essential for Ileal Asbt Function and Protection Against Proteases. Gastroenterology 146(5): S-51

Lavoie, B.; Roberts, J.A.; Sharkey, K.A.; Lian, J.B.; Mawe, G.M. 2014: Gut-Derived Serotonin Decreases Bone Density in the Dss Model of Colitis in Mice. Gastroenterology 146(5): S-51

Fang, K.; Sideri, A.; Law, I.K.M.; Bakirtzi, K.; Koon, H.W.; Oikonomopoulos, A.; Hommes, D.W.; Iliopoulos, D.; Pothoulakis, C. 2014: Identification of a Novel Substance P (Sp)-Neurokinin-1 Receptor (Nk-1R) MicroRna-221 Inflammatory Network in Human Colonic Epithelial Cells. Gastroenterology 146(5): S-51

Mahapatro, M.; He, G.; Günther, C.; Neurath, M.F.; Wirtz, S.J.; Becker, C. 2014: Interleukin-33 Promotes Intestinal Barrier Function by Direct Effects on Epithelial Proliferation and Differentiation. Gastroenterology 146(5): S-51

Law, I.K.M.; Bakirtzi, K.; Polytarchou, C.; Koon, H.W.; Hommes, D.W.; Iliopoulos, D.; Pothoulakis, C. 2014: Colonic MicroRna-133 Promotes Neurotensin-Associated Proinflammatory Responses in Human Colonocytes and Experimental Colitis. Gastroenterology 146(5): S-51-S-52

Ji, T.; Takabayashi, H.; Mao, M.Y.; Todisco, A. 2014: Regulation of Bmp-4 Expression by Inflammatory Cytokines. Gastroenterology 146(5): S-52

Engevik, A.C.; Feng, R.; Aihara, E.; Montrose, M.H.; Zavros, Y. 2014: Engraftment of Stem Cells Derived From Gastric Organoids Promotes Ulcer Repair in the Aged Stomach. Gastroenterology 146(5): S-52

Reddy, V.K.; Parang, B.; Poindexter, S.; Barrett, C.W.; Ning, W.; Bradley, A.; Harris, E.; Choksi, Y.A.; Naik, R.D.; Mittal, M.K.; Singh, K.; Chaturvedi, R.; Brand, T.; Washington, K.; Bader, D.M. 2014: Bves Loss Is Protective in Radiation Enteritis and Influences Intestinal Stem Cell Programs. Gastroenterology 146(5): S-52

Mahe, M.M.; Lo, Y.-H.; Watson, C.L.; Sundaram, N.; Wang, F.; Karns, R.; Park, J.-S.; Li, L.; Shroyer, N.F.; Helmrath, M.A. 2014: Intestinal Region-Specific Pattern Is Borne and Maintained Within the Intestinal Stem Cells. Gastroenterology 146(5): S-52-S-53

Mizutani, T.; Fukuda, M.; Mochizuki, W.; Matsumoto, T.; Nozaki, K.; Ichinose, S.; Watanabe, M.; Nakamura, T. 2014: Successful Engraftment of Cultured Small Intestinal Epithelial Stem Cells Onto Damaged Colonic Mucosa by Heterotopic Transplantation. Gastroenterology 146(5): S-53

Nandan, M.O.; Ghaleb, A.; Bialkowska, A.; Yang, V.W. 2014: Intestinal Stem Cell (Lgr5)-Specific Deletion of Krppel-Like Factor 5 in Mice Results in Acute Loss of Proliferation and Chronic Depletion of Stem Cells. Gastroenterology 146(5): S-53

Riehl, T.E.; Stenson, W. 2014: In Normal Intestinal Growth, Proliferation of Lgr5 Expressing Intestinal Crypt Stem Cells Is Supported by Endogenous Hyaluronic Acid Acting Through Tlr4. Gastroenterology 146(5): S-53

Crissey, M.A.S.; Kong, J.; Johnson, F.B.; Lengner, C.J.; Lynch, J.P. 2014: Live-Cell Imaging of Murine Enteroids Reveals Well-Ordered Nuclear Migration During Mitosis, and Disruption With Apc Loss. Gastroenterology 146(5): S-53

Gibson, D.; Heetun, Z.; Keegan, D.; Byrne, K.; Mulcahy, H.; Cullen, G.; Dohert, G. 2014: Accelerated Infliximab Rescue Reduces Early Colectomy Rate in Acute Severe Colitis. Gastroenterology 146(5): S-53-S-54

Van Schaik, T.; Roopram, R.K.; Maljaars, P.W.; Ipenburg, N.; Verwey, M.H.; Hardwick, J.C.; Veenendaal, R.; van der Meulen -de Jong, A.E. 2014: Influence of Combination Therapy With Immune Modulators on Anti-Tnf Trough Levels and Antibodies in Ibd Patients. Gastroenterology 146(5): S-54

Vaughn, B.P.; Martínez-Vazquez, M.; Patwardhan, V.; Moss, A.C.; Sandborn, W.J.; Cheifetz, A.S. 2014: Prospective Therapeutic Drug Monitoring to Optimizing Infliximab (Ifx) Maintenance Therapy in Patients With Inflammatory Bowel Disease (Ibd). Gastroenterology 146(5): S-54

Guerra, I.; Algaba, A.; Quintanilla, E.; Pérez-Calle, J.L.; García-Sánchez, M.C.; Taxonera, C.; Casis, B.; Chaparro, M.; Botella, B.; Pajares, R.; Arranz, M.D.M.ín; Castaño, A.; Arias, M.; López-SanRomán, A.; Bermejo, F. 2014: Management and Course of Inflammatory Bowel Disease Patients With Associated Cancer. Gastroenterology 146(5): S-54-S-55

Vaughn, B.P.; Martínez-Vazquez, M.; Patwardhan, V.; Moss, A.C.; Sandborn, W.J.; Cheifetz, A.S. 2014: A Pilot Study of Optimized Monotherapy With Infliximab for Patients With Inflammatory Bowel Disease. Gastroenterology 146(5): S-55

Brandse, J.F.; Jansen, J.M.; Baars, P.A.; Lowenberg, M.; Ponsioen, C.; van den Brink, G.R.; D'Haens, G.R. 2014: Serum Crp Is a Better Early Marker for Response to Infliximab Induction Therapy Than Fecal Calprotectin in Patients With Moderate to Severe Ulcerative Colitis. Gastroenterology 146(5): S-55-S-56

Wong, M.C.; Ching, J.; Chan, V.C.; Lam, T.Y.; Luk, A.K.; Ng, S.C.; Ng, S.S.; Sung, J.J.Y. 2014: The Comparative Cost-Effectiveness of Faecal Immunochemical Tests vs. Screening Colonoscopy in the Detection of Neoplastic Lesions. Gastroenterology 146(5): S-56

Kumar, S.; Thosani, N.C.; Kochar, R.; Friedland, S.; Ladabaum, U.; Chen, A.M.; Banerjee, S. 2014: A Prospective, Randomized Trial of Adenoma Miss Rates At Colonoscopy Associated With 3-Minute vs. 6-Minute Withdrawal Time. Gastroenterology 146(5): S-57

Fukudo, S.; Morishita, J.; Watanabe, S.; Kawabata, K.; Ishizu, N.; Tanaka, Y.; Watanuki, S.; Hiraoka, K.; Kano, M.; Kanazawa, M.; Yanai, K.; Tashiro, M. 2014: Evidence of Dopamine Release During Hypnotic Analgesia Under Visceral Stimulation in Humans. Gastroenterology 146(5): S-57-S-58

Heldsinger, A.; Grabauskas, G.; Wu, X.; Lu, Y.; Song, I.; Owyang, C. 2014: Hyperphagia Induced by High-Fat Diet Is Mediated by Prostaglandin, Which Activates the Epac-Rap-Plc Pathway in the Nodose Ganglia to Stimulate Tresk K+ Channels, Resulting in Vagal Hyporesponsiveness to Satiety Signals. Gastroenterology 146(5): S-58

Park, S.J.; Beyak, M. 2014: The Novel Socs-3 Inhibitor, Zoledronic Acid Prevents the Inhibitory Effects of Diet Induced Obesity on Vagal Afferent Excitability and Satiety Signalling. Gastroenterology 146(5): S-58

Yu, X.; Yu, S. 2014: Effects of Acid on Vagal Nociceptive Afferent Subtypes in Guinea Pig Esophagus. Gastroenterology 146(5): S-58

Acosta, A.; Shin, A.; Vazquez-Roque, M.I.; Iturrino, J.; Carlson, P.; Vella, A.; Burton, D.D.; Zinsmeister, A.R.; Camilleri, M. 2014: Associations of Obesity Candidate Genes With Satiation, Satiety, Gastric Motor Function and Plasma Glucagon-Like Peptide 1 in Overweight and Obesity. Gastroenterology 146(5): S-58-S-59

Perez-Pardo, P.; Douna, H.; Wijnands, T.; da Silva, S.L.; Forsyth, C.B.; Dodiya, H.B.; Garssen, J.; Olivier, B.; Keshavarzian, A.; Kraneveld, A.D. 2014: The Role of Toll-Like Receptor-4 in Gut-Brain Cross Talk in a Murine Model of Parkinson's Disease. Gastroenterology 146(5): S-59

Zhu, W.; Shi, H.N.; Walker, A.; Meng, D.; Necrotizing, L.L. 2014: Excessive Expression of Tlr4 in Human Fetal Colonic Epithelial Cells Is Developmentally Regulated: A Possible Mechanism for Necrotizing Enterocolitis. Gastroenterology 146(5): S-59

Moussaoui, N.; Ait-Belgnaoui, A.; Braniste, V.; Gaultier, E.; Ménard, S.; Olier, M.; Theodorou, V.; Martin, P.G.; Houdeau, E. 2014: Premature Gut and Neonatal Stress: High Intestinal Glucocorticoid Responsiveness in Early Life Shapes the Risk of Epithelial Barrier Defect in Response to Maternal Separation. Gastroenterology 146(5): S-59

Freddo, A.M.; Taniguchi, K.; Grosse, A.S.; Margolis, B.; Turner, J.R.; Gumucio, D.L. 2014: Ezrin, an Apical Surface Protein, Functions in a Distinct Type of Cell Division in the Early Intestinal Epithelium to Aid Expansion of Luminal Surface. Gastroenterology 146(5): S-60

Lammers, K.M.; Serena, G.; Sapone, A.; Riegler, G.; de Magistris, L.; Fasano, A. 2014: Cxcr3 Splice Variants in Celiac Disease and Non-Celiac Gluten Sensitivity. Gastroenterology 146(5): S-60

Hiremath, G.; Olive, A.; Davis, C.M.; Shulman, R.J.; Devaraj, S. 2014: Eosinophilic Esophagitis Related Cytokines in Saliva: Characterization and Methodological Considerations. Gastroenterology 146(5): S-60

Hotta, R.; Belkind-Gerson, J.; Thomas, A.R.; Pan, W.; Goldstein, A.M. 2014: Transplantation of Enteric Neuronal Precursors for the Treatment of Hirschsprung Disease. Gastroenterology 146(5): S-60

Sandborn, W.; Higgins, P.; Rimola, J.; Lu, T.; Coimbra, A.; Rutgeerts, P.J.; Luca, D.; Bruining, D.H.; Vermeire, S.; Santillan, C.; Al-Hawary, M.; Fidler, J.L.; Vanslembrouck, R.A.; Vanbeckevoort, D.; Peyrin-Biroulet, L. 2014: A Multicenter Study to Evaluate Magnetic Resonance Enterography (Mre) for Selection of Crohn's Disease Patients for Inclusion Into a Therapeutic Clinical Trial. Gastroenterology 146(5): S-60-S-61

Brennan, G.; Melton, S.D.; Spechler, S.J.; Feagins, L.A. 2014: Clinical Implications of Histologic Abnormalities in Ileocolonic Biopsy of Crohn's Patients in Clinical Remission. Gastroenterology 146(5): S-61

Cerrillo, E.; Beltran, B.; Pous, S.; Echarri, A.; Salazar, A.; Sánchez, G.; Aguas, M.; Martinez, M.L.; Alba, A.; Nos, P. 2014: Is Fecal Calprotectin (Fc) a Useful Tool for Screening Mr-Enterography in Inflammatory Small Bowel Crohn's Disease (Cd)?. Gastroenterology 146(5): S-61

Ferreiro, R.; Acosta, M.B.; Lorenzo, A.; Dominguez-Munoz, E. 2014: Usefulness of a Rapid Test for Fecal Calprotectin As Predictor of Relapse in Crohn's Disease Patients Under Maintenance Treatment With Adalimumab. Gastroenterology 146(5): S-61

Atreja, A.; Patel, S.S.; Colombel, J.-F.; Sands, B.E. 2014: Validation of Simplified Stricture Severity Score (4S) to Predict the Need for Surgery in Patients With Stricturing Crohn's Disease. Gastroenterology 146(5): S-61-S-62

Youssef, M.A.; Alhmoud, T.; Guo, S.; Osman, D.; Nighot, P.K.; Ma, T.Y. 2014: Determination of Intestinal Permeability in Patients With Active and Inactive Ulcerative Colitis. Gastroenterology 146(5): S-62

Belkind-Gerson, J.; Hotta, R.; Solorzano, J.J.; Thomas, A.R.; Goldstein, A.M. 2014: Colonic Inflammation Induces Neurogenesis via Transdifferentiation of Enteric Glial Cells. Gastroenterology 146(5): S-62

Dave, M.; Gajdos, G.B.; Svingen, P.A.; Faubion, W.A.; Ordog, T. 2014: Adult Stem Cells for Murine Interstitial Cells of Cajal Suppress Cellular Immunity via Pge2 Secretion. Gastroenterology 146(5): S-62

Kulkarni, S.; Li, C.; Micci, M.-A.; Pasricha, P.J. 2014: Identification and Characterization of a Subset of Enteric Glial Cells As Neural Precursors. Gastroenterology 146(5): S-63

Kondo, J.; Powell, A.; Wang, Y.; Musser, M.A.; Southard-Smith, M.; Coffey, R.J. 2014: Lrig1 Regulates Differentiation of a Subset of Interstitial Cells of Cajal (Icc). Gastroenterology 146(5): S-63

Raghavan, S.; Bitar, K.N. 2014: Extracellular Matrix Directs Differentiation of Motor Neuronal Subtypes in Tissue Engineered Innervated Intestinal Smooth Muscle. Gastroenterology 146(5): S-63

Ding, L.; Hayes, M.M.; Tsao, A.C.; Merchant, J.L. 2014: Hedgehog/Gli1 Signaling Regulates Phenotypic Changes in Myeloid Cells During Helicobacter-Induced Spem (Gastric Metaplasia). Gastroenterology 146(5): S-63

Choi, E.; Hendley, A.M.; Petersen, C.; Weis, V.G.; Leach, S.D.; Goldenring, J.R. 2014: Active Kras Leads to Rapid Transdifferentiation of Gastric Chief Cells Into Metaplasia With Progression to Dysplasia and Invasive Cancer. Gastroenterology 146(5): S-64

Petersen, C.; Weis, V.G.; Sousa, J.F.; Nam, K.T.; Fingleton, B.; Goldenring, J.R. 2014: Macrophages Promote the Progression of Metaplasia in the Stomach Following Acute Parietal Cell Loss. Gastroenterology 146(5): S-64

Sue, S.; Shibata, W.; Maeda, S. 2014: Inflammation-Induced Homeobox Gene, Isx, May Lead to Gastric Intestinal Metaplasia and Proliferative Response. Gastroenterology 146(5): S-64

Nguyen, T.-L.M.; Khurana, S.S.; Sagartz, J.E.; Mills, J.C.; DiPaolo, R. 2014: Ebi3 (Il-27/Il-35) Regulates the Progression From Atrophic Gastritis to Gastric Cancer by Regulating Il-17 Production in the Gastric Mucosa. Gastroenterology 146(5): S-64-S-65

Jeong, S.; Choi, E.; Petersen, C.; Roland, J.T.; Federico, A.; D, F.P.; Romano, M.; Goldenring, J.R. 2014: Autoimmune Atrophic Gastritis in Humans Is Associated With Spem and Intestinal Metaplasia but Shows Low Proliferation and Reduced Macrophage and Neutrophil Infiltrates. Gastroenterology 146(5): S-65

Cheng, M.; Ho, S.; Yoo, J.H.; Bakirtzi, K.; Kubota, Y.; Ichikawa, R.; Tran, D.H.; Gallo, R.; Pothoulakis, C.; Koon, H.W. 2014: Cathelicidin Inhibits Colitis Associated Colon Cancer Development by Inhibition of Epithelial-Mesenchymal Transition and Cancer Associated Fibroblasts. Gastroenterology 146(5): S-65

Menghini, P.; DiMartino, L.; Lopetuso, L.R.; Corridoni, D.; Webster, J.; Xin, W.; Pizarro, T.T.; Cominelli, F. 2014: A Novel Model of Colitis-Associated Cancer in Samp1/YtFc Mice With Experimental Crohn's Disease. Gastroenterology 146(5): S-65

O'Mahony, C.; Clarke, S.F.; Hurley, G.; O'Sullivan, O.; Gavin, A.M.; Quinlan, A.; Houston, A.; Mahmoud, A.; Bennett, M.; Cotter, P.D.; Shanahan, F.; Melgar, S. 2014: High Fat Feeding Alters Gut Microbiota and Protects Mice From Colitis and Colitis-Associated Colorectal Cancer. Gastroenterology 146(5): S-65

Walter, L.; Ravi, A.; Harper, C.W.; Bhatnagar, N.; Yan, Y.; Garg, P. 2014: Mmp9 Mediated Activation of Notch1 Is the Plausible Mechanism for Its Tumor Suppressive Role in Colitis Associated Cancer As Exhibited by Notch1Flox/Flox Crevillin Mice. Gastroenterology 146(5): S-66

McFadden, R.-M.T.; Larmonier, C.B.; Midura-Kiela, M.T.; Ramalingam, R.; Harrison, C.A.; Besselsen, D.G.; Chase, J.; Caporaso, G.; Ghishan, F.K.; Kiela, P.R. 2014: The Role of Curcumin in Modulating Colonic Microbiota During Colitis and Colon Cancer Prevention. Gastroenterology 146(5): S-66

Jeppsson, S.; Chandrasekharan, B.P. 2014: Neuropeptide Y (Npy) Promotes Colitis-Associated Cancer by Enhancing Epithelial Cell Proliferation via C-Myc / p21 Signaling. Gastroenterology 146(5): S-66

Kaji, I.; Akiba, Y.; Strugatsky, D.; Guth, P.H.; Engel, E.; Kaunitz, J.D. 2014: Bacterial Overload Enhances Duodenal Anion Secretion via Protein Kinase a Upregulation. Gastroenterology 146(5): S-66

Tarnawski, A.S.; Ahluwalia, A.; Jones, M.K. 2014: Novel Mechanisms and Signaling Pathways of Esophageal Keratinocyte Progenitor Cells: Interactions of Cox2/prostaglandin E, c-Amp/Pka and Kgf. Implications for Esophageal Epithelial Renewal, Healing and the Therapeutic Actions of Hydrotalcite. Gastroenterology 146(5): S-66-S-67

Magierowski, M.; Jasnos, K.; Krzysiek-Maczka, G.; Sliwowski, Z.; Ptak-Belowska, A.; Kwiecien, S.; Brzozowski, T. 2014: Exogenous and Endogenous Hydrogen Sulfide (H2S) in Gastroprotection Against Ischemia/Reperfusion Lesions Progressing Into Chronic Ulcers. Role of Endogenous Prostaglandins, Sensory Neuropeptides and Vanilloid Receptors. Gastroenterology 146(5): S-67

Rathor, N.; Chung, H.K.; Zou, T.; Liu, L.; Xiao, L.; Wang, J.-Y.; Turner, D.J.; Jaladanki, R.N. 2014: Polyamines Induce Association of Git1 With -Pix and Activate Rac1 During Intestinal Epithelial Restitution After Wounding. Gastroenterology 146(5): S-67

Vanormelingen, C.; Vanuytsel, T.; Vanheel, H.; Rasoel, S.S.; Tóth, J.G.; Berghe, P.V.; Farré, R.; Tack, J.F. 2014: Altered Duodenal Permeability in Diabetes Patients Is Not Associated With Gastric Symptoms. Gastroenterology 146(5): S-67

Gargus, M.; Binkley, J.; Rubin, D.C.; Shaker, A. 2014: Human Esophageal Myofibroblast-Like Stromal Cells Secrete Il-6 in Response to Injurious Luminal Agents. Gastroenterology 146(5): S-67-S-68

Derikx, M.; Kovacs, P.; Masson, E.; Chen, J.-M.; Mössner, J.; Ferec, C.; Drenth, J.P.; Witt, H.; Rosendahl, J. 2014: Impact of Prss1 and Cldn2 Variants in Alcoholic Versus Non-Alcoholic Chronic Pancreatitis. Gastroenterology 146(5): S-68

Leppkes, M.; Nowecki, S.; Wirtz, S.J.; Becker, C.; Neurath, M.F. 2014: Intestinal Microbiota Contributes to the Pathogenesis of Il-17A Induced Chronic Pancreatitis. Gastroenterology 146(5): S-68

Waldron, R.T.; Su, H.-Y.; Gong, R.; Pandol, S.; Lugea, A. 2014: Attenuation of Acute Pancreatitis by Activation of the Unfolded Protein Response Regulator, Ire-1. Gastroenterology 146(5): S-68

Barlass, U.; Garg, S.K.; Yuan, Z.; Dixit, A.K.; Roy, S.; Saluja, A.; Dawra, R. 2014: Increased Severity of Acute Pancreatitis Due to Morphine Treatment Is Mediated Through Mu Opioid Receptors. Gastroenterology 146(5): S-68

Nia, K.V.; Chattopadhyay, M.; Metkar, S.; Kodela, R.; Kvint, S.; Kashfi, K. 2014: Targeting Nf-B, FoxM1, and p53 in Pancreatic Cancer With Nosh-Aspirin. Gastroenterology 146(5): S-68-S-69

Edderkaoui, M.; Grippo, P.; Xu, S.; Swartwood, S.J.; Knudsen, B.; Pinkerton, K.E.; Pandol, S. 2014: Hdac-1 Inhibition Prevents Smoking Induced PanIn Lesions and Emt in Kras Mouse Model of Pancreatic Cancer. Gastroenterology 146(5): S-69

Zhang, Y.; Wu, S.; Lu, R.; Zhou, Z.; Petrof, E.O.; Claud, E.C.; Sun, J. 2014: Tight Junction Protein Claudin-2 Is a Direct Target of Vitamin D Receptor Signaling in Intestinal Epithelium. Gastroenterology 146(5): S-69

Yu, T.; Gu, B.-L.; Yan, J.-K.; Yan, W.-H.; Cai, W. 2014: Cugbp1 and HuR Regulate E-Cadherin Translation by Altering Recruitment of E-Cadherin mRna to Processing Bodies During Total Parenteral Nutrition. Gastroenterology 146(5): S-69

Xiao, L.; Jaladanki, R.N.; Gorospe, M.; Wang, J.-Y. 2014: LncRna Spry4-it1 Modulates Tight Junction Expression and Epithelial Barrier Function Through Interaction With the Rna-Binding Protein HuR. Gastroenterology 146(5): S-69

Liu, L.; Zhuang, R.; Jaladanki, R.N.; Xiao, L.; Zou, T.; Chung, H.K.; Kontoyiannis, D.; Wang, J.-Y. 2014: Deletion of Rna-Binding Protein HuR in Intestinal Epithelial Cells Delays Mucosal Repair After Ischemia/Reperfusion-Induced Injury. Gastroenterology 146(5): S-70

Akhtar, S.; Bu, H.-F.; Wang, X.; Liu, F.; Geng, H.; Tan, X.-D. 2014: Lipopolysaccharide Inhibits T-Cell Activation-Induced Intestinal Epithelial Cell Proliferation and Migration In Vivo: Role of MicroRna-21. Gastroenterology 146(5): S-70

Blanc, V.; Klos, C.L.; Giammanco, A.; Montenegro, G.; Xie, Y.; Kennedy, S.; Luo, J.; Chang, S.; Nalbantoglu, I.; Hla, T.; Dharmarajan, S.; Davidson, N. 2014: Conditional Intestine-Specific HuR Deletion (HuR-Iko) Modulates Distinct Wnt-Dependent and Independent Pathways of Proliferation and Apoptosis With No Effect on Ileal Asbt Expression or Bile Acid Metabolism. Gastroenterology 146(5): S-70

Naylor, K.B.; Fritz, C.D.; Kim, K.E. 2014: Comparing Screening Colonoscopy Quality Measures in Navigated Uninsured and Insured Patient Populations. Gastroenterology 146(5): S-70

Meester, R.G.; Lansdorp-Vogelaar, I.; Corley, D.A.; Doubeni, C.A.; Jensen, C.D.; Levin, T.R.; Quinn, V.P.; Schottinger, J.E.; Zauber, A.G.; Van Ballegooijen, M. 2014: Consequences of Delayed Diagnostic Colonoscopy Following a Positive Fecal Immunochemical Test. Gastroenterology 146(5): S-70-S-71

Doubeni, C.A.; Pietrofesa, R.; Jensen, C.D.; Ghai, N.R.; Quinn, V.P.; Bledsoe, K.; Lee, A.T.; Zhao, W.; Van Ballegooijen, M.; Zauber, A.G.; Schottinger, J.E.; Corley, D.A.; Levin, T.R. 2014: The Effect of Ambient Temperature on the Performance of Mailed Fecal Immunochemical Tests for Population-Based Screening. Gastroenterology 146(5): S-71

Torabi, M.; Green, C.; Nugent, Z.; Mahmud, S.; Demers, A.; Griffith, J.; Singh, H. 2014: Geographical Variation and Factors Associated With Colorectal Cancer Mortality in a Universal Health Care System. Gastroenterology 146(5): S-71-S-72

Lewis, A.D.; Tracy, H.; You, D. 2014: Race and Colorectal Cancer Stage in an Equal Access Medical System. Gastroenterology 146(5): S-72

Phillips, F.; Andreye, J. 2014: Bile Acid Malabsorption is a Very Common Cause of Diarrhoea Secondary to Different Cancer Therapies for a Whole Range of Different Cancer Types. Gastroenterology 146(5): S-72

Ferrier, L.; Benoit, B.; Sekkal, S.; Bessette, C.; Estienne, M.; Léonil, J.; Theodorou, V.; Plaisancié, P. 2014: Protective Effects of Beta-Cn(94-123), a Bioactive Peptide Present in Fermented Milk, in Inflammation and Stress-Related Gastrointestinal Disorders. Gastroenterology 146(5): S-72

Bisschops, R.; DeRuyter, V.; Demolin, G.; Baert, D.; Moreels, T.G.; Pattyn, P.; Verhelst, H.; Lepoutre, L.; Arts, J.; Ooghe, P.; Caenepeel, P.; Maisonobe, P.; Tac, J.F. 2014: Lanreotide Autogel 120 mg As a Treatment for Chronic Idiopathic Refractory Diarrhea: A Multicenter Prospective Trial. Gastroenterology 146(5): S-72

Miyoshi, J.; Miyamoto, H.; Matsumoto, S.; Fujino, Y.; Tanaka, K.; Nakamura, F.; Kagawa, M.; Goji, T.; Kitamura, S.; Muguruma, N.; Okahisa, T.; Takayama, T. 2014: Diamine Oxidase Activity As a Serum Biomarker for Intestinal Mucosal Damage, Appearance of Diarrhea and Malnutrition Due to Anticancer Drugs. Gastroenterology 146(5): S-72-S-73

Shen, L.; Lingaraju, A.; Wang, Y.; Edelblum, K.L.; Khramtsova, G.F.; Turner, J.R. 2014: Occludin Limits Epithelial Survival by Inducing Caspase-3 Expression. Gastroenterology 146(5): S-73

Lee, C.S.; Murphy, D.; Nolan, B.; McMahon, C.; Cullen, G.; Mulcahy, H.; Fennelly, D.; Doherty, G.; Ryan, E.J. 2014: Chemotherapy Induced Diarrhea in Colorectal Cancer: A Retrospective Analysis of Clinico-Pathological and Radiological Features. Gastroenterology 146(5): S-73

Modlin, I.; Kidd, M.; Drozdov, I.; Alaimo, D.; Callahan, S.P.; Teixeira, N.S.; Aslanian, H.R.; Bodei, L. 2014: A Multi-Transcript Blood Signature Outperforms Chromogranin a for Detecting Gut Neuroendocrine Tumors. Gastroenterology 146(5): S-73

Bodei, L.; Kidd, M.; Grana, C.M.; Drozdov, I.; Modlin, I.; Pagnelli, G. 2014: Factors Influencing the Development of Toxicity After Peptide Radio-Receptor Therapy for Nets: an Evaluation of 807 Patients. Gastroenterology 146(5): S-73

Kim, M.K.; Warner, R.R.; Ward, S.C.; Harpaz, N.; Roayaie, S.; Itzkowitz, S.H.; Wisnivesky, J. 2014: Prognostic Significance of the Extent of Lymph Node Metastases in Small Intestinal Neuroendocrine Tumors. Gastroenterology 146(5): S-74

Cros, J.; Hentic-Dhomé, O.; Rebours, V.; Zappa, M.; Maire, F.; Hammel, P.; Levy, P.; Ruszniewski, P.; Couvelard, A. 2014: O6-Methylguanine Dna Methyltransferase (Mgmt) Expression and Ki67 Index Predict Response to Temozolomide in Patients With Well Differentiated Pancreatic Neuroendocrine Tumors (Wdpnet). Gastroenterology 146(5): S-74

Riff, B.P.; Leiman, D.A.; Fraker, D.L.; Bennett, B.J.; Metz, D.C. 2014: Weight Gain After Acid Control in Zollinger Ellison Syndrome. Gastroenterology 146(5): S-74

Riff, B.P.; Yang, Y.-X.; Soulen, M.C.; Pryma, D.A.; Bennett, B.J.; Wild, D.; Nicolas, G.; Teitelbaum, U.R.; Metz, D.C. 2014: Prrt Induced Hepatotoxicity in Metastatic Gep-Net Patients With Liver Metastases. Gastroenterology 146(5): S-74

Nordstrom, C.; Karsan, S.S.; Reid, M.W.; Spiegel, B.M. 2014: Fulfillment of Quality Indicators (Qis) Predicts Length of Stay (Los) in Patients With Acute Gastrointestinal Bleeding (Gib). Gastroenterology 146(5): S-75

Atia, M.A.; Cheng, M.-R.; Koepke, L.; Traub, N.A.; Chang, Y.-H.; Abraham, N.S. 2014: Improving Gastrointestinal Bleeding Risk Prediction among Patients Prescribed Complex Antithrombotic Therapy. Gastroenterology 146(5): S-75-S-76

Laursen, S.B.; Dalton, H.R.; Murray, I.A.; Michell, N.; Johnston, M.R.; Schultz, M.; Hansen, J.M.; de Muckadell, O.B.S.; Blatchford, O.; Stanley, A.J. 2014: International Multicentre Study of Optimal Use of the Glasgow Blatchford Score in Identifying Low-Risk Patients With Upper Gastrointestinal Bleeding Suitable for out-Patient Management. Gastroenterology 146(5): S-76

Taha, A.S.; McCloskey, C.; Craigen, T.; Angerson, W.J. 2014: Antithrombotic Drugs and Non-Variceal Bleeding Outcomes and Risk Scoring Systems -Comparison of Blatchford, Rockall, and Charlson Scores. Gastroenterology 146(5): S-76

Vasant, D.H.; Mistry, S.; Michou, E.; Jayasekeran, V.; Hamdy, S. 2014: Modulation of Human Swallowing Motor Pathways Induced by Mri-Guided Cerebellar Repetitive Transcranial Magnetic Stimulation (rTms) Is Frequency and Duration Specific. Gastroenterology 146(5): S-76

Jiao, H.; Mei, L.; Babaei, A.; Sharma, T.; Sanvanson, P.; Kern, M.; Jadcherla, S.R.; Shaker, R. 2014: A Human Model of Restricted Ues Opening and Its Characteristic Pharyngeal and Ues Deglutitive Pressure Phenomena. Gastroenterology 146(5): S-77

Vasant, D.H.; Michou, E.; Tyrrell, P.; Mistry, S.; Jayasekeran, V.; Hamdy, S. 2014: Pharyngeal Electrical Stimulation (Pes) Expedites Swallowing Recovery in Dysphagia Post-Acute Stroke: a Phase Ii Double-Blinded Randomised Controlled Trial. Gastroenterology 146(5): S-77

Hasenstab, K.; Gao, X.; Jadcherla, S. 2014: Maturation and Stimulus-Volumes Modulate Pharyngeal Provocation Induced Pharyngeal Rhythms in Human Premature Infants. Gastroenterology 146(5): S-77-S-78

Sharma, T.; Mei, L.; Jiao, H.; Shaker, R. 2014: Nadir Ues Relaxation and Hypopharyngeal Intra Bolus Pressures Are More Sensitive to Consistency and Viscosity Challenge Than Pharyngeal Peristalsis Parameters Measured by High Resolution Manometry. Gastroenterology 146(5): S-78

de Lima, A.; Zelinkova, Z.; van der Ent, C.; van der Woude, C.J. 2014: Anti-Tnf is Safe to Stop in the Second Trimester of Pregnancy in Ibd Women in Remission. Gastroenterology 146(5): S-78

Poullenot, F.; Seksik, P.; Beaugerie, L.; Amiot, A.; Nachury, M.; Abitbol, V.; Stefanescu, C.; Reenaers, C.; Fumery, M.; Pelletier, A.-L.; Nancey, S.; Peyrin-Biroulet, L.; Bourreille, A.; Hebuterne, X.; Brixi, H. 2014: Risk of Incident Cancer in Patients With Inflammatory Bowel Disease Starting Anti-Tnf Therapy While Having Prior Malignancy Within Past 5 Years. Gastroenterology 146(5): S-78

Felice, C.; Pugliese, D.; Guidi, L.; Marzo, M.; Andrisani, G.; DeVitis, I.; Rapaccini, G.L.; Papa, A.; Armuzzi, A. 2014: Retreatment With Infliximab in Inflammatory Bowel Disease: Tolerability and Effectiveness of Different Re-Induction Regimens. Gastroenterology 146(5): S-78-S-79

Kariyawasam, V.C.; Ward, M.G.; Blaker, P.A.; Anderson, S.H.; Sanderson, J.D.; Irving, P.M. 2014: Azathioprine Decreases the Risk of Adalimumab Primary Non-Response and Secondary Loss of Response but Only if Adequately Dosed. Gastroenterology 146(5): S-79

Shah, S.; Pabby, V.; Dodge, L.E.; Moragianni, V.A.; Fox, J.H.; Missmer, S.A.; Ibrahim, Y.; Penzias, A.S.; Burakoff, R.; Friedman, S.; Cheifet, A.S. 2014: In-Vitro Fertilization in Women With Inflammatory Bowel Disease is as Successful as in Women From the General Infertility Population. Gastroenterology 146(5): S-79-S-80

Hiroko, M.; Watanabe, K.; Morimoto, K.; Nagami, Y.; Sugimori, S.; Miyazaki, T.; Kamata, N.; Sogawa, M.; Yamagami, H.; Tanigawa, T.; Shiba, M.; Tominaga, K.; Watanabe, T.; Fujiwara, Y.; Arakawa, T. 2014: Booster Doses of the Trivalent Influenza Vaccine Do Not Elicit a Significant Immune Response in Patients With Inflammatory Bowel Disease: A Prospective Randomized Controlled Trial. Gastroenterology 146(5): S-80

Demitrack, E.; Gifford, G.B.; Samuelson, L.C. 2014: Notch Regulates Gastric Antral Lgr5+ Stem Cells to Control Epithelial Cell Homeostasis. Gastroenterology 146(5): S-80

Khramtsova, E.A.; Liang, G.; Weber, C.R.; Tamura, A.; Shen, L.; Tsukita, S.; Turner, J.R. 2014: Casein Kinase 2 (Ck2) Inhibition Limits Damage-Induced and Immune-Mediated Colitis by Distinct Mechanisms. Gastroenterology 146(5): S-80

Goettel, J.A.; Biswas, S.; Lexmond, W.S.; Sun, J.; Ouahed, J.; McCann, K.; Shouval, D.S.; Milford, E.; Fiebiger, E.; Muise, A.; Marasco, W.A.; Pai, S.-Y.; Norarangelo, L.D.; Snapper, S.B. 2014: Human Hematopoietic Stem Cells With a Defined Immunodeficiency and Enteropathy Transfer Clinical Phenotype to a Novel Humanized Mouse Strain. Gastroenterology 146(5): S-81

Ikezawa, K.; Shigekawa, M.; Hikita, H.; Iwahashi, K.; Shimizu, S.; Takatoshi, N.; Sakamori, R.; Miyagi, T.; Tatsumi, T.; Takehara, T. 2014: The Significance of Bcl-Xl in the Development of KrasG12D-Driven Pancreatic Neoplasia. Gastroenterology 146(5): S-81

Goretsky, T.; Bradford, E.; Ryu, H.; Barrett, T.A. 2014: Pi3K/14-3-3 Cytosol Activating Complex of -Catenin in Intestinal Epithelial Cells. Gastroenterology 146(5): S-81

Tulachan, S.S.; El-Gohary, Y.; Gittes, G.K. 2014: Pancreatic Duct-to--Cell Transdifferentiation Represents the Most Likely Source of New Beta Cells During Post-Natal Growth and Regeneration. Gastroenterology 146(5): S-81-S-82

Watanabe, M.; Yoshimura, N.; Motoya, S.; Tominaga, K.; Iwakiri, R.; Watanabe, K.; Hibi, T. 2014: Ajm300, an Oral 4 Integrin Antagonist, for Active Ulcerative Colitis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2A Study. Gastroenterology 146(5): S-82

Piacentino, D.; Rossi, S.; Alvino, V.; Cantarini, R.; Badiali, D.; Pallotta, N.; Corazziari, E. 2014: Effects of Low-Fodmap and Gluten-Free Diets in Irritable Bowel Syndrome Patients. A Double-Blind Randomized Controlled Clinical Study. Gastroenterology 146(5): S-82

Labus, J.S.; Mayer, E.A.; Derrien, M.; Van Hylckama Vlieg, J.E.; LeNevé, B.; Guyonnet, D.; Brazeilles, R.; Van Horn, J.D.; Torgerson, C.; Ashe-McNalley, C.; Tillisch, K. 2014: Human Gut Microbial Clusters Correlate with Anatomical Brain Signatures: A Pilot Study. Gastroenterology 146(5): S-82

Allam, S.; Krueger, D.; Kelber, O.; Demir, I.E.; Ceyhan, G.O.; Zeller, F.; Schemann, M. 2014: Effects of the Herbal Drug Stw 5 and Its Individual Components on Human Intestinal Motility. Gastroenterology 146(5): S-82-S-83

Rekdal, V.M.; Alnahhas, M.F.; Rainey, J.F.; Reigstad, C.S.; Khanna, S.; Grover, M.; Devine, M.D.F.; Chia, N.; Loftus, E.V.; Boardman, L.A.; Ahlquist, D.A.; Pardi, D.S.; Farrugia, G.; Kashyap, P.C. 2014: Chronic Diarrhea in Subset of Patients With Ibd and Ibs is Associated With Altered Microbiota. Gastroenterology 146(5): S-83

Guarino, M.P.L.; Barbara, G.; Altomare, A.; Barbaro, M.R.; Cocca, S.; Scirocco, A.; Cremon, C.; Stanghellini, V.; Cicala, M.; Severi, C. 2014: Impairment of Human Colonic Smooth Muscle Contractility Following Exposure to Mucosal Biopsy Supernatants Obtained From Irritable Bowel Syndrome Patients. Gastroenterology 146(5): S-83

Lashermes, A.; Gelot, A.; Barnich, N.; Darfeuille-Michaud, A.; Eschalier, A.; Ardid, D.; Carvalho, F.A. 2014: Crohn's Disease Associated Adherent-Invasive Escherichia coli Intestinal Infection Induces Low-Grade Inflammation and Enhances Spontaneous Visceral Hypersensitivity. Gastroenterology 146(5): S-83

Garg, S.; Song, Y.; Han, M.A.T.; Girotra, M.; Fricke, W.F.; Dutta, S. 2014: Post-Infectious Irritable Bowel Syndrome in Patients Undergoing Fecal Microbiota Transplantation for Recurrent Clostridium difficile Colitis. Gastroenterology 146(5): S-83-S-84

Gilroy, M.; Kalani, A.; Del Pozo, J.; Lawson, M.J. 2014: Non-Gi Related Healthcare Utilization of Adolescents With Irritable Bowel Syndrome: The Effect of a Behavioral Intervention. Gastroenterology 146(5): S-84

Smith, N.R.; Levin, T.G.; Erickson, C.J.; Bubbers, E.J.; Abe, J.; Wong, M.H. 2014: The Cancer Stem cell Marker Cd166/Alcam Regulates Signaling Pathways that Govern Intestinal Epithelial cell Growth. Gastroenterology 146(5): S-84

Patel, N.J.; Karuturi, R.; Al-Horani, R.A.; Baranwal, S.; Patel, J.; Desai, U.R.; Patel, B.B. 2014: Synthetic, Non-Saccharide Glycosaminoglycan Mimetics Selectively Target Colon Cancer Stem cells. Gastroenterology 146(5): S-84-S-85

Sakamori, R.; Yu, S.; Sun, J.; Zhang, X.; Gao, N. 2014: Colorectal Cancer Cells Exploit the Pleiotropic Functions of Cell Division Cycle 42 for Immediate Pro-Survival Niche Construction. Gastroenterology 146(5): S-85

Yu, Y.; Nagia-Makker, P.; Rajendra, S.; Levi, E.; Majumdar, A.P. 2014: MicoRna's in Regulation of Colon Cancer Stem Cells. Gastroenterology 146(5): S-85

Rothenberg, M.E.; Cintra, T.; Chen, E.C.; Kalisky, T.; Sahoo, D.; Mobley, B.; Quake, S.; Clarke, M.F. 2014: Loss of Gpsm2 Disrupts Stem Cell Dynamics and Mitotic Spindle Orientation in Normal Colon and Colon Cancer. Gastroenterology 146(5): S-85-S-86

Davis, H.L.; Irshad, S.; Rafferty, H.; Boitsova, T.; Jeffery, R.; Richard, P.; Bansal, M.; Wang, L.M.; Rodriguez-Justo, M.; Novelli, M.; Silver, A.; East, J.E.; Tomlinson, I.; Leedham, S. 2014: Aberrant Epithelial Grem1 Expression Promotes Stem-Cell Plasticity and Ectopic Crypt Formation in the Pathogenesis of Familial and Sporadic Human Polyps. Gastroenterology 146(5): S-86

Zhao, P.; Barlow, N.; Lieu, T.; Metcalf, M.; Veldhuis, N.; Jensen, D.D.; Kocan, M.; Sostegni, S.; Haerteis, S.; Lindstrom, E.; Korbmacher, C.; Bunnett, N.W. 2014: Cathepsin S Induces Inflammation and Pain via Biased Agonism of Par2 and Trpv4. Gastroenterology 146(5): S-86

Poole, D.P.; Rajasekhar, P.; Canals, M.; Lieu, T.; Bunnett, N.W.; Halls, M. 2014: Compartmentalized Delta Opioid Receptor Signaling in Sensory Neurons. Gastroenterology 146(5): S-86

Ni, Y.; Sinnett-Smith, J.; Young, S.H.; Soares, H.P.; Rozengurt, E. 2014: Protein Kinase D1 (Pkd1) Regulates the Accumulation of the Second Messenger Phosphatidylinositol (3,4,5)-Trisphosphate in Intestinal Epithelial Cells. Gastroenterology 146(5): S-86

Martini, E.; Wittkopf, N.; Günther, C.; Okada, H.; Neurath, M.F.; Becker, C. 2014: Survivin Deletion Drives Mitotic Catastrophe in Intestinal Epithelial Cells. Gastroenterology 146(5): S-86-S-87

Song, J.; Li, J.; Weiss, H.L.; Gao, T.; Townsend, C.M.; Evers, B.M. 2014: Ampk Positively Regulates Neurotensin Secretion Through Inhibition of mTorc1 Signaling. Gastroenterology 146(5): S-87

Choe, J.W.; Lee, B.J.; Joo, M.K.; Kim, H.jung; Park, J.-J.; Kim, J.S.; Bak, Y.-T.; Yang, D.S. 2014: Intestinal Epithelial Deletion of Sphingosine Kinase 1 Suppresses Crypt Regeneration Following Radiation Injury. Gastroenterology 146(5): S-87

Olszak, T.; Neves, J.F.; Dowds, M.C.; Baker, K.; Glickman, J.; Davidson, N.; Jobin, C.; Brand, S.; Muller, W.; Wada, K.; Katayama, K.; Nakajima, A.; Mizuguchi, H.; Kawasaki, K.; Nagata, K. 2014: A Self-Reinforcing Pathway of Protective Mucosal Immunity Mediated by Epithelial Cd1d. Gastroenterology 146(5): S-87

Berger, E.; Yuan, D.; Waldschmitt, N.; Rath, E.; Allgäuer, M.; Staszewski, O.; Boekschoten, M.V.; Müller, M.; Prinz, M.; Weber, A.; Gerhard, M.; Janssen, K.-P.; Heikenwälder, M.; Haller, D. 2014: Mitochondrial Unfolded Protein Responses Control Epithelial Stem Cell Proliferation in the Intestine. Gastroenterology 146(5): S-87

Bhatnagar, N.; Walter, L.; Laroui, H.; Garg, P. 2014: Epithelial Derived Mmp9 Exhibits Tumor Suppressive Role in Colitis Associated Cancer. Gastroenterology 146(5): S-87-S-88

Darby, T.; Smith, E.; Quinlan, A.; Hurley, G.; Clarke, D.; Shanahan, F.; Nally, K.; Melgar, S. 2014: The Colonic Adherent-Invasive Escherichia coli Strain Hm605 Induces Anti-Apoptotic Responses in Intestinal Epithelial Cells, Reduces Barrier Integrity and Worsens Experimental Colitis. Gastroenterology 146(5): S-88

Krug, S.M.; Bojarski, C.; Dames, P.; Turner, J.R.; Fromm, M.; Schulzke, J.D. 2014: Impaired Epithelial Barrier for Macromolecules in Ulcerative Colitis Is Caused by Downregulation of the Tricellular Tight Junction Protein Tricellulin, Mediated by the Interleukin-13 Receptor 2-Activated Pathway. Gastroenterology 146(5): S-88

Johnson, L.A.; Rodansky, E.; Huang, S.; Spence, J.R.; Higgins, P.D. 2014: Intestinal Organoids: A Model of Intestinal Fibrosis. Gastroenterology 146(5): S-88

Hupa, K.J.; Stoffels, B.; Lysson, M.; Kalff, J.C.; de Jonge, W.; Wehner, S. 2014: A BiPhasic Il-1 Response Mediates Postoperative Ileus via Enteric Glia Activation. Gastroenterology 146(5): S-88

Chen, F.; Yu, Y.; Wang, P.; Dong, Y.; Wang, T.; Zuo, X.; Li, Y. 2014: Brain-Derived Neurotrophic Factor Accelerates Gut Motility in Slow-Transit Constipation. Gastroenterology 146(5): S-89

Wang, G.-D.; Wang, X.; Qu, M.-H.; Xia, Y.; Wood, J.D. 2014: Reversal of Opioid-Induced Constipation by Lubiprostone (Amitiza) in Guinea Pig Ileum. Gastroenterology 146(5): S-89

Spohn, S.N.; Lavoie, B.; MacEachern, S.; Roberts, J.A.; Wilcox, R.; Sharkey, K.A.; Mawe, G.M. 2014: Intraluminal 5-Ht4 Agonist Treatment Improves Dss Colitis in Mice. Gastroenterology 146(5): S-89

Gomez-Pinilla, P.J.; DiGiovangiulio, M.; Nemethova, A.; Stakenborg, N.; Farro, G.; Bosmans, G.; Matteoli, G.; Boeckxstaens, G.E. 2014: Prucalopride Activates the Intestinal Cholinergic Anti-Inflammatory Pathway and Prevents Postoperative Ileus. Gastroenterology 146(5): S-89

Fornai, M.; Pellegrini, C.; Colucci, R.; Antonioli, L.; Sacco, D.; Tirotta, E.; Levandis, G.; Cerri, S.; Blandini, F.; Blandizzi, C. 2014: Effects of L-Dopa/Benserazide Co-Treatment on the Patterns of Colonic Neuromuscular Excitatory Cholinergic and Tachykininergic Pathways in the Presence of Experimental Parkinson's Disease. Gastroenterology 146(5): S-90

Toti, L.; Holmes, G.M.; Alberto, R. 2014: Dietary Lectins As the Environmental Unknown Pathogen in Parkinson's Disease. Gastroenterology 146(5): S-90

Yuan, P.-Q.; Karasawa, H.; Tache, Y. 2014: Abdominal Surgery Induced Gastric Ileus and Activation of M1 Macrophages in the Gastric Myenteric Plexus: Prevention by Central Vagal Activation in Rats. Gastroenterology 146(5): S-90

Tominaga, K.; Fujikawa, Y.; Tanaka, F.; Yamagami, H.; Tanigawa, T.; Shiba, M.; Watanabe, K.; Watanabe, T.; Fujiwara, Y.; Arakawa, T. 2014: Are Morphological Changes Caused by Acute and Chronic Stresses in Enteric Glial Cells of the Colon Reversible or Irreversible Throughout Aging in Rats?. Gastroenterology 146(5): S-90

Rajasekaran, M.R.; Bhargava, V.; Salehi, M.; Sinha, S.; Mittal, R.K. 2014: Role of Wnt- Catenin Signaling in Anal Sphincter Injury & Repair. Gastroenterology 146(5): S-91

Lin, Y.M.; Li, F.; Choudhury, B.; Winston, J.H.; Sarna, S.K.; Shi, X.-Z.P. 2014: Effects of Mechanical Stress on Myenteric Neurons in the Colon. Gastroenterology 146(5): S-91

Syed, S.A.; Lee, J.H.; Yan, H.; Zhang, Z.; Hayashi, Y.; Ordog, T. 2014: Genome-Wide Epigenetic Determinants of Interstitial Cell of Cajal (Icc) Dysfunction. Gastroenterology 146(5): S-91

Brun, P.; Caputi, V.; Spagnol, L.; Schirato, G.; Petrelli, L.; Porzionato, A.; Galeazzi, F.; Sturniolo, G.C.; Castagliuolo, I.; Giron, M.C. 2014: Tlr9 Signaling Tunes Innate Immunity and Neuromuscular Function in Murine Small Intestine. Gastroenterology 146(5): S-91

Zaidi, S.F.; Tomoe, Y.; Lee, J.; Kim, J.-H.; Kadowaki, M. 2014: Activation of Murine Isolated Enteric Neurons by IgE-Antigen and Mediators Released From Mucosal Type Bone Marrow-Derived Mast Cells. Gastroenterology 146(5): S-92

Liu, Z.; Xi, J.; Tse, M.; Myers, A.C.; Li, X.; Pasricha, P.J.; Yu, S. 2014: Allergic Inflammation-Induced Structural and Functional Changes in Esophageal Epithelium in a Guinea Pig Model of Eosinophilic Esophagitis. Gastroenterology 146(5): S-92

Merves, J.; Chandramouleeswaran, P.M.; Benitez, A.J.; Muir, A.; Lee, A.J.; Lim, D.; Mehta, I.; Wang, M.-L. 2014: Altered Histamine Receptor Expression in the Esophageal Epithelium During Eosinophilic Esophagitis (EoE): Implications on Disease Pathogenesis. Gastroenterology 146(5): S-92

Mishra, A. 2014: Invariant Natural Killer T-cells Neutralization Is a Possible Target Therapy for Human Eosinophilic Esophagitis. Gastroenterology 146(5): S-92

Muir, A.; Dods, K.K.; Benitez, A.J.; Noah, Y.; Toltzis, S.; DeMarshall, M.; Falk, G.W.; Wang, M.-L. 2014: Maturational Changes in Esophageal Fibroblasts: Implications Upon the Natural History and Treatment of Eosinophilic Esophagitis. Gastroenterology 146(5): S-92-S-93

Park, J.Y.; Zhang, X.; Nguyen, N.; Souza, R.F.; Spechler, S.J.; Cheng, E. 2014: Different Effects of Proton Pump Inhibitors (Ppis) on Eotaxin-3 Protein Expression by the Proximal and Distal Esophagus of Children With Esophageal Eosinophilia. Gastroenterology 146(5): S-93

LaFond, J.; Perkins, M.; Intagliata, N.M.; Northup, P.G. 2014: Serum-Ascites Albumin Gradient and Ascites Total Protein Levels Are Not Good Predictors of Ascites Due to Portal Hypertension After Liver Transplantation. Gastroenterology 146(5): S-93

Confer, B.; Theethira, T.G.; Dugum, M.; Hanouneh, I.A.; Esfeh, J.M.; Lopez, R.; Zein, N.N. 2014: Rifaximin in Addition to Standard Medical Therapy Significantly Reduces the Time to First Esophageal Variceal Bleed. Gastroenterology 146(5): S-93-S-94

Bouwense, S.A.; Van Brunschot, S.; Van Santvoort, H.C.; Besselink, M.; Bollen, T.L.; Bakker, O.J.; Banks, P.A.; Boermeester, M.A.; Cappendijk, V.C.; Carter, R.; Charnley, R.; Van Eijck, C.H.; Dijkgraaf, M.G.; Freeny, P.C.; Hermans, J.J. 2014: Describing Peripancreatic Collections According to the 2013 Revised Atlanta Classification of Acute Pancreatitis: An International Interobserver Agreement Study Using the Pancode System. Gastroenterology 146(5): S-94

Chaudhary, V.; Sharma, R.; Rana, S.S.; Sharma, V.; Dutta, U.; Bhasin, D.K. 2014: Impact of Nasojejunal Feeding on Outcome of Patients With Walled off Pancreatic Necrosis (Wopn) Presenting With Pain: A Pilot Study. Gastroenterology 146(5): S-94

de-Madaria, E.; Faghih, M.; Rey-Riveiro, M.; Afghani, E.; Acevedo-Piedra, N.G.; Sinha, A.; Quesada-Vázquez, N.; Marin, C.S.; Lluís, F.; Zapater, P.; Singh, V.K. 2014: A Multicenter Study of Early Administration of Intravenous Fluid Bolus and Outcome in Acute Pancreatitis. Gastroenterology 146(5): S-94-S-95

Sharma, V.; Sharma, R.; Rana, S.S.; Chaudhary, V.; Bhasin, D.K. 2014: Impact of Vitamin D Supplementation on the Course, Severity, Complications and Outcome of Patients of Acute Pancreatitis With Vitamin D Deficiency. Gastroenterology 146(5): S-95

Bertilsson, S.; Kalaitzakis, E. 2014: Use of Pancreatitis-Associated Drugs Is Very Common in Patients With Acute Pancreatitis but Is Not Related to Pancreatitis Etiology, Severity or Recurrence: A 10-Year Population-Based Cohort Study. Gastroenterology 146(5): S-95

Bishu, S.; Pollock, N.; Stello, K.; Koutroumpakis, E.; Whitcomb, D.C.; Papachristou, G.I. 2014: The 251 A/A Interleukin-8 Genotype Confers Susceptibility to Acute Pancreatitis. Gastroenterology 146(5): S-95-S-96

Redman, J.E.; Newton, R.; Malhotra, S.; Dawsey, S.M.; Wernisch, L.; Lao-Sirieix, P.; Fitzgerald, R. 2014: Biomarkers for Early Detection of Esophageal Squamous Cell Dysplasia and Carcinoma. Gastroenterology 146(5): S-96

Link, A.; Schirrmeister, W.; Langner, C.; Varbanova, M.; Bornschein, J.; Wex, T.; Malfertheiner, P. 2014: Gastric Cancer-Associated Micro Rnas are Differentially Expressed in Preneoplastic Gastric Mucosa. Gastroenterology 146(5): S-96

Shan, W.; Johnson, C.E.; Bierman-Harrar, Y.; Oelschlager, K.; Cook, R.W.; Rosen, D.G.; Badve, S.S.; Kessler, H.P.; Saxena, R. 2014: A Proprietary Immunohistochemistry (Ihc)-Based Test That Accurately Predicts Extreme Resistance to Fluorouracil (5Fu)-Based Neoadjuvant Chemoradiation (Neoctrt) Therapy in Patients of Esophageal Adenocarcinoma (Eac). Gastroenterology 146(5): S-96

Phipps, S.; Behan, F.; Garry, C.; Duggan, S.P.; Kelleher, D. 2014: Screening the Invasive Potential of Oesophageal Cancer Using siRna Library Knockdown and High Content Analysis. Gastroenterology 146(5): S-96-S-97

Van Baal, J.W.; Bus, P.; Kestens, C.; Ten Kate, F.T.; Peters, W.H.; Drenth, J.P.; Roodhart, J.; Voest, E.E.; Siersema, P.D. 2014: Comprehensive Profiling of Plasma Micro Rnas Reveals Potential Biomarkers for Barrett's Esophagus and Esophageal Adenocarcinoma. Gastroenterology 146(5): S-97

Chak, A.; Moinova, H.; Lutterbaugh, J.; Chandar, A.; Willis, J.; Markowitz, S. 2014: Aberrant Vimentin Methylation in Esophageal Brushings: A Biomarker for Detecting Barrett's Esophagus and Esophageal Adenocarcinoma. Gastroenterology 146(5): S-97

Nan, H.; Hutter, C.; Lin, Y.; Ulrich, C.M.; White, E.; Berndt, S.I.; Brenner, H.; Casey, G.; Chang-Claude, J.; Fuchs, C.; Giovannucci, E.; Newcomb, P.A.; Ogino, S.; Potter, J.D.; Slattery, M.L. 2014: Genome-Wide Gene-Environment Interaction Analysis of Aspirin and Non-Steroidal Anti-Inflammatory Drug Use and Colorectal Cancer Identifies Loci At Chromosomes 12p12.3 and 15q25.2. Gastroenterology 146(5): S-97

Pietrofesa, R.; Marks, A.R.; Jensen, C.D.; Lee, A.; Corley, D.A.; Doubeni, C.A. 2014: Use of Metformin and Risk of Recurrence of Colorectal Adenoma. Gastroenterology 146(5): S-97-S-98

Roy, H.K.; Turzhitsky, V.; Wali, R.K.; Radosevich, A.; Jovanovic, B.D.; DellaZanna, G.; Rubin, D.T.; Goldberg, M.J.; Bianchi, L.K.; DeLaCruz, M.; Rodriguez, L.M.; Chatterton, R.T.; Skripkauskas, S.; Poast, E.; Richmond, E. 2014: Correlation of Spectral Signatures With Rectal Prostaglandin E2 Levels As Biomarkers for Aspirin Chemoprevention of Colon Carcinogenesis: Results From a Placebo-Controlled Double Blinded Phase 2B Trial. Gastroenterology 146(5): S-98

Zhu, L.; Shi, J.; Jin, H.; Liu, A.B.; Yang, C.S.; Wang, T.C.; Tu, S. 2014: The Combination of Curcumin and Celecoxib Inhibits Gastric Inflammation and Neoplasia in Il- 1beta Transgenic Mice. Gastroenterology 146(5): S-98

DeLaCruz, M.; Momi, N.; Weinstein, J.; Wali, R.K.; Roy, H.K. 2014: The Anti-Proliferative Effects of Caffeine: A Novel Chemopreventive Agent for Hepatocellular Carcinoma (Hcc). Gastroenterology 146(5): S-98-S-99

Lichtenberger, L.M.; Phan, T.M.; Dial, E. 2014: Phosphatidylcholine Association Enhances the Chemopreventive Activity of Non-Steroidal Anti-Inflammatory Drugs. Gastroenterology 146(5): S-99

Parian, A.M.; Limketkai, B.N.; Ha, C.Y.; Montgomery, E.A.; Lazarev, M. 2014: Serrated Epithelial Change is Associated With a Longer Time to Dysplasia in Patients With Chronic Ulcerative Colitis. Gastroenterology 146(5): S-99

Fumery, M.; Buisson, A.; Amiot, A.; Hebuterne, X.; Nancey, S.; Abitbol, V.; Stefanescu, C.; LeMouel, J.-P.; Bressenot, A.; Bouhnik, Y.; Peyrin-Biroulet, L. 2014: Risk of Dysplasia and Cancer Complicating Colonic Strictures in Inflammatory Bowel Disease: A Getaid Study. Gastroenterology 146(5): S-99

Cole, E.B.; Abbas, A.; Yola, I.M.; Koleva, Y.N.; Khan, N. 2014: Association Between Adherence to Colorectal Cancer Surveillance Guidelines and Cancer Staging at Colectomy in Ulcerative Colitis Patients. Gastroenterology 146(5): S-100

Meckel, K.; Bissonnette, M.; Yen, E.F.; Kwon, J.H.; Rubin, D.T.; Hanauer, S.B.; Almoghrabi, A.; Cohen, R.D.; Hanan, I.M.; Sakuraba, A.; Li, Y.C.; Pekow, J. 2014: Correlation Between Serum Vitamin D With Tissue Vdr, Colonic Epithelial Junction Transcripts, and Mucosal Inflammation in a Prospective Ulcerative Colitis Cohort. Gastroenterology 146(5): S-100

Natalis, A.; Louis, E.; Van Kemseke, C.; Seidel, L.; Belaiche, J.; Catherine, R. 2014: Clinical Outcome of Perianal Crohn's Disease: Natural History and Impact of Medical and Surgical Strategies Over the Time. Gastroenterology 146(5): S-100

Cheddani, H.; Dauchet, L.; Charpentier, C.; Fumery, M.; Salleron, J.; Bouvier, A.-M.; Dupas, J.-L.; Vasseur, F.; Lerebours, E.; Laberenne, E.; Peyrin-Biroulet, L.; Colombel, J.-F.; Savoye, G.; Gower-Rousseau, C. 2014: Cancer in Elderly-Onset Inflammatory Bowel Disease: A Population-Based Study. Gastroenterology 146(5): S-101

Gulati, I.K.; Shubert, T.; Gao, X.; Jadcherla, S. 2014: Reactivity of Lower Esophageal Sphincter (Les) Upon Pharyngeal Provocation in Infants With Hypoxic Ischemic Encephalopathy (Hie). Gastroenterology 146(5): S-101

Wiklendt, L.; Costa, M.; Rommel, N.; Liesenborghs, C.; Tack, J.F.; Dinning, P.G.; Omari, T. 2014: The Use of Combine Pressure-Impedance Measurement to Define Neurally Mediated Contraction and Relaxation in the Human Oesophagus In Vivo. Gastroenterology 146(5): S-101

Lin, Z.; Kahrilas, P.J.; Lin, C.-Y.; Friesen, L.; Mogni, B.; Yim, B.H.; Pandolfino, J.E. 2014: Assessing the Esophagogastric Pressure Gradient (Egpg) Using Nadir Impedance Pressures During the 4 Phases of Bolus Transit. Gastroenterology 146(5): S-101-S-102

Okeke, F.C.; Raja, S.; Lynch, K.; Dhalla, S.; Nandwani, M.; Roland, B.C.; Stein, E.M.; Khashab, M.; Saxena, P.; Kumbhari, V.; Pasricha, P.J.; Clarke, J.O. 2014: What Is the Clinical Significance of Egj Outflow Obstruction? Evaluation of 60 Patients at a Tertiary Referral Center. Gastroenterology 146(5): S-102

Duraiswamy, S.; Mello, M.; Price, L.; Li, Y.; Patel, A.; Gyawali, C.P. 2014: Merged Smooth Muscle Contraction Segments on Esophageal High Resolution Manometry (Hrm) Suggest Esophageal Inhibitory Dysfunction. Gastroenterology 146(5): S-102-S-103

Rogers, M.; Lin, Z.; Lin, C.-Y.; Mogni, B.; Friesen, L.; Kahrilas, P.J.; Pandolfino, J.E. 2014: The Effect of Volumetric Distention on Esophageal Function: A Study in Asymptomatic Controls. Gastroenterology 146(5): S-103

Yang, J.-C.; Lin, C.-J.; Chen, J.-D.; Wang, H.-L.; Shun, C.-T.; Lu, C.-W.; Lin, B.-R.; Shieh, M.J.; Chang, M.-C.; Chang, Y.-T.; Wei, S.-C.; Lin, L.-C.; Yeh, W.-C.; Kuo, J.-S.; Tung, C.-C. 2014: Efficacy of Optimized High Dose Dual Therapy, Sequential Therapy and Triple Therapy in Helicobacter pylori EradicationA Prospective, Comparative, Randomized Control Study. Gastroenterology 146(5): S-103

Molina-Infante, J.; Lucendo, A.J.; Angueira, T.; Huerta, A.; Martin-Noguerol, E.; Rodriguez, B.J.G.ómez; Barrio, J.; Ariño, I.; Gomez-Camarero, J.; Aisa, A.P.; Modolell, I.; Botargues, J.M.; Herranz-Bachiller, M.; Lima, A.; Rodríguez-Sánchez, J. 2014: Optimized Triple and Concomitant Therapy for Helicobacter pylori Eradication: The Optricon Study. Gastroenterology 146(5): S-103-S-104

Furuta, T.; Sugimoto, M.; Yamade, M.; Uotani, T.; Sahara, S.; Ichikawa, H.; Kagami, T.; Iwaizumi, M.; Yamada, T.; Osawa, S.; Sugimoto, K. 2014: Personalized Therapy for H. pylori Infection Based on Automated Snp Analysis. Gastroenterology 146(5): S-104

Sugimoto, M.; Uotani, T.; Sahara, S.; Ichikawa, H.; Yamade, M.; Kagami, T.; Sugimoto, K.; Furuta, T. 2014: Efficacy of Tailored Helicobacter pylori Eradication Treatment Based on Clarithromycin Susceptibility and Maintenance of Acid Secretion for 24 H. Gastroenterology 146(5): S-104

Song, M.; Ang, T.L.; Fock, K.M. 2014: An Update: A Randomized Controlled Trial of Triple Therapy Versus Sequential Therapy Versus Concomitant Therapy As First Line Treatment for H. pylori Infection in Singapore. Gastroenterology 146(5): S-104-S-105

Wang, F.; Johnson, R.L.; DeWitt, M.; Snyder, P.W.; Fleet, J.C. 2014: Inducible, Colon-Specific Cre-Recombinase Expression in Cac Transgenic Mice With Dextran Sulfate Sodium (Dss)-Induced Colon Inflammation. Gastroenterology 146(5): S-105

Marchelletta, R.R.; Park, Y.S.; Bernts, L.; Myers, S.; Smith, T.; Krishnan, M.; Barrett, K.E.; McCole, D.F. 2014: In Vivo Ptpn2-Deficiency and a Dominant-Negative Ptpn2 Mutation Cause Increased Intestinal Permeability and Alter Tight Junction Composition. Gastroenterology 146(5): S-105

Chaudhry, K.K.; Mir, H.; Manda, B.; Gangwar, R.; Rao, R.(R.K.) 2014: L-Glutamine Attenuates Ethanol-Induced Disruption of Tight Junctions and Adherens Junctions in Mouse Colonic Epithelium and Ameliorates Gut Barrier Dysfunction and Liver Injury. Gastroenterology 146(5): S-105

Gao, J.; Zhang, G.; Zhou, H.; Wu, X.; Owyang, C. 2014: Downregulation miR-29 Is Responsible for Mucosal Inflammation in Chronically Stressed Rats: Mediation by Peripheral Action of Crf-Tgf Pathways. Gastroenterology 146(5): S-105

Rieder, F.; Doyon, G.; Ouyang, Z.; West, G.; Fiocchi, C. 2014: Adipocyte and Preadipocyte Derived-Mediators Induce a Pro-Fibrogenic Phenotype in Human Intestinal Mesenchymal Cells -A Novel Link Between Fat and Intestinal Fibrosis. Gastroenterology 146(5): S-106

Kasper, S.; Spalinger, M.R.; Leonardi, I.; Cee, A.; Atrott, K.; Frey-Wagner, I.; Fried, M.; Rogler, G.; Scharl, M. 2014: Mice With a Loss of Ptpn2 in the Colon Epithelium Show Increased Mucosal Inflammation After Acute Dss Treatment. Gastroenterology 146(5): S-106

Soayfane, Z.; Cantiello, M.; Robenek, H.; Nauze, M.; Bézirard, V.; Payre, B.; Allart, S.; Capilla, F.; Cartier, C.; Peres, C.; Saati, T.A.; Tercé, F.; Collet, X.; Coméra, C. 2014: Intestinal Membrane Transporters Follow the Trail of Fat Into Cytosolic Lipid Droplets During Digestion. Gastroenterology 146(5): S-106

Lim, D.W.; Wales, P.W.; Vine, D.F.; Borthwick, F.; Nation, P.N.; Wizzard, P.R.; Sigalet, D.L.; Bigam, D.L.; Turner, J. 2014: Exogenous Glucagon-Like Peptide 2 Therapy in a Piglet Model of Neonatal Short Bowel Syndrome Promotes Intestinal Adaptation. Gastroenterology 146(5): S-106

Brandt, C.F.; Tribler, S.; Moser, C.; Hvistendahl, M.; Staun, M.; Tjellesen, L.; Haderslev, K.V.; Holtug, K.; Mortensen, P.B.; Jeppesen, P.B. 2014: A Potential Association Between Remnant Bowel Anatomy and the Incidence of Catheter-Related Blood-Stream Infections (Crbsis) in Adult Intestinal Failure (If) Patients Depending in Home Parenteral Nutrition(Hpn). Gastroenterology 146(5): S-107

Smith, S.A.; Chau, L.; Sheng, M.; Chen, J.; Charrier-Hisamuddin, L.; Chen, Y.-Y.; Keilbaugh, S.A.; Bennett, M.J.; Wu, G.D. 2014: Colonic Butyrate Oxidation Is Inversely Related to Long Chain Fatty Acid Oxidation Where It Is Dispensable for Normal Epithelial Proliferation. Gastroenterology 146(5): S-107

Nguyen, N.Q.; Debreceni, T.L.; Bambrick, J.E.; Chia, B.; Wishart, J.M.; Deane, A.M.; Wittert, G.A.; Rayner, C.; Horowitz, M.; Young, R.L. 2014: Accelerated Glucose Absorption in Proximal Intestine and Its Relationship to Glucose Transporters, Incretin Hormones and Glycaemia in Morbidly Obese Humans: the X-Factor of the Foregut Theory?. Gastroenterology 146(5): S-108

McFarlane, M.R.; Engelking, L. 2014: Ezetimibe Modulates Endogenous Lxr Ligands to Regulate Intestinal Ldlr Receptors via Idol. Gastroenterology 146(5): S-108

Orand, A.C.; Shih, W.; Ju, T.; Presson, A.P.; Heendeniya, N.; Mayer, E.A.; Naliboff, B.D.; Chang, L. 2014: Catecholaminergic Genetic Polymorphisms Are Associated With Autonomic Nervous System (Ans) Function in Irritable Bowel Syndrome. Gastroenterology 146(5): S-108

Shiotani, A.; Kusunoki, H.; Manabe, N.; Nakato, R.; Ishii, M.; Tarumi, K.; Kamada, T.; Hata, J.; Haruma, K. 2014: Biomarkers for Predicting Effectiveness of Ramosetron in Ibs-D: Expression of S100a Protein and Polymorphisms of Tph-1and 5-Htt. Gastroenterology 146(5): S-108

Camilleri, M.; Shin, A.; Busciglio, I.A.; Acosta, A.; Bharucha, A.E.; Carlson, P.; Burton, D.D.; Ryks, M.; Rhoten, D.L.; Lamsam, J.; Lueke, A.J.; Donato, L.; Zinsmeister, A.R. 2014: GpBar1 Genotype Predicts Bowel Function and Pathophysiology in Diarrhea-Predominant Irritable Bowel Syndrome. Gastroenterology 146(5): S-109

Smith, S.B.; Maixner, W.; Palsson, O.S.; Van Tilburg, M.A.; Kanazawa, M.; Whitehead, W.E. 2014: Fkbp5 Gene is Associated with Ibs Diagnosis. Gastroenterology 146(5): S-109

Labus, J.S.; Van Horn, J.D.; Torgerson, C.; Gupta, A.; Ashe-McNalley, C.; Liu, C.; Naliboff, B.D.; Tillisch, K.; Mayer, E.A. 2014: Architecture of Anatomical Brain Networks Differs in Irritable Bowel Syndrome Compared to Healthy Controls. Gastroenterology 146(5): S-109

Watissée, M.; Thielemans, L.; Armstrong, M.; McCracken, N. 2014: Httr4 and Tph1 Variants As a Potential Predictive Composite Marker in Patients With Chronic Constipation. Gastroenterology 146(5): S-110

Coffin, B.; Pattou, F.; Hebuterne, X.; Ledoux, S.; Mion, F.; Hajage, D.; Msika, S. 2014: Impact of Intra-Gastric Balloon (Igb) Before Laparoscopic Gastric by-Pass (Lgbp) in Patients With Morbid Obesity: A Randomized Multicenter Study Comparing Igb to Standard Medical Care (Smc) During the Pre-Operative Period. (Bigpom Study). Gastroenterology 146(5): S-110

Anbazhagan, A.N.; Priyamvada, S.; Gujral, T.; Alrefai, W.A.; Dudeja, P.K.; Borthakur, A. 2014: Distinct Roles of the Long-Chain Fatty Acid Receptor Gpr120 in Different Cell Types of the Intestinal Epithelium. Gastroenterology 146(5): S-110-S-111

Munoz, R.; Miquel, J.F.; Arrese, M.; Irribarra, V.; Pimentel, F.; Sharp, A.C.; Turiel, D.; Pizarro, P.; Young, A.; Brown, K.; Maggs, D.; Kaplan, L.M.; Escalona, A. 2014: Duodenojejunal Bypass Liner Increases Fasting and Postprandial Serum Levels of Bile Acids in Patients With Severe Obesity. Gastroenterology 146(5): S-111

Bilski, J.; Mazur-Bialy, A.I.; Surmiak, M.; Hubalewska-Mazgaj, M.; Brzozowski, B.; Zwolinska-Wcislo, M.M.; Brzozowski, T. 2014: Exercise Training Attenuates the Severity of Experimental Rodent Colitis. The Importance of Crosstalk Between Adipose Tissue and Skeletal Muscles. Gastroenterology 146(5): S-111

Abidi, W.M.; Meoli, L.; Yilmaz, O.; Stylopoulos, N.; Thompson, C.C. 2014: The Gluttonous Roux: Evidence of Increased Glucose and Lipid Metabolism in the Roux Limb After Gastric Bypass Surgery in Human Patients. Gastroenterology 146(5): S-111

Glawe, A.; Harriett, L.; Pytynia, M.; LePard, K.J.; Evans, C.C.; Ciancio, M.J. 2014: Continuous Epithelial Cell Heat Shock Protein 70 Expression Protects Against High Fat, Diet-Induced Obesity in Mice. Gastroenterology 146(5): S-111-S-112

Franchi, L.; Monteleone, I.; Morgan, R.; Opipari, A.W.; Carter, L.; Glick, G.; Monteleone, G. 2014: Modulation of the F1F0-Atpase Induces Apoptosis of Mouse and Human Lamina Propria T-cells and Is Efficacious in Models of Ibd. Gastroenterology 146(5): S-112

Nowacki, T.M.; Bettenworth, D.; Tepasse, P.R.; Remaley, A.T.; Vowinkel, T.; Lügering, A.; Nofer, J.-R. 2014: Anti-Inflammatory Effects of ApoA-I in Experimental Colitis Through Inhibition of Intestinal Monocyte Infiltration and Activiation. Gastroenterology 146(5): S-112

Im, E.; Pothoulakis, C.; Rhee, S.H. 2014: Deletion of Phosphatase and Tensin Homolog Pten in the Intestinal Epithelium Causes Spontaneous Early-Onset Colitis in an Il-10 Deficient Environment. Gastroenterology 146(5): S-112

Van Welden, S.; Laukens, D.; Devisscher, L.; Devlies, H.; Olievier, K.; Correale, C.; D'Alessio, S.; Danese, S.; DeVos, M.; Hindryckx, P. 2014: Silencing of Prolyl Hydroxylase 1 in Intestinal Microvascular Endothelial Cells Prevents Inflammation-Induced Endothelial Dysfunction and Dampens Murine Colitis. Gastroenterology 146(5): S-112-S-113

Essien, B.E.; Yang, A.; Merchant, J.L. 2014: Transcription Factor Zbp-89 Protects the Colon From Aom/Dss-Induced Tumorigenesis by Interacting With -Catenin. Gastroenterology 146(5): S-113

Ihara, S.; Hirata, Y.; Serizawa, T.; Suzuki, N.; Kinoshita, H.; Nakagawa, H.; Ijichi, H.; Koike, K. 2014: Transforming Growth Factor-Beta Signaling on Dendritic Cells Regulates Bacterial Communities and Gut Homeostasis. Gastroenterology 146(5): S-113

Rubio-Tapia, A.; Brantner, T.L.; Van Dyke, C.T.; Brogan, D.L.; Rajkumar, V.S.; Murray, J.A. 2014: Case-Finding Is Insufficient to Detect Most Persons With Celiac Disease: A Population-Based Study. Gastroenterology 146(5): S-113

Iskandar, H.; Gray, D.M.; Vu, H.T.; Mirza, F.; Rude, M.K.; Regan, K.; Abdalla, A.; Gaddam, S.; Almaskeen, S.A.; Mello, M.; Marquez, E.O.; Meyer, C.; Bolkhir, A.; Kanuri, N.D.; Sayuk, G.S. 2014: Celiac Disease Screening is Suboptimal in a Tertiary Gastroenterology Setting. Gastroenterology 146(5): S-113-S-114

Myléus, A.; Petersen, S.; Carlsson, A.; Hammarroth, S.; Högberg, L.; Nordyke, K.; Stenlund, H.; Ivarsson, A. 2014: Health-Related Quality of Life in Adolescents With Screening-Detected Celiac Disease: Assessments Before Diagnosis and After One Year With Gluten-Free Diet. Gastroenterology 146(5): S-114

Kurek, L.; Genta, R.M.; DeFelice, A.R.; Green, P.H.; Reilly, N.R. 2014: Additional Gastrointestinal Findings Among Children With Celiac Disease: Are the Espghan Guidelines Missing Something?. Gastroenterology 146(5): S-114

Basson, M.; Mezzarobba, M.; Weill, A.; Ricordeau, P.; Allemand, H.; Alla, F.; Carbonnel, F. 2014: Severe Malabsorption Associated with Olmesartan: A French Nationwide Cohort Study. Gastroenterology 146(5): S-114

Kim, J.T.; Liu, C.; Townsend, C.M.; Evers, B.M. 2014: Neurotensin, a Novel Target of Wnt/-Catenin Pathway, Promotes Growth of Neuroendocrine Tumor Cells. Gastroenterology 146(5): S-114

Ray, S.K.; Li, J.; Gene, A.B.L. 2014: Functional Synergy Between Histone Demethylation and Acetylation Defines an Epigenetic Signature for NeuroD Regulated Gene Transcription in Enteroendocrine Cells. Gastroenterology 146(5): S-114-S-115

Yamada, K.; Imam, N.A.; Pintar, J.E.; Brubaker, P.L. 2014: Insulin-Like Growth Factor Binding Protein-4 Is Required for the Growth Effects of Glucagon-Like Peptide-2 in Murine Intestine. Gastroenterology 146(5): S-115

Li, J.; Leiter, A.B. 2014: Transcriptome Sequencing Reveals Overlapping Gene Expression in Intestinal Endocrine Cell Subtypes. Gastroenterology 146(5): S-115

Bohórquez, D.V.; Liddle, R.A. 2014: The Gut-Brain Axis: Not an Imaginary Line Anymore Neurocircuit Unveiled. Gastroenterology 146(5): S-115

Latorre, R.; Huynh, J.; Gupta, A.; Mazzoni, M.; Clavenzani, P.; Chang, L.; Mayer, E.A.; DeGiorgio, R.; Sternini, C. 2014: Mucosal Bitter Taste Receptor Expression in Overweight and Obese Subjects. Gastroenterology 146(5): S-115-S-116

Manabe, N.; Kamada, T.; Kusunoki, H.; Shiotani, A.; Inoue, K.; Hata, J.; Haruma, K. 2014: Newly Developed Bioelectrical Admittance Measurement Distinguishes Patients with Non-Erosive Reflux Disease from those with Functional Heartburn. Gastroenterology 146(5): S-116

Cui, R.; Zhang, H.; Lu, J.; Xue, Y.; Wang, Y.; Zhou, L. 2014: Diagnostic Value of Combination of Intercellular Space Measurement and Histopathologic Score for Gastroesophageal Reflux Disease. Gastroenterology 146(5): S-116

Ribolsi, M.; Balestrieri, P.; Emerenziani, S.; Cicala, M. 2014: Intra-Bolus Pressure, Assessed With High Resolution Manometry, is Inversely Related With Higher Esophageal Acid Exposure and Directly With Proximal Migration of Refluxate in Gerd Patients. Gastroenterology 146(5): S-116

Zhou, L.; Wang, Y.; Lu, J.; Lin, L.; Cui, R.; Zhang, H.; Xue, Y.; Ding, S.; Lin, S. 2014: Accuracy of the Diagnosis of Gastroesophageal Reflux Disease by Gerdq Questionnaire, Esophageal Impedance Monitoring and Histology. Gastroenterology 146(5): S-116-S-117

Ates, F.; Higginbotham, T.; Slaughter, J.C.; Mabary, J.; Vaezi, M.F. 2014: Esophageal Mucosal Impedance (Mi) Pattern Is Distinct in Patients With Gerd Compared to Those Without Gerd. Gastroenterology 146(5): S-117

Choi, C.H.R.; Rutter, M.; Kang, M.kyu; Warusavitarne, J.; Thomas-Gibson, S.; Moorghen, M.; Saunders, B.P.; Graham, T.A.; Har, A. 2014: Long-Term Colonoscopic Surveillance for Ulcerative Colitis Reveals a Low Rate Overall Rate of Cancer Progression and the Significant Risk of Cancer Following an Indefinite for Dysplasia Diagnosis. Gastroenterology 146(5): S-118

Leoz, M.L.; Moreira, L.; Carballal, S.; Baiges, A.; Rodriguez, R.; Ocana, T.; Pellise, M.; Lopez-Ceron, M.; Castells, A.; Balaguer, F. 2014: Risk of Advanced Neoplasm in Individuals With Family History of Colorectal Cancer. Gastroenterology 146(5): S-118

Harinck, F.; Konings, I.C.; Poley, J.-W.; Krak, N.; Biermann, K.; Van Hooft, J.E.; Nio, C.Y.; Aalfs, C.M.; Van Rens, A.; Van Eijck, C.H.; Gouma, D.; Dijkgraaf, M.G.; Dullemen, H.V.; Sijmons, R.H.; Fockens, P. 2014: A Comparative Prospective Blinded Analysis of the Effectiveness of Eus and Mri As Screening Tools for Pancreatic Cancer. Gastroenterology 146(5): S-118-S-119

Marwaha, P.; Xicola, R.M.; Kim, Y.C.; Snyder, C.L.; Carroll, T.; Syngal, S.; Buxbaum, S.; Zhang, M.Q.; Want, S.M.; Lynch, H.T.; Bessa, X.; Andreu, M.; Jover, R.; Carracedo, A.; Castells, A. 2014: Unveiling of Dna Repair Gene Alterations in Non-Lynch Hereditary Colorectal Cancer Through Exome Sequencing. Gastroenterology 146(5): S-119

Camilleri, M.; Shin, A.; Busciglio, I.A.; Acosta, A.; Burton, D.D.; Lamsam, J.; Lueke, A.J.; Donato, L.; Zinsmeister, A.R. 2014: Validating a Biomarker for Irritable Bowel Syndrome. Gastroenterology 146(5): S-119-S-120

Morris, R.; Fagan-Murphy, A.; Patel, B.A. 2014: In Situ Electrochemical Fecal Pellet Sensor for Simultaneous Monitoring of Mucosal Serotonin Release and Colonic Motility. Gastroenterology 146(5): S-120

Liu, Y.-A.; Chung, Y.-C.; Shen, M.-Y.; Kuo, C.-W.; Li, W.-L.; Pasricha, P.J.; Tang, S.-C. 2014: Whole-Villus Neurohistology with Optical Clearing. Gastroenterology 146(5): S-120

Raja, S.; Okeke, F.C.; Stein, E.M.; Dhalla, S.; Nandwani, M.; Roland, B.C.; Lynch, K.; Gyawali, C.P.; Clarke, J.O. 2014: Does three Dimensional high Resolution Anorectal Manometry Increase Diagnostic Yield?. Gastroenterology 146(5): S-120-S-121

Kumar, L.; Zaman, F.; Emmanue, A. 2014: Endo Flip: A New Diagnostic Modality for For Demonstrating Anal Canal Function and the Sampling Reflex. Gastroenterology 146(5): S-121

Samarasena, J.B.; Chang, K.J.; Ahluwalia, A.; Shinoura, S.; Choi, K.D.; Lee, J.G.; Tarnawski, A.S. 2014: Novel Insight Into Gastric Enteric Nervous System Using Eus-Guided Needle Based Confocal Laser Endomicroscopy, Neuronal Probe and Molecular Imaging. Evidence for Common Mediators and Cross-Talk Between Neural Epithelial & Ecl Cells. Gastroenterology 146(5): S-121

Kuo, B.; Sclocco, R.; Kim, J.; Garcia, R.G.; Sheehan, J.D.; Thurler, A.H.; Castel, S.; Beissner, F.; Barbieri, R.; Napadow, V. 2014: Brain Circuitry of Autonomic Nervous System Outflow in Response to Nausea. Gastroenterology 146(5): S-121

Iyer, P.G.; Borah, B.J.; Heien, H.; Chak, A. 2014: Rates and Predictors of Progression to Adenocarcinoma in a Large Population Based Barrett's Esophagus Cohort. Gastroenterology 146(5): S-121-S-122

Van Olphen, S.H.; Biermann, K.; Kastelein, F.; Hansen, B.E.; Stoop, H.; Spaander, M.C.; Looijenga, L.; Bruno, M.J. 2014: Sox2 As a Novel Marker to Predict Neoplastic Progression in Barrett's Esophagus. Gastroenterology 146(5): S-122

Pohl, H.; Arash, H.; Ell, C.; Manner, H.; May, A.; Vieth, M.; Sonnenberg, A.; Pech, O. 2014: Length of Barrett's Esophagus and Cancer Risk -Implications From a Population Based Study. Gastroenterology 146(5): S-122

MacCarthy, F.P.; Duggan, S.P.; Feighery, R.; O, J.; Ravi, N.; Kelleher, D.; Reynolds, J.V.; O'Toole, D. 2014: Il-1B and Serpina-3 Are Novel Markers of Aggressive Barrett's Oesophagus Phenotype Using Rna Deep Sequencing Analysis. Gastroenterology 146(5): S-122

El-Serag, H.; Kramer, J.R.; Duan, Z.; Shakhatreh, M.H.; Helm, A.; Pathak, A.; Hinojosa-Lindsey, M.; Chen, G.; Naik, A. 2014: Surveillance Endoscopy Is Associated With Improved Outcomes of Esophageal Adenocarcinoma (Ea) Detected in Patients With Barrett's Esophagus (Be). Gastroenterology 146(5): S-123

Gaddam, S.; Thota, P.N.; Vennalaganti, P.; Gupta, N.; Wani, S.; Higbee, A.D.; Mathur, S.C.; Rastogi, A.; Young, P.E.; Cash, B.D.; Moawad, F.J.; Bansal, A.; Vargo, J.J.; Falk, G.W.; Lieberman, D.A. 2014: Proton Pump Inhibitor Use but Not Statin Use Is Associated With Decreased Risk for High-grade Dysplasia and Esophageal Adenocarcinoma in Patients With Barrett's Esophagus: Results From a Large, Multicenter Cohort Study. Gastroenterology 146(5): S-123

Ghoshal, U.C.; Srivastava, D.; Ghoshal, U.; Misra, A. 2014: Randomized Double-Blind Placebo-Controlled Trial of Antibiotic Treatment in Patients With Irritable Bowel Syndrome Directed Against Small Intestinal Bacterial Overgrowth Diagnosed Using Upper Gut Aspirate Culture and Glucose Hydrogen Breath Test. Gastroenterology 146(5): S-123

Lam, C.; Tan, W.; Leighton, M.; Williams, J.; Agrawal, A.; Sen, S.; Foley, S.; Rutter, M.; Ramadas, A.; Whorwell, P.J.; Montgomery, A.; Spiller, R.C. 2014: A Multi-Centre, Parallel Group, Randomised Placebo Controlled Trial of Mesalazine for Treatment of Diarrhoea-Predominant Irritable Bowel Syndrome (Ibs-D). Gastroenterology 146(5): S-123-S-124

Barbara, G.; Cremon, C.; Bellacosa, L.; DeGiorgio, R.; Stanghellini, V.; Corinaldesi, R. 2014: Randomized Placebo Controlled Mulicenter Trial of Mesalazine in Patients With Irritable Bowel Syndrome (Ibs). Gastroenterology 146(5): S-124

Barbara, G.; Cremon, C.; Bellacosa, L.; DeGiorgio, R.; Santos, J.; Vicario, M.; Pigrau, M.; Alonso, C.; Varannes, S.B.; Neunlist, M.; DeFilippis, D.; DiMarzo, V.; Iuvone, T.; Corinaldesi, R.; Stanghellini, V. 2014: Randomized Placebo-Controlled Multicenter Study on the Effect of Palmitoyl-Ethanolamide and Polydatin on Immune Activation in Patients With Irritable Bowel Syndrome. Gastroenterology 146(5): S-124

Faurot, K.(K.)R.; Gaylord, S.; Palsson, O.S.; Garland, E.L.; Mann, J.D.; Whitehead, W.E. 2014: Mindfulness Meditation Has Long-Term Therapeutic Benefits in Women With Irritable Bowel Syndrome (Ibs): Follow-Up Results From a Randomized Controlled Trial. Gastroenterology 146(5): S-124

Boland, B.S.; Widjaja, C.E.; Banno, A.; Kim, S.H.; Peterson, M.R.; Jones, M.C.; Su, H.I.; Crowe, S.E.; Bui, J.; Aramburu, J.F.; Lopez-Rodriguez, C.; Sandborn, W.; Chang, J.T. 2014: Immunodeficiency and Autoimmune Enterocolopathy Linked to Nfat5 Deficiency. Gastroenterology 146(5): S-125

Parang, B.; Bradley, A.; Mittal, M.K.; Washington, K.; Revetta, F.; Bilotta, A.; Smith, J.J.; Chen, X.; Shroyer, N.F.; Williams, C.S. 2014: Loss of Mtgr1 Accelerates Intestinal Tumor Burden. Gastroenterology 146(5): S-125

Moran, C.J.; Kelsen, J.R.; Kaplan, J.L.; Baril-Dore, M.; Petit, E.; Al-Lawati, T.; Vais, B.; Xavier, R.J.; Kirschner, B.S.; Baldassano, R.; Winter, H.; Daly, M.J. 2014: Whole Exome Sequencing in Cohort of Very Early Onset Inflammatory Bowel Disease. Gastroenterology 146(5): S-125

Hulur, I.; Skol, A.; Llor, X.; Onel, K.; Ellis, N.A.; Kupfer, S. 2014: Expression Quantitative Trait Loci Mapping in the Human Colon. Gastroenterology 146(5): S-125-S-126

Clendenning, M.; Crawford, W.J.; Woodall, S.; Arnold, J.; Sweet, K.; Nagler, B.N.; Walters, R.J.; Win, A.K.; Jenkins, M.A.; Hopper, J.; Aronson, M.; Gallinger, S.; Young, J.; Rosty, C.; Parry, S. 2014: Rare Variants in Crc Susceptibility Genes Do Not Predispose to Serrated Polyposis Syndrome. Gastroenterology 146(5): S-126

Shiotani, A.; Murao, T.; Fujita, Y.; Fujimura, Y.; Sakakibara, T.; Kamada, T.; Nishio, K.; Haruma, K. 2014: Novel Single Nucleotide Polymorphism Markers for Low Dose Aspirin-Associated Small Bowel Bleeding: A Dmet Microarray Profiling Study. Gastroenterology 146(5): S-126

Prakash, R.K.; Maradey-Romero, C.; Lewis, S.; Perzynski, A.; Fas, R. 2014: Risk of Acute Myocardial Infarction in Patients With Gastro-Esophageal Reflux Disease: A Nationwide Database Study. Gastroenterology 146(5): S-126

Jadcherla, S.; Wagner, A.; Gao, X.; Castile, R.G.; Shaker, R. 2014: Distinguishing the Effects of the Proximal Migration of Gastro-Esophageal Reflux (Ger) on Symptoms and Characteristics of Refluxate in Premature Infants. Gastroenterology 146(5): S-126-S-127

Vaezi, M.F.; Vakil, N.B.; Schmalz, M.J.; Raymond, A. 2014: A Multi-Center Prospective Study of the Upper Esophageal Sphincter (Ues) Assist Device for the Treatment of Extraesophageal Reflux. Gastroenterology 146(5): S-128

Gerson, L.B.; Fass, R. 2014: The Value of Endoscopy, Proton Pump Inhibitor Therapy, and Pain Modulators in Patients With Non-Cardiac Chest Pain (Nccp): Systematic Review and Meta-Analysis. Gastroenterology 146(5): S-128

Salieb, L.A.; Kolman, D.; Patel, N.B.; Friedenberg, F.K.; Cordova, F.C.; Toyoda, Y.; Smith, M.S. 2014: Gastroesophageal Reflux and Esophageal Dysmotility Are Common in Idiopathic Pulmonary Fibrosis Patients Undergoing Lung Transplant Evaluation and Cannot Be Predicted by Symptoms. Gastroenterology 146(5): S-128-S-129

Long, M.; Leszczynski, A.; Thompson, K.D.; Wasan, S.K.; Calderwood, A.H. 2014: The Gender Gap in Authorship in Academic Gastroenterology -A Look Over 20 Years. Gastroenterology 146(5): S-129

Walter, D.; Van Boeckel, P.G.; Groenen, M.; Weusten, B.L.; Witteman, B.J.; Tan, G.; Brink, M.A.; Nicolai, J.; Tan, A.C.; Alderliesten, J.; Venneman, N.G.; Laleman, W.; Jansen, J.M.; Bodelier, A.; Wolters, F. 2014: Quality of Life After Stent Placement for Palliation of Common Bile Duct Obstruction: A Randomized Controlled Trial Comparing Plastic and Metal Stents. Gastroenterology 146(5): S-129

Ismail, M.S.; Omar, O.O.A.; Sengupta, S.; Keohan, J. 2014: The Effect of Acetaminophen (Paracetamol) Legislation on Admissions for Acetaminophen Overdose in a Single Referral Center. Gastroenterology 146(5): S-129

El-Serag, H.; Kuzniarek, J.; Ramsey, D.J.; Tabasi, S.T.; White, D.L.; Kanwal, F. 2014: Beverage Intake and the Risk of Advanced Fibrosis in Hcv: Coffee, Tea, or Sodas?. Gastroenterology 146(5): S-129-S-130

Pasricha, S.; Triadafilopoulos, G.; Li, N.; Muthusamy, V.R.; Wolf, W.A.; Chmielewski, G.W.; Cotton, C.C.; Corbett, F.S.; Camara, D.S.; Shaheen, N.J. 2014: All-Cause Mortality in Patients With Barrett's Esophagus Undergoing Radiofrequency Ablation: Results From the U.S. Rfa Registry. Gastroenterology 146(5): S-130

Fink, S.P.; Yamauchi, M.; Nishihara, R.; Jung, S.; Kuchiba, A.; Wu, K.; Cho, E.; Giovannucci, E.; Fuchs, C.; Ogino, S.; Markowitz, S.; Chan, A.T. 2014: Aspirin Use and the Risk of Colorectal Cancer Is Modified According to Colonic 15-Prostaglandin Dehydrogenase Expression. Gastroenterology 146(5): S-130-S-131

Wolf, W.A.; Overholt, B.F.; Li, N.; Lightdale, C.J.; Cotton, C.C.; Wolfsen, H.C.; Pasricha, S.; Wang, K.K.; Shaheen, N.J. 2014: Durability of Radiofrequency Ablation (Rfa) in Barrett's Esophagus With Dysplasia: the Aim Dysplasia Trial At Five Years. Gastroenterology 146(5): S-131

Waldner, M.J.; Bindea, G.; Mlecnik, B.; Angell, H.K.; Foersch, S.; Höpken, U.E.; Wirtz, S.J.; Becker, C.; Neurath, M.F.; Galon, J. 2014: Cxcl13-Cxcr5 Signaling Is Required for the Anti-Tumor Immune Response in Colorectal Cancer. Gastroenterology 146(5): S-131

Noah, T.K.; Shroyer, N.F. 2014: Spdef Mediates the Notch-Atoh1 Effects on Colonic Tumor Cell Proliferation and Is Sufficient but Not Required for the Notch-Atoh1 Effects in Colonic Tumor Stem Cells. Gastroenterology 146(5): S-131-S-132

Raimondo, M.; Yab, T.C.; Mahoney, D.W.; Taylor, W.R.; Kisiel, J.B.; Allawi, H.; Lidgard, G.P.; Ahlquist, D.A. 2014: Sensitive Dna Marker Panel for Detection of Pancreatic Cancer by Assay in Pancreatic Juice. Gastroenterology 146(5): S-132

Samadder, N.J.; Curtin, K.; Pappas, L.; Boucher, K.M.; Provenzale, D.; Mineau, G.P.; Smith, K.; Fraser, A.; Kinney, A.Y.; Burt, R.W. 2014: Risk of Incident Colorectal Cancer Diagnosis After Colonoscopy: A Population-Based Study in Utah. Gastroenterology 146(5): S-132-S-133

Wallace, K.L.; Zheng, L.; Kanazawa, Y.; Zhang, H.; Ichikawa, R.; Chen, J.; Sidhu, M.; Zhang, X.; Pothoulakis, C.; Koon, H.W.; Targan, S.; Shih, D.Q. 2014: Tl1A Modulates the Differential Effect of Il-17 Blockade on Mucosal Inflammation. Gastroenterology 146(5): S-133

Van Sommeren, S. 2014: Trans-Ethnic Association Study of Ibd Identifies 14 New Disease Loci and Demonstrates Pervasive Sharing of Genetic Risk Factors and Phenotypic Features Between Europeans and Non-Europeans. Gastroenterology 146(5): S-133

Shouval, D.S.; Biswas, A.; Goettel, J.A.; McCann, K.; Conaway, E.; Samsom, J.N.; Escher, J.C.; Weiss, B.; Somech, R.; Beier, R.; Conklin, L.; Ebens, C.L.; Bhan, A.K.; Klein, C.; Muise, A. 2014: Anti-Inflammatory Macrophage Function Requires Il10 Receptor Signaling and Regulates Mucosal Homeostasis in Mice and Humans. Gastroenterology 146(5): S-133-S-134

Brandse, J.F.; van der Kleij, D.; Wolbink, G.-J.; Rigter, I.M.; Baars, P.A.; Lowenberg, M.; Ponsioen, C.; Jansen, J.M.; van den Brink, G.R.; Mathôt, R.A.; D'Haens, G.R. 2014: The Pharmacokinetics of Infliximab Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis. Gastroenterology 146(5): S-134

Trotter, A.; Rodriguez-Palacios, A.; Kaydo, L.; Pietropaoli, D.; Xin, W.; Croniger, C.M.; Cominelli, F. 2014: A High Fat Diet Containing Coconut Oil Prevents the Onset of Chronic Intestinal Inflammation in Experimental Crohn's Disease. Gastroenterology 146(5): S-134

Yarur, A.; Kubiliun, M.; Drake, K.; Hauenstein, S.; Barkin, J.S.; Sussman, D.A.; Deshpande, A.R.; Quintero, M.A.; Singh, S.; Abreu, M.T. 2014: Higher 6-Thioguanine Nucleotide Concentrations Are Associated With Higher Trough Levels of Infliximab in Patients on Combination Therapy. Gastroenterology 146(5): S-134-S-135

Strege, P.R.; Bernard, C.E.; Mazzone, A.; Beyder, A.; Gibbons, S.J.; Farrugia, G. 2014: A Novel Exon of the Human Calcium-Activated Chloride Channel Ano1 Imparts Greater Sensitivity of Cl-Current to Intracellular Ca2+. Gastroenterology 146(5): S-135

Labus, J.S.; Van Horn, J.D.; Gupta, A.; Torgerson, C.; Ashe-McNalley, C.; Liu, C.; Irimia, A.; Tillisch, K.; Mayer, E.A. 2014: Multivariate Pattern Analysis Identifies Diffusion Tensor Imaging-Based Brain Signatures that Accurately Discriminate Irritable Bowel Syndrome Patients from Healthy Controls. Gastroenterology 146(5): S-135

Lomasney, K.W.; Cryan, J.F.; Hyland, N.P. 2014: Probiotics Influence Colonic Secretomotor Function and Gastrointestinal Physiology in the Mouse: In Vitro and In Vivo Studies With Bifidobacterium Infantis 35624 and Lactobacillus Salivarius Ucc118. Gastroenterology 146(5): S-135-S-136

Pasricha, P.J.; Yates, K.P.; Clarke, J.O.; Unalp, A.; Tonascia, J.; Koch, K.L.; Hasler, W.L.; Miriel, L.A.; Abell, T.L.; Snape, W.J.; Calles, J.; McCallum, R.W.; Sarosiek, I.; Hamilton, F.A.; Farrugia, G. 2014: Mortality and Predictors of Improvement in Patients With Gastroparesis: 4-Year Outcomes From the Gastroparesis Clinical Research Consortium. Gastroenterology 146(5): S-136

Hayashi, Y.; Toyomasu, Y.; Milosavljevic, S.; Nagy, R.A.; Heppelmann, C.J.; Bergen, H.R.; Shen, K.R.; Linden, D.R.; Szurszewski, J.H.; Farrugia, G.; Ordog, T. 2014: Neuronal Nitric Oxide Synthase (Nos1) Regulates Body Weight following Chronic Dietary Restriction. Gastroenterology 146(5): S-136

Fujikawa, Y.; Tominaga, K.; Tanaka, F.; Yamagami, H.; Tanigawa, T.; Shiba, M.; Watanabe, K.; Watanabe, T.; Fujiwara, Y.; Arakawa, T. 2014: Morphological and Functional Changes Caused by Physical Stress in Enteric Glial Cells Induce Colonic Hyper-Contraction via a Neuron-Glia Transmission in Maternally Separated Rats. Gastroenterology 146(5): S-136

Kerdsirichairat, T.; Bellin, M.; Arain, M.A.; Attam, R.; Sutherland, D.; Beilman, G.; Chinnakotla, S.; Pruett, T.L.; Schwarzenberg, S.J.; Radosevich, D.M.; Freeman, M.L. 2014: 794a Total Pancreatectomy and Auto-Islet Transplantation (Tpiat) for Disabling and Refractory Idiopathic Recurrent Acute Pancreatitis (iRap) Without Evident Chronic Pancreatitis (Cp): Impact on Quality of Life and Pain. Gastroenterology 146(5): S-136-S-137

Bertilsson, S.; Kalaitzakis, E. 2014: 794b Natural History of Acute Pancreatitis: Results of a Population-Based Cohort Study. Gastroenterology 146(5): S-137

Jaïs, B.; Rebours, V.; Kim, M.-H.; Ha, Y.; Kimura, W.; Hirai, I.; Marchegiani, G.; Castillo, C.F.; Gomatos, I.P.; Neoptolemos, J.; Sperti, C.; Milanetto, A.C.; Wang, H.; Ricci, C.; Casadei, R. 2014: 794c Pancreatic Serous Cystadenoma Related Mortality Is Nil. Results of a Multinational Study Under the Auspices of the International Association of Pancreatology and the European Pancreatic Club. Gastroenterology 146(5): S-137-S-138

Heeg, S.; Das, K.K.; Reichert, M.; Takano, S.; Bakir, B.; Lieberman, A.E.; Hahn, C.; Rustgi, A.K. 2014: 794d The Ets Transcription Factor Etv5 Regulates Ductal Morphogenesis and Differentiation in Association With Sox9. Gastroenterology 146(5): S-138

Iwahashi, K.; Hikita, H.; Shigekawa, M.; Ikezawa, K.; Shimizu, S.; Takatoshi, N.; Sakamori, R.; Miyagi, T.; Tatsumi, T.; Takehara, T. 2014: 794e Lack of Basal Autophagy in Pancreatic Acinar Cells Develops Chronic Pancreatitis in Mice. Gastroenterology 146(5): S-138

Dolai, S.; Orabi, A.I.; Liang, T.; Javed, T.A.; Lam, P.P.; Rubin, D.C.; Husain, S.Z.; Gaisano, H.Y. 2014: 794f Syntaxin 2 Deficiency Predisposes Mice to Pancreatitis by Enhancing Basolateral Exocytosis and Autophagy. Gastroenterology 146(5): S-138

Powell, A.; Choi, E.; Vlacich, G.R.; Coffey, R.J.; Goldenring, J.R. 2014: Lrig1 in the Gastric Mucosa: Discrete Roles in the Fundus and Antrum. Gastroenterology 146(5): S-138-S-139

Lo, Y.-H.; Noah, T.K.; Shroyer, N.F. 2014: Spdef Regulates -Catenin Transcriptional Activity through Protein-Protein Interaction. Gastroenterology 146(5): S-139

Feng, R.; Engevik, A.C.; Schumacher, M.A.; Zavros, Y. 2014: The Ulcer Associated Cell Lineage Glands Are Hedgehog Targets in Response to Gastric Injury. Gastroenterology 146(5): S-139

Takabayashi, H.; Mao, M.Y.; Ji, T.; Eaton, K.A.; Todisco, A. 2014: Regulation of Lgr5+Ve Progenitor Cell Homeostasis by Bone Morphogenetic Protein (Bmp) Signaling During Gastric Inflammation. Gastroenterology 146(5): S-139

Voorneveld, P.; Kodach, L.L.; Rosekrans, S.; Jacobs, R.J.; van den Brink, G.R.; Hardwic, J.C. 2014: Conditional Activation of Bmp Signalling Leads to Loss of the Stem Cell Compartment. Gastroenterology 146(5): S-139-S-140

Bertaux-Skeirik, N.; Feng, R.; McCracken, K.; Schumacher, M.A.; Engevik, A.C.; Ottemann, K.; Wang, J.; Wells, J.M.; Zavros, Y. 2014: Cd44 Marks a Population of Gastric Stem Cells and Plays a Functional Role in H. pylori-Induced Epithelial Proliferation. Gastroenterology 146(5): S-140

Zhou, H.; Gillilland, M.; Zhou, S.-Y.; Song, I.; Gao, J.; Zhang, G.; Lu, Y.; Owyang, C. 2014: Bile Acids Regulate Intestinal Stem Cell and Paneth Cell Functions and Contribute to Gut Dysbiosis Induced by High Fat Feeding. Gastroenterology 146(5): S-140

Shetty, A.; Chandrasekharan, B.P.; Mwangi, S.M.; Srinivasan, S. 2014: Gdnf Mediated Protection against Diet induced Obesity is Associated with Altered Gut Microbiota. Gastroenterology 146(5): S-140

Zarrinpar, A.; Yooseph, S.; Chaix, A.; Adams, M.D.; Panda, S. 2014: Diet and Time Restricted Feeding Modulate Cyclical Changes in the Gut Microbiome and Can Affect Metabolic Homeostasis Through Bile Acid Signaling. Gastroenterology 146(5): S-140

Davies, J.M.; Dheer, R.; Hua, H.-U.; Martinez, M.; Bhattacharya, S.K.; Abreu, M.T. 2014: Stool Phospholipids and the Microbiota: Using Mass Spectrometry and Microbial Profiling to Generate Disease-Specific Signatures. Gastroenterology 146(5): S-140-S-141

van der Sommen, F.; Zinger, S.; de With, P.H.; Schoon, E.J. 2014: Computer-Aided Detection of Early Neoplastic Lesions in Barrett's Esophagus: Towards a Supportive Detection System in Endoscopy. Gastroenterology 146(5): S-141

Yang, C.; Hou, V.W.; Nelson, L.Y.; Seibel, E.J. 2014: In Vitro Validation of Multispectral Fluorescence Endoscopy for Detecting Live Molecular Targets of High Grade Dysplasia and Esophageal Adenocarcinoma in Real-Time Wide-Field Video With <50:1 Signal-to-Background Ratio. Gastroenterology 146(5): S-141

Aihara, H.; Abidi, W.M.; Kumar, N.; Ryou, M.; Ryan, M.B.; Thompson, C.C. 2014: A Clip-Based Suture-Pulley System Facilitates Gastric and Colorectal Endoscopic Submucosal Dissection. Gastroenterology 146(5): S-141-S-142

Moshkowitz, M.; Arber, N. 2014: Safety and Proof of Concept Demonstrated With a Novel Prep-Less X-Ray Imaging Capsule for Colon Cancer Screening. Gastroenterology 146(5): S-142

Obstein, K.L.; Pasricha, T.; Mitchell, V.R.; Smith, B.F.; Valdastri, P. 2014: In Vivo Colonic Insufflation via a Disposable Co2 Insufflation System. Gastroenterology 146(5): S-142

Catalano, M.F.; Sorser, S.A.; Henderson, J.B.; Ali, S.; Enteric, A.A. 2014: Successful Closure of Enteric Fistulas Using the Apollo Overstitch Suturing System. Gastroenterology 146(5): S-142-S-143

Kumar, N.; Thompson, C.C. 2014: Management of Endoscopic Perforation With Abdominal Exploration and Full-Thickness Sutured Closure. Gastroenterology 146(5): S-143

Van Tilburg, M.A.; Hyams, J.S.; Leiby, A.; Walker, L.S.; Palsson, O.S.; Tack, J.F.; Spiegel, B.M.; Spiller, R.C.; Yang, Y.; Whitehead, W.E. 2014: Functional Dyspepsia in Children: Can We Distinguish Epigastric Pain and Postprandrial Distress?. Gastroenterology 146(5): S-143

Wolfson, S.; Jacobs, C.; Monagas, J.J.; DiLorenzo, C.; Cocjin, J.; Hyman, P.E. 2014: Effect of Colon Transection on Spontaneous High-Amplitude-Propagating Contractions in Children. Gastroenterology 146(5): S-143

Van Tilburg, M.A.; Walker, L.S.; Palsson, O.S.; Kim, S.M.; Spiegel, B.M.; Spiller, R.C.; Tack, J.F.; Yang, Y. 2014: Prevalence of Child/Adolescent Functional Gastrointestinal Disorders in a National U.S. Community Sample. Gastroenterology 146(5): S-143-S-144

Thiagarajah, J.; Yildiz, H.; Miller, S.; Carlson, T.; Carrier, R.L.; Goldstein, A.M. 2014: Altered Goblet Cell Differentiation and Surface Mucus Properties in Hirschsprung Disease. Gastroenterology 146(5): S-144

Williams, A.E.; Self, M.; Czyzewski, D.I.; Weidler, E.M.; Chumpitazi, B.P.; Shulman, R.J. 2014: Poor Agreement Between Prospective Diary Data and Retrospective Report of Abdominal Pain and Stooling Symptoms in Children With Irritable Bowel Syndrome (Ibs). Gastroenterology 146(5): S-144

Chumpitazi, B.P.; Tsai, C.M.; McMeans, A.R.; Shulman, R.J. 2014: A Low Fodmaps Diet Ameliorates Symptoms in Children With Irritable Bowel Syndrome: A Double Blind, Randomized Crossover Trial. Gastroenterology 146(5): S-144

Gevers, D.; Kugathasan, S.; Denson, L.; Vázquez-Baeza, Y.; Van Treuren, W.; Ren, B.; Schwager, E.; Knights, D.; Song, S.J.; Yassour, M.; Morgan, X.; Kostic, A.D.; Luo, C.; Gonzalez, A.; McDonald, D. 2014: 850a The treatment-naive microbiome in early-onset Crohn's Disease. Gastroenterology 146(5): S-144

Huizinga, J.D.; Pawelka, A.J.; Parsons, S.; Chen, J.-H. 2014: 850b The intestine switches between propulsion and segmentation through a nutrient-or neurally-induced transient pacemaker. Gastroenterology 146(5): S-145

Sehgal, A.; Blomenkamp, K.S.; Qian, K.; Fishman, S.; Butler, J.S.; Milstein, S.; Kuchimanch, S.; Barros, S.; Bettencourt, B.; Charisse, K.B.; Simon, A.; Bumcrot, D.; Fitzgerald, K.; Teckman, J. 2014: 850c Rnai Therapeutics Ameliorate Liver Disease Associated with Alpha-1-Antitrypsin Deficiency. Gastroenterology 146(5): S-145

Li, L.; Masica, D.; Ishida, M.; Kalloo, A.N.; Singh, V.K.; Khashab, M.; Li, Z.; Okolo, P.; Lennon, A.M.; Saxena, P.; Canto, M.I.; Law, J.K.; Goggins, M.G.; Shin, E.J.; Kumbhari, V. 2014: 850d Human bile contains microRna-laden exosomes that can be used for cholangiocarcinoma diagnosis. Gastroenterology 146(5): S-145

Roda, G.; Hovhannisyan, Z.; Yeretssian, G.; Mayer, L. 2014: 850e Ceacam5 small peptides to restore the suppressive activity of lamina propria Cd8+ T cells in Crohn's disease. Gastroenterology 146(5): S-145

Fernandes, P.; Hashiguchi, T.; Fujii, M.; Yoneyama, H. 2014: 850f Anti-Nash Effects of Solithromycin in Nash-Hcc Mouse Model. Gastroenterology 146(5): S-145-S-146

Gockel, I.; Becker, J.; Niebisch, S.; Wouters, M.M.; Schulz, H.G.; Müller, M.; Boeckxstaens, G.E.; Lang, H.; Nöthen, M.M.; Knapp, M.; Schumacher, J. 2014: Systematic Association Study of Exonic Variants in Idiopathic Achalasia. Gastroenterology 146(5): S-146

Torres-Villalobos, G.; Armando, G.-D.; Svarch, A.E.; Villa-Baños, A.; Ceballos, J.C.; Llorente, L.; Martín-del-Campo, L.A.; Baños, M.A.; Enríquez, A.B.; Valdovinos, M.A.; Furuzawa-Carballeda, J. 2014: Achalasia As an Autoimmune Inflammatory Disease. Gastroenterology 146(5): S-146

Kappelle, W.; Bogte, A.; Siersema, P.D. 2014: Hydraulic Dilation in Idiopathic Achalasia Using the EsoFlip Dilation Balloon: A Prospective Cohort Study. Gastroenterology 146(5): S-146

Johnston, E.R.; Cho, Y.K.; Nicodème, F.; Lipowska, A.; Gawron, A.J.; Lin, Z.; Tiftikci, A.; Kahrilas, P.J.; Pandolfino, J.E. 2014: Novel Impedance Measurements to Assess Bolus Retention in Achalasia. Gastroenterology 146(5): S-146-S-147

Ponds, F.A.; Bredenoord, A.J.; Kessing, B.F.; Rohof, W.O.; Oors, J..; Smout, A.J. 2014: Measurement of Esophagogastric Junction Distensibility Identifies a Subgroup of Achalasia Patients With Manometrically Normal Les Relaxation. Gastroenterology 146(5): S-147

Vennalaganti, P.; Kanakadandi, V.; Goldblum, J.R.; Patil, D.T.; Mathur, S.C.; Parasa, S.; Gupta, N.; Rastogi, A.; Bansal, A.; Sharma, P. 2014: Revised Classification of Low Grade Dysplasia (Lgd) in Barrett's Esophagus (Be): Time to Rethink the Role of Lgd As a Risk Stratification Strategy in Be. Gastroenterology 146(5): S-147

Masclee, G.; Coloma, P.M.; de Wilde, M.; Kuipers, E.J.; Sturkenboom, M.C. 2014: Incidence of Barrett's Esophagus and Esophageal Adenocarcinoma in the United Kingdom and the Netherlands: Have We Reached a Plateau?. Gastroenterology 146(5): S-147-S-148

Chen, Z.; Hong, J.; Belkhiri, A.; El-Rifai, W. 2014: Ape1 Mediates Acidic Bile Salt-Induced Activation of Nf-B in Barrett's Tumorigenesis. Gastroenterology 146(5): S-148

Duggan, S.P.; Kirca, M.; Li, X.; Behan, F.M.; McGarrigle, S.A.; Jankowski, J.A.; Kelleher, D. 2014: A Genomic Intestinal Signature of Barrett's Esophagus (Be) Defines Reflux Inducible Transcription Factors Proximally Encoded to Be and Adenocarcinoma Associated Genetic Loci. Gastroenterology 146(5): S-148

Uno, K.; Anderson, M.; Lutzke, L.S.; Leggett, C.L.; Wang, K.K. 2014: Effects of Inflammation on Senescence in Epithelial Cells Is Mediated by Fibroblasts in Barrett's Esophagus. Gastroenterology 146(5): S-148

Iyer, P.G.; Dunagan, K.T.; Johnson, M.L.; Yab, T.C.; Devanna, S.; Simonson, J.A.; Devens, M.E.; Mahoney, D.W.; Yang, D.; Ahlquist, D.A. 2014: Highly Discriminant Methylated Dna Markers for Detection of Barrett's Esophagus. Gastroenterology 146(5): S-148-S-149

Osterman, M.T.; Aberra, F.; Cross, R.; Liakos, S.; McCabe, R.P.; Shafran, I.; Wolf, D.C.; Hardi, R.; Nessel, L.; Gilroy, E.D.; Brensinger, C.M.; Lewis, J.D. 2014: A Randomized Controlled Trial of Mesalamine Dose Escalation for Ulcerative Colitis in Remission. Gastroenterology 146(5): S-149

Danese, S.; Rudzinski, J.C.; Brandt, W.; Dupas, J.-L.; Peyrin-Biroulet, L.; Bouhnik, Y.; Kleczkowski, D.; Uebel, P.; Lukas, M.; Knutsson, M.; Erlandsson, F.; Hansen, M.B.; Keshav, S. 2014: Tralokinumab (Cat-354), an Interleukin 13 Antibody, in Moderate to Severe Ulcerative Colitis: A Phase 2A Randomized Placebo-Controlled Study. Gastroenterology 146(5): S-149

Sands, B.E.; Sandborn, W.; Rutgeerts, P.J.; Xu, J.; Abhyankar, B.; Fox, I. 2014: Efficacy of Vedolizumab Induction Therapy in Patients With Crohn's Disease Who Have Experienced Tumor Necrosis Factor Antagonist Failure or Are Tumor Necrosis Factor Antagonist Naive. Gastroenterology 146(5): S-149

Sandborn, W.J.; Colombel, J.-F.; Ghosh, S.; Sands, B.E.; Xu, L.-A.; Luo, A. 2014: Phase Iib, Randomized, Placebo-Controlled Evaluation of the Efficacy and Safety of Induction Therapy With Eldelumab (Anti-Ip-10 Antibody; Bms-936557) in Patients With Active Ulcerative Colitis. Gastroenterology 146(5): S-150

Roblin, X.; Rinaudo-gaujous, M.; Del Tedesco, E.; Phelip, J.M.; Genin, C.; Peyrin-Biroulet, L.; Pau, S. 2014: Development of an Algorithm Incorporating Pharmacokinetics of Adalimumab in Inflammatory Bowel Diseases. Gastroenterology 146(5): S-150

Reinisch, W.; Vermeire, S.; Cataldi, F.; Vogelsang, H.; Allez, M.; Desreumaux, P.; Van Gossum, A.M.; Van Gossum, A.M.; Baumgart, D.C.; Sandborn, W.J.; Ransohoff, R.M.; Stuve, O.; Cheng, J.B.; Zhang, Y.; Rivers, S. 2014: Anti-MadCam Monoclonal Antibody Pf-00547659 Does Not Affect Immune Surveillance in the Central Nervous System of Crohn's Disease Patients Who Are Anti-Tnf Inadequate Responders: Results From the Tosca Study. Gastroenterology 146(5): S-150

Ahluwalia, A.; Jones, M.K.; Tarnawski, A.S. 2014: Direct Autocrine Regulation of Colon Cancer Cell Growth by Vegf Is Mediated via Activation of Vegf-R1/2 and Transactivation of Egf-R: Direct Effect of Vegf on Crc Cell Proliferation and Reduced Apoptosis. Gastroenterology 146(5): S-151

Lau, W.M.; Zang, Z.J.; Teng, E.; Das, K.; Yong, W.-P.; Teh, M.; Tan, J.W.; Chia, L.M.T.; Tay, A.; Shabbir, A.; Kono, K.; Chan, S.L.; Tan, P.; So, J.B. 2014: Discovery and Therapeutic Potential of Fgfr2 Gene Amplification in Diffuse Gastric Cancer. Gastroenterology 146(5): S-151

Tseng-Rogenski, S.; Hamaya, Y.; Choi, D.Y.; Carethers, J.M. 2014: Il-6 Signaling Drives hMsh3 Mismatch Repair Dysfunction to Generate Emast Formation in Colon Cancer. Gastroenterology 146(5): S-151

Choi, D.Y.; Martin, P.; Tseng-Rogenski, S.; Carethers, J.M. 2014: Identification and Characterization of Nuclear Export and Import Signals Within the Mismatch Repair Protein hMsh3 That Control Its Subcellular Location in Response to Inflammation. Gastroenterology 146(5): S-151

Tao, Y.; Messer, J.S.; Goss, K.H.; Hart, J.; Bissonnette, M.; Chang, E.B. 2014: Hsp70 Is Required for Loss of Heterozygosity in the ApcMin/+ Model of Colorectal Cancer. Gastroenterology 146(5): S-151-S-152

Shapira, S.; Shapira, A.; Kazanov, D.; Kraus, S.; Oren, M.; Arber, N. 2014: The Trojan Horse Strategy: Selective Eradication of Cancer Cells by Adenovirus-Based Delivery of Cytotoxic Agents: An Alternative Method for Targeting Pancreatic (Pc) and Colorectal Cancers (Crc). Gastroenterology 146(5): S-152

Dillman, J.R.; Stidham, R.W.; Johnson, L.A.; Rubin, J.M.; Higgins, P.D. 2014: Ultrasound Shear Wave Elastography Detects Bowel Wall Fibrosis in Ex Vivo Human Crohn's Disease Specimens. Gastroenterology 146(5): S-152

Iacucci, M.; Gasia, M.F.; Love, J.R.; Panaccione, R.; Kaplan, G.; Ghosh, S.; Gui, X. 2014: Complete Mucosal Healing Defined by Endoscopic Mayo Subscore Still Demonstrates Abnormalities by Novel iScan Endoscopic and Refined Histological Gradings. Gastroenterology 146(5): S-152

Novak, K.L.; Kaplan, G.; Kellar, A.; Wilson, A.; Panaccione, R.; Afshar, E.E.; Wilson, S.R. 2014: Use of Contrast Enhanced Transabdominal Ultrasound in the Prospective Evaluation of Crohn's Disease: Contrast Enhancement Responsiveness and Nonresponse to Treatment With Adalimumab. Gastroenterology 146(5): S-152-S-153

Shiotani, A.; Hata, J.; Fujita, M.; Matsumoto, H.; Tarumi, K.; Honda, K.; Kusunoki, H.; Kawakami, M.; Manabe, N.; Haruma, K. 2014: Patency Capsule Combined With Abdominal Ultrasound to Detect and Confirm the Site of Small Bowel Strictures. Gastroenterology 146(5): S-153

Yassin, N.A.; Lung, P.F.; Askari, A.; Edwards, P.; Phillips, R.K.; Gupta, A.; Hart, A.L. 2014: Crohn's Perianal Fistulae -Assessing Response to Biological Therapy Using Novel Imaging Techniques. Gastroenterology 146(5): S-153

Adar, T.; Biron, R.; Shitrit, A.B.; Wengrower, D.; Kuint, R.C.; Halpern, I.H.; Goldin, E.; Bogo, N.R. 2014: Dual Energy Computerized Tomography (De-Ct) -A Novel Decision Making Tool in Predicting the Need for Surgery in Patients With Crohn's Disease and Obstructing Intestinal Lesions. Gastroenterology 146(5): S-153-S-154

Calabrese, E.; Zorzi, F.; Stasi, E.; Lolli, E.; Condino, G.; Onali, S.; Petruzziello, C.; Fantini, M.C.; Cerro, P.; Scarozza, P.; Biancone, L.; Pallone, F. 2014: Accuracy of Small Intestine Contrast Ultrasonography Compared to Magnetic Resonance Enterography in Characterizing Lesions in Patients With Crohn's Disease. Gastroenterology 146(5): S-154

Guevara-Morales, G.R.; Amieva-Balmori, M.; Luna, E.P.; Rojano-Gonzalez, R.; de Jesús Sanchez-Maza, Y.; Meixueiro, A.; Remes-Troche, J.M. 2014: Effects of Telmisartan in Anal Sphincter Physiology in Asymptomatic Volunteers and Patients With Anal Sphincter Hypertension With Chronic Proctalgia. Gastroenterology 146(5): S-154

Thin, N.N.; Taylor, S.J.; Bremner, S.A.; Hounsome, N.; Bannister, S.M.; Williams, N.S.; Allison, M.; Emmanuel, A.; Vaizey, C.; Alam, A.; Thomas, G.; Knowle, C.H. 2014: Randomised Mixed Methods Trial of Sacral and Percutaneous Tibial Nerve Stimulation for Faecal Incontinence. Gastroenterology 146(5): S-154

Markland, A.D.; Burgio, K.L.; Whitehead, W.E.; Richter, H.E.; Granstaff, U.S.; Wilcox, C.M.; Redden, D.T.; Beasley, T.M.; Goode, P.S. 2014: Fiber or Imodium Prescription (Rx) Management for Bowel Incontinence: The Firm Randomized Clinical Trial. Gastroenterology 146(5): S-154-S-155

Palsson, O.S.; Van Tilburg, M.A.; Spiegel, B.M.; Tack, J.F.; Spiller, R.C.; Walker, L.S.; Yang, Y.; Whitehead, W.E. 2014: Fecal Incontinence (Fi) Prevalence and Associated Gastrointestinal Risk Factors in the U.S. General Population. Gastroenterology 146(5): S-155

Patcharatrakul, T.; Gonlachanvit, S. 2014: Treatment Tasks of Biofeedback Therapy Protocol for Dyssynergic Defecation Based on Individual Physiologic Problem of Defecation: Their Prevalence and Association With Successful Treatment. Gastroenterology 146(5): S-155

Liu, L.; Zhu, Y.; Li, Q.; Caterina, M.; Pasricha, P.J. 2014: A Novel Link Between Tgf 1, Trpv1 and Nociception-an In Vitro and In Vivo Study in Rats With Chronic Pancreatitis. Gastroenterology 146(5): S-155-S-156

Grabauskas, G.; Wu, X.; Heldsinger, A.; Owyang, C. 2014: Analgesic Action of Resolvin D1 to Combat Visceral Pain in a Rat Model of Visceral Hypersensitivity. Gastroenterology 146(5): S-156

Harrington, A.M.; Castro, J.; Garcia-Caraballo, S.; Maddern, J.; Craik, D.; Adams, D.J.; Brierley, S.M. 2014: 888 -Conotoxin Vc1.1 Targets Gabab Receptors Modulating CaV2.2 and CaV2.3 Calcium Channels in Sensory Pathways Mediating Chronic Visceral Pain. Gastroenterology 146(5): S-156

Scanzi, J.; Accarie, A.; Muller, E.; Carvalho, F.A.; Pereira, B.; Boudieu, L.; Gelot, A.; Abergel, A.; Bommelaer, G.; Eschalier, A.; Ardid, D.; Dapoigny, M. 2014: Micro-Inflammation and Overexpression of CaV3.2 Ion Channel in the Colonic Mucosa of Ibs Patients: A Case-Control Study. Gastroenterology 146(5): S-156

Matsumoto, K.; Tashima, K.; Kato, S.; Horie, S. 2014: Role of Transient Receptor Potential Melastatin 2 (Trpm2) Channels in Visceral Pain and Hypersensitivity in Rats. Gastroenterology 146(5): S-156-S-157

Choi, Y.J.; Kim, N.; Kim, J.; Hwang, S.W.; Nam, R.H.; Lee, D.H. 2014: Up-Regulation of Gastric Trpv1 mRna Expression in Functional Dyspepsia Patients of Epigastric Pain Syndrome Subtype. Gastroenterology 146(5): S-157

Kraynak, T.E.; Siegle, G.J.; Srinath, A.I.; Keljo, D.J.; Jones, N.; Regueiro, M.; Szigethy, E. 2014: Pain-Associated Periaqueductal Gray Resting State Functional Connectivity in Pediatric Inflammatory Bowel Disease. Gastroenterology 146(5): S-157

Dotson, J.L.; Kappelman, M.; Chisolm, D.; Crandall, W. 2014: Healthcare Disparities in Hospitalized Children and Adolescents With Crohn's Disease: Is Race Associated With Differences in Complications or Procedures?. Gastroenterology 146(5): S-157

Izaguirre, M.R.; Taft, T.; Keefer, L. 2014: Preliminary Development of a Self-Efficacy Scale for Adolescents and Young Adults With Inflammatory Bowel Disease. Gastroenterology 146(5): S-157-S-158

Malaty, H.M.; Abraham, B.; Walsh, S.M.; Ferry, G. 2014: Treatment Outcomes With Biologics on Inflammatory Bowel Disease in Children: A Follow-Up Study. Gastroenterology 146(5): S-158

Van Tilburg, M.A.; Claar, R.; Romano, J.; Langer, S.L.; Whitehead, W.E.; Abdullah, B.; Christie, D.; Levy, R. 2014: Coping Predicts Disability, Quality of Life and Depression in Both Ibd and Fap Patients. Gastroenterology 146(5): S-158

Palmadottir, J.G.; Maharjan, A.; Draghi, A.; Sylvester, F.A.; Carlson, M.E. 2014: Inflammatory Bowel Disease Impairs the Regenerative Capacity of Skeletal Muscle Stem Cells. Gastroenterology 146(5): S-158

Lembo, A.; Camilleri, M.; McCallum, R.W.; Sastre, R.F.; Breton, C.F.; Spence, S.C.; White, J.; Gottesdiener, K.; Stoner, E. 2014: 929a A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Rm-131 in Patients with Diabetic Gastroparesis. Gastroenterology 146(5): S-158-S-159

Wang, C.; Rasmussen, H.; Perrow, W.; Kelly, C.P.; Leffler, D.; Green, P.; Fedorak, R.N.; DiMarino, A.J.; Bercik, P.; Murray, J.A.; Bachir, N.M. 2014: 929b Larazotide Acetate, a First In-Class, Novel Tight Junction Regulator, Meets Primary Endpoint and Significantly Reduces Signs and Symptoms of Celiac Disease in Patients on a Gluten-Free Diet: Results of a Multicenter, Randomized, Placebo Controlled Trial. Gastroenterology 146(5): S-159

Moayyedi, P.; Surette, M.; Wolfe, M.; Taraschi, R.; Kim, P.; Libertucci, J.; Armstrong, D.; Marshall, J.K.; Reinisch, W.; Le, C.H. 2014: 929c A randomized, placebo controlled trial of fecal microbiota therapy in active ulcerative colitis. Gastroenterology 146(5): S-159

Lembo, A.; Dove, S.; Andrae, D.; Davenport, J.M.; McIntyre, G.; Almenoff, J.; Covington, P.S. 2014: 929d Eluxadoline for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: Results of 2 Randomized, Double-blind, Placebo-Controlled Phase 3 Clinical Trials of Efficacy and Safety. Gastroenterology 146(5): S-159

Andreone, P.; Colombo, M.; Enejosa, J.V.; Koksal, I.; Ferenci, P.; Maieron, A.; Müllhaupt, B.; Horsmans, Y.; Weiland, O.; Reesink, H.W.; Jr, L.R.; Hu, Y.B.; Podsadecki, T. 2014: 929e Pearl-Ii: Randomized Phase 3 Trial of Interferon-Free, 12-Week Regimen of Abt-450/r/Abt-267, Abt-333 With or Without Ribavirin in Hepatitis C Virus Genotype 1b-Infected, Treatment-Experienced Patients. Gastroenterology 146(5): S-159

Dik, V.K.; Gralnek, I.M.; Segol, O.; Suissa, A.; Moons, L.M.; Domanov, S.; Segev, M.; Rex, D.K.; Siersema, P.D. 2014: 929f Comparing standard colonoscopy with Endo Rings colonoscopy: a randomized, multicenter tandem colonoscopy study interim results of the Clever study. Gastroenterology 146(5): S-160

Yiannakou, Y.; Bouchoucha, M.; Schiefke, I.; Piessevaux, H.; Filip, R.; Stephenson, D.; Green, A.; Levine, A. 2014: 929g Efficacy and safety of prucalopride in men with chronic constipation: a phase 3, randomized, double-blind, placebo-controlled trial. Gastroenterology 146(5): S-160

Zhang, Q.; Peng, S.; Zhang, X.; Yu, C.; Huo, X.; Cheng, E.; Bajpai, M.; Das, K.M.; Wang, D.H.; Spechler, S.J.; Souza, R.F. 2014: Acid and Bile Salts Induce Features of Epithelial Mesenchymal Transition in Non-Neoplastic Barrett's Epithelial Cells Through Increased Vegfsignaling. Gastroenterology 146(5): S-160

Yu, C.; Huo, X.; Zhang, X.; Theiss, A.L.; Cheng, E.; Zhang, Q.; Wang, D.H.; Lobie, P.E.; Spechler, S.J.; Souza, R.F. 2014: Non-Neoplastic, Barrett's Epithelial Cells That Express Oncogenic Ras Can Be Transformed Through Forced Expression of Constitutively Active Stat3. Gastroenterology 146(5): S-160

Peng, D.; Hu, T.; Soutto, M.; Belkhiri, A.; El-Rifai, W. 2014: Loss of Glutathione Peroxidase 7 Promotes Tnf--Induced Nf-kB Activation in Barrett's Carcinogenesis. Gastroenterology 146(5): S-161

Behan, F.; Duggan, S.P.; Garry, C.; Phipps, S.; Kelleher, D. 2014: Immune Factors Involved in the Promotion of Esophageal Adenocarcinoma As Defined by siRna Library Screening. Gastroenterology 146(5): S-161

Weaver, J.M.; Ross-Innes, C.; Shannon, N.B.; Lynch, A.; Forshew, T.; Barbera, M.; Ong, C.-A.J.; Murtaza, M.; Lao-Sirieix, P.; Dunning, M.J.; Smith, L.; Smith, M.; Carvalho, B.; Underwood, T.; May, A. 2014: The Timing of Oncogenic Events in the Evolution of the Oesophageal Adenocarcinoma Genome and Implications for Clinical Diagnostics. Gastroenterology 146(5): S-161

Zaidi, A.H.; Gopalakrishnan, V.; Kasi, P.M.; Malhotra, U.; Balasubramanian, J.; Visweswaran, S.; Zeng, X.; Sun, M.; Bergman, J.J.; Bigbee, W.L.; Jobe, B.A. 2014: 935a Evaluation of a Four-Protein Biomarker Panel (Biglycan, Annexin-A6, Myeloperoxidase and Protein S100-A9; B-Amp ) for Detection of Esophageal Adenocarcinoma. Gastroenterology 146(5): S-161

Matsuda, T.; Fujii, T.; Sano, Y.; Kudo, S.; Oda, Y.; Kaneko, K.; Hotta, K.; Shimoda, T.; Saito, Y.; Kobayashi, N.; Konishi, K.; Ikematsu, H.; Iishi, H.; Kobayashi, K.; Yamaguchi, Y. 2014: Randomized Comparison of Surveillance Intervals After Colonoscopic Removal of Adenomatous Polyps: Results From the Japan Polyp Study. Gastroenterology 146(5): S-161-S-162

Wong, R.K.; Wong, M.L.; Chan, Y.H.; Feng, Z.; Wai, C.T.; Yeoh, K.G. 2014: Barriers, Misconceptions and the Lack of Physicians' Recommendation Account for Poor Screening Uptake in Colorectal Compared With Cervical Cancer: Findings of a National Population Representative Survey. Gastroenterology 146(5): S-162

Stoffel, E.M.; Erichsen, R.; Frøslev, T.; Vyberg, M.; Koeppe, E.S.; Hamilton, S.R.; Baron, J.A.; Sørensen, H.T. 2014: High Prevalence of Mismatch Repair Deficiency Among Colorectal Cancers Diagnosed After Colonoscopy. Gastroenterology 146(5): S-162

Razzak, A.; Yu, K.; Pinsky, P.; Riley, T.; Schoen, R.E. 2014: Association Between Family History of Colorectal Cancer and Incident Colorectal Cancer in the Plco Trial. Gastroenterology 146(5): S-162-S-163

Singh, S.; Singh, P.P.; Samadder, N.J. 2014: Prevalence and Risk Factors for Interval Colorectal Cancers: A Systematic Review and Meta-Analysis. Gastroenterology 146(5): S-163

Perisetti, A.; Sahmoun, A.E. 2014: Colorectal Cancer Screening Among Insured Individuals: Is Cost a Barrier to Routine Screening?. Gastroenterology 146(5): S-163-S-164

Yan, W.; Wu, K.; Yang, Y.; Guo, M. 2014: Epigenetic Silencing of Dach1 Induces the Invasion and Migration of Gastric Cancer by Activating Tgf- Signaling. Gastroenterology 146(5): S-164

Kim, Y.-I.; Cho, S.-J.; Shin, J.-Y.; Kook, M.-C.; Ryu, K.W.; Kim, Y.-W.; Choi, I.J. 2014: MicroRna 135a Suppresses Lymph Node Metastasis Through Down-Regulation of Rock1 in Early Gastric Cancer. Gastroenterology 146(5): S-164

Okugawa, Y.; Toiyama, Y.; Hur, K.; Tanaka, K.; Inoue, Y.; Kusunoki, M.; Boland, C.R.; Goel, A. 2014: Methylation Status in a Panel of Micro Rnas Predicts the Development of Ucassociated Colorectal Neoplasia. Gastroenterology 146(5): S-164-S-165

Zhang, J.; Li, X.; Wang, J.; Gao, J.; Go, M.Y.; Sung, J.J.Y.; Yu, J. 2014: Promoter Hypermethylation of a Novel Tumor Suppressor Gene Ca4 Associated With Colon Cancer Recurrence. Gastroenterology 146(5): S-165

Lochhead, P.J.; Mayer, C.-D.; Hold, G.L.; El-Omar, E. 2014: Genome-Wide Analysis of Dna Methylation in Low-Grade Colorectal Adenomas and Normal Colonic Mucosa. Gastroenterology 146(5): S-165

Jeoung, Y.; Joo, M.K.; Park, J.-J.; Yoo, H.S.; Choe, J.W.; Kim, J.; Kim, H.; Kim, H.jung; Lee, B.J.; Kim, J.S.; Bak, Y.-T. 2014: CpG Island Promoter Hypermethylation of Rassf1A Contributes Gastric Carcinogenesis. Gastroenterology 146(5): S-165

Limsrivilai, J.; Charatcharoenwitthaya, P.; Pausawasdi, N.; Leelakusolvong, S. 2014: Imipramine for Treatment of Esophageal Hypersensitivity and Functional Heartburn: a Randomized Double-Blind, Placebo-Controlled Trial. Gastroenterology 146(5): S-165

Sugimoto, M.; Uotani, T.; Sahara, S.; Ichikawa, H.; Yamade, M.; Kagami, T.; Sugimoto, K.; Furuta, T. 2014: Efficacy of Surgical Spinal Correction in Patients With Severe Spinal Kyphotic Deformity for Gastroesophageal Reflux Disease. Gastroenterology 146(5): S-166

Lin, D.; Triadafilopoulos, G. 2014: Dual Ambulatory pH Monitoring in Patients With Gastroesophageal Reflux Rendered Asymptomatic With Proton Pump Inhibitor Therapy. Gastroenterology 146(5): S-166

Lo, W.-K.; Burakoff, R.; Goldberg, H.J.; Feldman, N.; Boukedes, S.; Chan, W.W. 2014: Proton Pump Inhibitor Use is Associated with Decreased Rejection after Lung Transplantation. Gastroenterology 146(5): S-166-S-167

Konemura, T.; Date, I.; Okada, H. 2014: Ono-8539, a Novel Prostanoid Ep1 Receptor Antagonist, Suppresses Transient Lower Esophageal Sphincter Relaxations in Monkeys. Gastroenterology 146(5): S-167

Siersema, P.D.; Bredenoord, A.J.; Conchillo, J.M.; Ruurda, J.P.; Bouvy, N.D.; van Berge Henegouwen, M.I.; Chiu, P.W.; Booth, M.; Hani, A.C.; Reddy, D.N.; Smout, A.J.; Wu, J.C.; Escalona, A. 2014: Electrical Stimulation Therapy (Est) of the Lower Esophageal Sphincter (Les) -an Effective Therapy for Refractory Gerd -Interim Results of an International Multicenter Trial. Gastroenterology 146(5): S-167

Mendelsohn, R.B.; Calo, D.; Zauber, A.G.; Carlesimo, M.; DeLeon, S.; Wang, J.J.; Kuk, D.; Winawer, S.J. 2014: Prevalence of Colorectal Adenomas in Blacks, Whites and Hispanics Having Screening Colonoscopy in a Patient Navigation Program: A Prospective Multicenter Study. Gastroenterology 146(5): S-168

Samuel, S.; Groman, A.; Iyer, R. 2014: Racial and Geographical Disparities in the Outcome of Hepatocellular Carcinoma Within a High Prevalence Birth Cohort for Chronic Viral Hepatitis. Gastroenterology 146(5): S-168

Mehta, S.J.; Jensen, C.D.; Ghai, N.R.; Quinn, V.P.; Levin, T.R.; Schottinger, J.E.; Lee, A.T.; Zhao, W.; Zauber, A.G.; Van Ballegooijen, M.; Laiyemo, A.O.; Goodman, M.; Fletcher, R.H.; Corley, D.A.; Doubeni, C.A. 2014: The Effect of an Organized Screening Program on Racial and Ethnic Disparities and Choice of Colorectal Cancer Screening Test. Gastroenterology 146(5): S-168-S-169

van der Steen, A.; Knudsen, A.B.; Van Hees, F.; Walter, G.; Berger, F.G.; Daguise, V.; Kuntz, K.M.; Zauber, A.G.; Van Ballegooijen, M.; Lansdorp-Vogelaar, I. 2014: Optimal Colorectal Cancer Screening Strategy for States' Low-Income, Uninsured Populations -The Case of South Carolina. Gastroenterology 146(5): S-169

Abdallah, J.; Anna, K.; Hassan, T.; Jain, A.K. 2014: Vaccination Outcomes in Inflammatory Bowel Disease. Gastroenterology 146(5): S-170

Mahadevan, U.; Martin, C.F.; Dubinsky, M.; Kane, S.V.; Sands, B.E.; Sandborn, W. 2014: Exposure to Anti-Tnf Therapy in the Third Trimester of Pregnancy Is Not Associated With Increased Adverse Outcomes: Results From the Piano Registry. Gastroenterology 146(5): S-170

Nguyen, G.C.; Bernstein, C.N.; Benchimol, E.I. 2014: Risks of Hospitalizations and Surgery in Elderly-Onset Inflammatory Bowel Disease: A Population Based Study. Gastroenterology 146(5): S-171

Bernstein, M.T.; Sexton, K.A.; Targownik, L.; Graff, L.A.; Miller, N.; Rogala, L.; Walker, J.R. 2014: Sources of Concern Over Time in Ibd: A Prospective Study of the Complex Relationship Between Symptomatic Disease Activity and Perceived Stress. Gastroenterology 146(5): S-171

Christensen, B.; Erlich, J.; Hanauer, S.B.; Rubin, D.T. 2014: Agreement Between Deep Histological Remission and Mucosal Healing in Ulcerative Colitis and Predictors of Each Outcome. Gastroenterology 146(5): S-172

Benninga, M.A.; Mugie, S.M.; Korczowski, B.; Green, A.; Ausma, J.; Kerstens, R.; Ruth, M.; Levine, A. 2014: Efficacy and Safety of Prucalopride in Children With Functional Constipation: Results of a Multicenter, Placebo-Controlled, Phase 3 Trial. Gastroenterology 146(5): S-172

Rutten, J.M.; Vlieger, A.M.; Frankenhuis, C.J.; George, E.K.; Groeneweg, M.; Norbruis, O.F.; Ten, W.T.; Van Wering, H.M.; Benninga, M.A. 2014: Gut Directed Hypnotherapy in Children With Irritable Bowel Syndrome or Functional Abdominal Pain: A Randomized Controlled Trial on Self Exercises At Home Using Cd Versus Individual Therapy by Qualified Therapists. Gastroenterology 146(5): S-172

Rosen, R.L.; Amirault, J.; Hu, L.; Ward, D.V.; Baskind, M.; Nurko, S. 2014: The Impact of Full Column, Non-Acid Reflux on Oropharyngeal Flora and Its Implications for Acid Suppression Use. Gastroenterology 146(5): S-172

Singendonk, M.; Kritas, S.; Cock, C.; Ferris, L.; McCall, L.; Rommel, N.; Van Wijk, M.P.; Benninga, M.A.; Moore, D.; Omari, T. 2014: Applying the Chicago Classification to a Pediatric Cohort: The Effects of Patient Age and Size on the Diagnosis of Esophageal Motility Disorders in Children. Gastroenterology 146(5): S-172-S-173

Olen, O.; Sandström, O.; Myléus, A.; Rosén, A.; Carlsson, A.; Högberg, L.; Stenlund, H.; Simren, M.; Ivarsson, A. 2014: Functional Gastrointestinal Disorders and the Association to Celiac Disease -A Population Based Screening Study in Children. Gastroenterology 146(5): S-173

Yang, C.H.; Punati, J. 2014: Naspghan Guidelines for Functional Constipation Compared to the Current Practices of Pediatricians. Gastroenterology 146(5): S-173

Rimola, J.; Sandborn, W.; Higgins, P.; Coimbra, A.; Lu, T.; Rutgeerts, P.J.; Luca, D.; Bruining, D.H.; Vermeire, S.; Panes, J.; Santillan, C.; Al-Hawary, M.; Fidler, J.L.; Vanbeckevoort, D.; Vanslembrouck, R.A. 2014: Feasibility, Precision and Reproducibility of Mr Enterography for Detection of Inflammation in Crohn's Disease in a Multicenter Clinical Trial. Gastroenterology 146(5): S-174

Minderhoud, I.; Steyerberg, E.W.; Van Bodegraven, A.A.; van der Woude, C.J.; Hommes, D.W.; Dijkstra, G.; Fidder, H.; Schwartz, M.P.; Oldenburg, B. 2014: Predicting Mucosal Inflammatory Activity in Crohn's Disease: A New, Validated Non-Endoscopic Disease Activity Index. Gastroenterology 146(5): S-174

Christensen, B.; Erlich, J.; Hanauer, S.B.; Rubin, D.T. 2014: Histological Normalization in Ulcerative Colitis: A New Treatment Outcome. Gastroenterology 146(5): S-174

Wright, E.K.; DeCruz, P.; Kamm, M.A.; Hamilton, A.L.; Ritchie, K.J.; Krejany, S.; Leach, S.T.; Keenan, J.I.; Gorelik, A.; Liew, D.; Prideaux, L.; Lawrance, I.C.; Andrews, J.M.; Bampton, P.A.; Sparrow, M. 2014: Faecal Calprotectin Is Superior to Faecal Lactoferrin and S100A12 As a Surrogate Marker for Post-Operative Crohn's Disease Endoscopic Recurrence. Prospective Longitudinal Endoscopic Validation. Results From the Pocer Study. Gastroenterology 146(5): S-174

Lockton, S.; Princen, F.; Singh, S. 2014: Classification of non-Ibd, Crohn's Disease and Ulcerative Colitis in a Young Patient Population Using a Multi-Marker Diagnostic Panel. Gastroenterology 146(5): S-174-S-175

Khanna, R.; Zou, G.; D'Haens, G.R.; Rutgeerts, P.J.; McDonald, J.W.; Daperno, M.; Feagan, B.G.; Sandborn, W.; Dubcenco, E.; Vandervoort, M.K.; Luo, A.; Levesque, B.G. 2014: Agreement Among Central Readers in the Evaluation of Endoscopic Disease Activity in Crohn's Disease. Gastroenterology 146(5): S-175

Erichsen, R.; Baron, J.A.; Hamilton-Dutoit, S.J.; Snover, D.; Torlakovic, E.E.; Frøslev, T.; Pedersen, L.; Vyberg, M.; Hamilton, S.R.; Sørensen, H.T. 2014: Risk of Colorectal Cancer in Patients With Sessile Serrated Adenomas/Polyps Is of the Same Magnitude or Even Higher Than in Patients With Conventional Adenomas. Gastroenterology 146(5): S-175

Davenport, J.; Smalley, W.E.; Su, Y.; Ness, R.; Zheng, W.; Shrubsole, M.J. 2014: Contributions of Cigarette Smoking to the Development of Sessile Serrated Adenomas in a Distinct Population. Gastroenterology 146(5): S-175-S-176

Richardson, D.P.; Rabeneck, L.; Saskin, R.; Tinmouth, J.M.; Paszat, L.; Baxter, N.N. 2014: Patient Level Features of Missed and Detected Cancers At Colonoscopy. Gastroenterology 146(5): S-176

Chiu, H.-M.; Lee, Y.-C.; Wu, M.-S. 2014: Fecal Hemoglobin Concentration Is Associated With the Risk of Colonoscopy Interval Cancers in a Fecal Immunochemical Test-Based Population Colorectal Cancer Screening Program. Gastroenterology 146(5): S-176

El-Serag, H.; Duan, Z.; Kramer, J.R.; Kanwal, F. 2014: Patient Race and Risk of Cirrhosis and Hepatocellular Cancer in a National Sample of Veterans With Hcv. Gastroenterology 146(5): S-176

Konijeti, G.G.; Song, M.; Yuan, C.; Ananthakrishnan, A.N.; Ogino, S.; Fuchs, C.; Giovannucci, E.; Ng, K.; Chan, A.T. 2014: Circulating 25-Hydroxyvitamin D, Vitamin D Binding Protein, and Risk of Colorectal Cancer. Gastroenterology 146(5): S-176

Khalili, H.; Ananthakrishnan, A.N.; Konijeti, G.G.; Higuchi, L.M.; Richter, J.M.; Fuchs, C.; Chan, A.T. 2014: Circulating Testosterone Is Associated With Risk of Crohn's Disease Among Women. Gastroenterology 146(5): S-176-S-177

Ananthakrishnan, A.N.; Khalili, H.; Konijeti, G.G.; de Silva, P.S.; Higuchi, L.M.; Fuchs, C.; Richter, J.M.; Chan, A.T. 2014: Reduced Sleep Duration Is Associated With an Increased Risk of Ulcerative Colitis: A Prospective Cohort Study. Gastroenterology 146(5): S-177

Gaines, L.S.; Horst, S.N.; Slaughter, J.C.; Shelton, R.; Haman, K.; Wang, L.; Martin, C.F.; Kappelman, M.; Long, M.D.; Sandler, R.S.; Beaulieu, D.B.; Schwartz, D.A. 2014: An Internet-Based Cohort Study of the Association Between Depression and Exacerbation of Crohn's Disease. Gastroenterology 146(5): S-177

Ananthakrishnan, A.N.; Nguyen, D.D.; Sauk, J.; Yajnik, V.; Xavier, R.J. 2014: Genetic Polymorphisms in Cyp2A6 and Gstp1 Modify the Association Between Smoking and Inflammatory Bowel Diseases. Gastroenterology 146(5): S-177

Khalili, H.; Peloquin, J.M.; Garber, J.; Ananthakrishnan, A.N.; Konijeti, G.G.; Higuchi, L.M.; Fuchs, C.; Richter, J.M.; Yajnik, V.; Chan, A.T. 2014: High Dietary Potassium Intake As Measured by 24-Hour Urine Collection Is Associated With Lower Risk of Ulcerative Colitis. Gastroenterology 146(5): S-177

Ng, S.C.; Tang, W.; de Silva, H.J.; Niriella, M.A.; Senanayake, Y.U.; Ooi, C.J.; Ling, K.-L.; Ong, D.E.; Goh, K.L.; Hilmi, I.; Ouyang, Q.; Wang, Y.-F.; Hu, P.; Chen, M.; Zeng, Z. 2014: Natural History of Inflammatory Bowel Disease in Asia: A Follow-Up Population-Based Cohort Study. Gastroenterology 146(5): S-178

Olen, O.; Stephansson, O.; Backman, A.-S.; Törnblom, H.; Simren, M.; Altman, M. 2014: Pre-and Perinatal Stress and Irritable Bowel Syndrome in Young Adults -A National Register-Based Cohort Study. Gastroenterology 146(5): S-178

Sayuk, G.S.; Bruce, S.E.; White, K.S.; Cassell, B.; Kanuri, N.D.; Gott, B.M.; Nix, B.D.; Sabzpoushan, A.; Gyawali, C.P. 2014: Depression and Anxiety Mediate the Effect of Abuse History on Ibs Symptoms and Health-Related Quality of Life. Gastroenterology 146(5): S-178

Kang, H.W.; Lee, C.G.; Kim, J.H.; Lim, Y.J.; Lee, J.K.; Koh, M.S.; Lee, J.H. 2014: Visceral Abdominal Obesity As a Risk Factor for Irritable Bowel Syndrome: A Case-Control Study. Gastroenterology 146(5): S-178

Saito, Y.A.; Almazar, A.E.; Locke, G.R.; Bouras, E.P.; Howden, C.W.; Lacy, B.E.; DiBaise, J.K.; Prather, C.M.; Abraham, B.; El-Serag, H.; Moayyedi, P.; Szarka, L.A.; Herrick, L.M.; Tilkes, K.E.; Schleck, C.D. 2014: Gi Bowel Symptom Comorbidity in Functional Dyspepsia. Gastroenterology 146(5): S-178-S-179

Saito, Y.A.; Almazar, A.E.; Locke, G.R.; Bouras, E.P.; Howden, C.W.; Lacy, B.E.; DiBaise, J.K.; Prather, C.M.; Abraham, B.; El-Serag, H.; Moayyedi, P.; Szarka, L.A.; Herrick, L.M.; Tilkes, K.E.; Schleck, C.D. 2014: The Functional Dyspepsia Treatment Trial (Fdtt): 5-Htt Lpr and Gn 3 825C>T Are Not Pharmacogenetic Markers for Fd Antidepressant Treatment Response. Gastroenterology 146(5): S-179

Palsson, O.S.; Van Tilburg, M.A.; Spiegel, B.M.; Tack, J.F.; Spiller, R.C.; Walker, L.S.; Yang, Y.; Whitehead, W.E. 2014: Irritable Bowel Syndrome (Ibs) Prevalence in the U.S. General Population: Results From the Rome Normative Gastrointestinal Symptoms Survey (Rngss). Gastroenterology 146(5): S-179

Mastrodonato, M.; Mentino, D.; Portincasa, P.; Calamita, G.; Wang, D.Q.; Liquori, G.E.; Ferri, D. 2014: High-Fat Diet Alters the Oligosaccharide Chains of Colon Mucins in Mice. Gastroenterology 146(5): S-179

Liang, Q.; Yau, T.O.; Chan, F.K.L.; Sung, J.J.Y.; Yu, J. 2014: Establishment of Taqman Probe-Based Quantitative Pcr Assays for Evaluation of Bacterial Markers in Human Fecal Samples. Gastroenterology 146(5): S-179-S-180

Isakov, N.F.; Sagi, S.Z.; Halpern, Z.; Webb, M.; Gluzman, I.; Kariv, R. 2014: Metabolic Features Are Associated With Colonic Polyps and Their Neoplastic Potential. Gastroenterology 146(5): S-180

DeLaCruz, M.; Wali, R.K.; Weinstein, J.; Goldberg, M.J.; Bianchi, L.K.; Bajaj, S.; Momi, N.; Roy, H.K. 2014: Targeting Fatty Acid Synthase (Fasn) As a Modality to Ameliorate Obesity Related Colorectal Cancer (Crc). Gastroenterology 146(5): S-180

Vipperla, K.; Ou, J.; Wahl, E.; Ruder, E.H.; DeLany, J.P.; Carbonero, F.; Gaskins, H.R.; O'Keefe, S.J. 2014: Halving the Meat and Fat and Doubling Fiber Intake Suppresses Microbiota Phenotypic and Mucosal Proliferative Biomarkers of Colon Cancer Risk Within 2 Weeks. Gastroenterology 146(5): S-180-S-181

Kupfer, S.; Witonsky, D.; Chase, M.; Ceryes, K.; DiRienzo, A. 2014: Transcriptional Response to 1,25(Oh)2 Vitamin D in the Human Colon: Differences by Ethnicity and Colorectal Cancer Affection. Gastroenterology 146(5): S-181

den Hollander, W.J.; Sonnenschein-van der Voort, A.M.M.; Holster, I.L.; de Jongste, J.C.; Jaddoe, V.W.; Perez-Perez, G.I.; Moll, H.A.; Blaser, M.J.; Duijts, L.; Kuipers, E.J. 2014: Helicobacter pylori Colonization, Respiratory Outcomes and Eczema in School-Age Children: The Generation R Study. Gastroenterology 146(5): S-181-S-182

Okuda, M.; Kikuchi, S.; Ueda, J.; Osaki, T.; Osaki, K.; Maekawa, K.; Lin, Y.; Kamiya, S.; Fukuda, Y. 2014: Prevalence of Helicobacter pylori Infection in Children and Test and Treat to Junior High School Students: Strategies for Extermination of Gastric Cancer in Japan. Gastroenterology 146(5): S-182

Esmail, M.; Swennes, A.G.; Bacon, R.; Feng, Y.; Shen, Z.; Sharma, P.; Cohen, J.K.; Whary, M.T.; Fox, J.G. 2014: Zoonotic Gastric Helicobacter Spp. Identified in Captive Sooty Mangabeys (Cercocebus Atys) With Gastric Adenocarcinoma. Gastroenterology 146(5): S-182

Suraci, E.; Larussa, T.; Leone, I.; Nazionale, I.; Abenavoli, L.; Imeneo, M.; Luzza, F. 2014: High Exposure, Spontaneous Clearance and Low Incidence of Active Helicobacter pylori Infection: The Sorbo San Basile Study. Gastroenterology 146(5): S-182

van Zanten, S.V.; Aplin, L.; Chang, H.-J.; Morse, A.L.; Lazarescu, A.; Girgis, S.; Goodman, K.J. 2014: Community-Driven Research on Helicobacter pylori Infection in the Canadian Arctic: the Fort Mcpherson H. pylori Project. Gastroenterology 146(5): S-183

Serrao, S.; Jackson, C.S.; Juma, D.; Ibrahim, D.; Soret, S.; Randhawa, M.; Gerson, L.B. 2014: Socio Economic Status and Type of Insurance Affects In-hospital Mortality From Peptic Ulcer Bleeding. Gastroenterology 146(5): S-183

Wu, P.; Szczesniak, M.M.; Craig, P.I.; Choo, L. 2014: A Novel Predictor of Rebleeding in High Risk Peptic Ulcer Disease Selects Patients Who Would Benefit Most From Prophylactic Arterial Embolisation. Gastroenterology 146(5): S-183

Watanabe, T.; Higuchi, K.; Kato, M.; Fujishiro, M.; Kinoshita, Y.; Iwakiri, R.; Umegaki, E.; Sugisaki, N.; Okada, Y.; Ogawa, H.; Arakawa, T.; Fujimoto, K. 2014: Prevention of Recurrence of Gastric and Duodenal Ulcers by Rabeprazole in Patients Taking Low-Dose Aspirin -A Phase 2/3, Randomized, Parallel-Group, Double-Blind, Double-Dummy, Active-Controlled, Multicenter Study. Gastroenterology 146(5): S-183-S-184

Chan, F.K.L.; Wong, G.; Otani, K.; Ching, J. 2014: Underestimation of Small Bowel Bleeding in Users of Nonselective Nonsteroidal Anti-Inflammatory Drugs (Nsaids) and Low-Dose Aspirin (Asa): A Prospective Study. Gastroenterology 146(5): S-184

Khalili, H.; Boylan, M.R.; Huang, E.S.; Chan, A.T. 2014: Measures of Obesity and Risk of Gastric and Duodenal Ulcers. Gastroenterology 146(5): S-184

Rockey, D.C.; Melo, S.W.; Ahn, C. 2014: A Randomized Controlled Trial of Nasogastric Tube Placement in Patients With Upper Gastrointestinal Bleeding. Gastroenterology 146(5): S-184

Gawron, A.J.; Feinglass, J.; Pandolfino, J.E.; Tan, B.K.; Bove, M.; Shintani-Smith, S. 2014: Predictors of Brand Name Proton Pump Inhibitor Prescribing From the National Ambulatory Medical Care Survey. Gastroenterology 146(5): S-184-S-185

Targownik, L.; Leslie, W.D. 2014: Residual Confounding From Medical Comorbidity May Explain the Association Between Proton Pump Inhibitor Use and Fracture. Gastroenterology 146(5): S-185

Miller, M.C.; Brenner, A.; Kroep, S.; Inadomi, J.M.; Hu, C. 2014: Systematic Review: Is There a Secular Trend in Barrett's Esophagus Prevalence and Incidence?. Gastroenterology 146(5): S-185

Wu, C.W.; Kisiel, J.B.; Mahoney, D.W.; Taylor, W.R.; Yab, T.C.; Ahlquist, D.A. 2014: A Stool-Based MicroRna and Dna Marker Panel for the Detection of Pancreatic Cancer. Gastroenterology 146(5): S-186

Wheat, C.L.; Strate, L.L. 2014: Associations Between Age, Ethnicity and Obesity and Risk of Diverticulitis in the Nationwide Inpatient Sample. Gastroenterology 146(5): S-186

Spiegel, B.M.; Reid, M.W.; Bolus, R.; Whitman, C.B.; Talley, J.; Melmed, G.Y.; Cohen, E.R.; Fuller, G.; Teal, C.; Hodgkins, P.; Dea, S.K.; Erder, M.H.; Karsan, H. 2014: Development and Validation of a Disease-Targeted Quality of Life Instrument for Chronic Diverticular Disease: the Dv-Qol. Gastroenterology 146(5): S-186-S-187

Kruis, W.; Kardalinos, V.; Curtin, A.; Dorofeyev, A.E.; Zakko, S.F.; Wölkner, J.; Alonso, M.M.D.; Peeters, H.; Koutroubakis, I.E.; Talley, N.J.; Dilger, K.; Mohrbacher, R.; Greinwald, R. 2014: Daily Mesalamine Fails to Prevent Recurrent Diverticulitis in a Large Placebo Controlled Multicenter Trial. Gastroenterology 146(5): S-187

Khanna, R.; Levesque, B.G.; Bressler, B.; Zou, G.; Stitt, L.; Greenberg, G.R.; Panaccione, R.; Bitton, A.; Pare, P.; Vermeire, S.; D'Haens, G.R.; MacIntosh, D.G.; Sandborn, W.; Vandervoort, M.K.; Morris, J.C. 2014: Early Combined Immunosuppression for the Management of Crohn's Disease: A Community-Based Cluster Randomized Trial. Gastroenterology 146(5): S-187

Molander, P.; Färkkilä, M.A.; Ristimäki, A.; Salminen, K.; Kemppainen, H.; Blomster, T.; Koskela, R.; Jussila, A.; Rautiainen, H.; Nissinen, M.; Haapamäki, J.; Arkkila, P.E.; Nieminen, U.; Kuisma, J.; Punkkinen, J. 2014: Elevated Fecal Calprotectin Predicts Relapse in Inflammatory Bowel Disease Patients After Stopping Tnf-Blocking Agents. Gastroenterology 146(5): S-187-S-188

Devlin, S.M.; Melmed, G.Y.; Irving, P.M.; Rubin, D.T.; Kornbluth, A.; Kozuch, P.L.; Raffals, L.H.; Velayos, F.S.; Sparrow, M.; Baidoo, L.; Bressler, B.; Cheifetz, A.S.; Jones, J.; Kaplan, G.; Greene, J. 2014: Recommendations for Creating a High Quality Endoscopy Report for Inflammatory Bowel Disease Patients: Results From a Rand-Appropriateness Panel. Gastroenterology 146(5): S-188

Targownik, L.; Nugent, Z.; Tennakoon, A.; Singh, H.; Bernstein, C.N. 2014: The Prevalence and Persistence of the Use of Biologic Therapy in Inflammatory Bowel Disease in a Population-Based Setting. Gastroenterology 146(5): S-188-S-189

Dinning, P.G.; Patton, V.E.; Jones, M.P.; Stewart, P.; Lubowski, D.Z.; Cook, I.J. 2014: Sa1063 Long-Term Efficacy of Sacral Nerve Stimulation for Treating Slow Transit Constipation. Gastroenterology 146(5): S-189

Almario, C.V.; Chey, W.D.; Kaung, A.; Whitman, C.B.; Fuller, G.; Reid, M.W.; Bolus, R.; Dennis, R.A.; Encarnacion, R.; Martinez, B.M.; Talley, J.; Modi, R.; Agarwal, N.; Lee, A.; Bolus, S. 2014: Sa1064 Computer Automated Evaluation of Gastrointestinal Symptoms (Aegis) Outperforms Physician-Documented History of Presenting Illness (Hpi): Results of a Blinded Comparison. Gastroenterology 146(5): S-189

Marya, N.B.; Baptista, V.; Patel, K.; Barton, B.A.; Foley, A.; Christopher, M.; Cave, D.R. 2014: Sa1067 Development and Validation of a Clinical Scoring System to Differentiate Patients With Inflammatory Bowel Disease and Diarrhea-Predominant Irritable Bowel Disease. Gastroenterology 146(5): S-191

Spungen, A.M.; Asselin, P.K.; Kornfeld, S.D.; Knezevic, S.; Bauman, W.; Korsten, M.A. 2014: Sa1068 Exoskeletal-Assisted Walking in Persons With Paraplegia Improves Bowel Function. Gastroenterology 146(5): S-191

Langhorst, J.; Lauche, R.; Janzen, A.; Lüdtke, R.; Cramer, H.; Dobos, G.J. 2014: Sa1071 Efficacy of Caraway Oil Poultices in the Treatment of Irritable Bowel Syndrome -A Randomized Controlled Cross-Over Trial. Gastroenterology 146(5): S-192

Solem, C.T.; Patel, H.; Mehta, S.; Mody, R.; Katyal, M.; Macahilig, C.; Gao, X. 2014: Sa1072 Symptom Control, Quality of Life, and Treatment Satisfaction in Patients Treated With Lubiprostone vs. Other Treatments for Irritable Bowel Syndrome-Constipation (Ibs-C). Gastroenterology 146(5): S-192

Alioto, A.; Yardley, H.; Yacob, D.; DiLorenzo, C. 2014: Sa1073 Intensive Treatment of Adolescent Rumination Syndrome (Ars) -Predictors of Treatment Outcome. Gastroenterology 146(5): S-192

Jouet, P.; Bellini, M.; Halphen, M.; Sabate, J.-M. 2014: Sa1075 Patient Perspective on Constipation's Characteristics, Impact on Quality of Life, and Treatment Habits and Choice. An International Internet Survey. Gastroenterology 146(5): S-193

Taylor, D.C.; Buono, J.L.; Spalding, W.M.; Carson, R. 2014: Sa1076 The Relationship Between Chronic Constipation Symptoms and Health-Related Quality of Life: Results From 2 Phase 3 Trials. Gastroenterology 146(5): S-193

Shields, H.M.; Fernandez-Becker, N.Q.; Flier, S.N.; Clarke, P.D.; Vaughn, B.P.; Tukey, M.; Kelsey, P.B.; O'Farrell, R.P.; Blanco, P.G.; Kappler, S.; Sepe, P.S.; Berzin, T.M.; Magge, S.; Ketwaroo, G.A.; Xavier-Depina, F. 2014: Sa1077 Volunteer Patients, Small Groups and Mandatory Faculty Development Are Key Elements for Abdominal Examination's Teaching Excellence Over a Five Year Period. Gastroenterology 146(5): S-193

Menees, S.B.; Kurlander, J.; Goel, A.; Powell, C.C.; Chey, W.D. 2014: Sa1079 A Meta-Analysis of the Utility of Common Serum and Fecal Biomarkers in Adults With Ibs. Gastroenterology 146(5): S-194

Tack, J.F.; Capriati, A.; Schumacher, K.; Ligas, F.; Ott, K.; Tonini, G.; Scartoni, S.; Otranto, I.; Nuti, A.; Maggi, C.A. 2014: Sa1080 Concordance Among Outcome Variables Assessing the Response to Treatment With Ibodutant in Irritable Bowel Syndrome With Diarrhea (Ibs-D; the Iris-2 Study). Gastroenterology 146(5): S-194

Wang, Y.T.; Kwok, V.; Tan, S.M.; Yek, M.H.; Ong, W.C.; Barbier, S.; N, B.Y. 2014: Sa1081 Comprehensive Psychological Intervention Program in a Tertiary Gastroenterology Unit Improved the Outcome of Patients With Refractory Functional Gastrointestinal Disorder: A Cohort Study. Gastroenterology 146(5): S-194

Guentner, A.; Menees, S.B.; Saad, R.J.; Chey, W.D. 2014: Sa1082 How Do Us Gastroenterologists Use Over-the-Counter and Prescription Laxatives in Patients With Chronic Constipation?. Gastroenterology 146(5): S-194

Gawron, L.M.; Goldberger, A.R.; Gawron, A.J.; Hammond, C.; Keefer, L. 2014: Sa1083 Disease-Related Pregnancy Concerns and Reproductive Planning in Women With Inflammatory Bowel Disease. Gastroenterology 146(5): S-195

Elseviers, M.M.; Van Camp, Y.P.; Vermeersch, S.; Tanghe, A.; Anneman, L. 2014: Sa1084 Antibiotic Associated Diarrhea: Incidence, Risk Factors and Treatment. Gastroenterology 146(5): S-195

Carrillo-Ramos, M.J.; Duarte-Chang, C.; Maldonado-Perez, B.; Beltran-Castaño, R.; Castro-Laria, L.; Argüelles-Arias, F.; Benitez-Roldan, A.; Caunedo-Alvarez, A.; Pellicer-Bautista, F.; Herrerias, J.M. 2014: Sa1086 Adalimumab or Infliximab for the Treatment of Inflammatory Bowel Disease Patients: Which Is More Effective?. Gastroenterology 146(5): S-196

Payne, M.C.; Osgood, R.; Brown, A. 2014: Sa1087 H. pylori Frequency in a Case Series of 119 Patients With Parasitic Diseases. Gastroenterology 146(5): S-196

Shukla, S.; Munjal, S.; Dimova, R.B.; Mahl, T. 2014: Sa1088 Providing Gastroenterology Care to Rural Patients Through Telemedicine. Gastroenterology 146(5): S-196

Staller, K.; Khalili, H.; Kuo, B. 2014: Sa1090 Bowel Prophylaxis With Sennosides and Docusate Combination Therapy Reduces Inpatient Length of Stay in Heart Failure Patients: A Retrospective Cohort Analysis. Gastroenterology 146(5): S-197

Jung, K.W.; Jo, M.-W.; Kim, S.-H.; Son, W.-S.; Lee, H.J.; Yang, D.-H.; Yoon, I.J.; Seo, S.Y.; Kim, J.-B.; Park, S.H.; Kim, K.-J.; Ye, B.D.; Byeon, J.-S.; Jung, H.-Y.; Yang, S.-K. 2014: Sa1091 Validation of the Eq-5D Questionnaire in Female Patients With Chronic Constipation in a Tertiary Care Center. Gastroenterology 146(5): S-197

Kinsinger, S.W.; Keefer, L. 2014: Sa1094 Mental Health Provider's Use of Psychological Treatments for Gastrointestinal Conditions. Gastroenterology 146(5): S-198

Agreus, L.; Andreasson, A.; Talley, N.J.; Forsberg, A.M.; Hellström, P.M.; Wallner, B. 2014: Sa1095 Gastroesophageal Reflux Symptoms As Predictors of Erosive Esophagitis in the General Population. Gastroenterology 146(5): S-198

Rozati, H.; Zafar, S.; Trevatt, A.; Besherdas, K. 2014: Sa1096 How Well Do We Investigate Iron Deficiency Anaemia With Colonoscopy Following a Normal Gastroscopy?. Gastroenterology 146(5): S-198

Shahnavaz, N.; Carter, L.A.; Harrison, M.S.; Dietz-Lindo, K.A.; Hanfelt, J.; Srinivasan, S.; Christie, J. 2014: Sa1098 The Association Between Socioeconomic Status and Quality of Life of Diabetic Patients With Constipation. Gastroenterology 146(5): S-199

Nojkov, B.; Eswaran, S.L.; Chey, W.D. 2014: Sa1099 Dietary Restrictions Predict Worse Disease-Specific Quality of Life in Patients With Irritable Bowel Syndrome. Gastroenterology 146(5): S-199

Thurler, A.H.; Savitt, L.R.; Dassatti, A.; Guarino, A.J.; Castel, S.; Kuo, B. 2014: Sa1100 Incongruence of Identifying Constipation Prevalence Among Hospitalized Older Patients From the Patient and Healthcare Provider Perspective. Gastroenterology 146(5): S-199

Singh, S.; Al-Darmaki, A.; Frolkis, A.D.; Seow, C.H.; Leung, Y.; Novak, K.L.; Ghosh, S.; Panaccione, R.; Kaplan, G. 2014: Sa1102 Post-Operative Mortality for the Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis of Population-Based Studies. Gastroenterology 146(5): S-200

Knight, T.; D'Sylva, L.; Barish, C.F. 2014: Sa1103 Economic and Medical Resource Use (Mru) Burden of Iron Deficiency Anemia (Ida) in an Inflammatory Bowel Disease (Ibd) Population in the United States (Us). Gastroenterology 146(5): S-200

Nguyen, D.L.; Palmer, L.; McClave, S.A.; Martindale, R.G.; Bechtold, M.L. 2014: Sa1104 Specialized Enteral Nutrition Therapy Improves Initial Response and Long-Term Clinical Remission Among Crohn's Patients on Infliximab Therapy: A Meta-Analysis. Gastroenterology 146(5): S-200-S-201

Ashraf, I.; Nguyen, D.L.; Choudhary, A.; Matteson-Kome, M.L.; Bechtold, M.L. 2014: Sa1105 Ursodiol As a Chemoprotective Agent for Colorectal Cancer in Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Meta-Analysis. Gastroenterology 146(5): S-201

Kopylov, U.; Al-Taweel, T.; Yaghoobi, M.; Bitton, A.; Lakatos, P.L.; Ben-Horin, S.; Seidman, E.G.; Afif, W. 2014: Sa1106 Adalimumab Monotherapy Versus Combination Therapy With Adalimumab and Immunomodulators for Crohn's Disease: A Meta-Analysis. Gastroenterology 146(5): S-201

Abhyankar, A.; Moss, A.C. 2014: Sa1107 Intravenous or Oral Iron to Treat Iron Deficiency in Patients With Inflammatory Bowel Disease. Gastroenterology 146(5): S-201

Thorlund, K.; Druyts, E.; Kanters, S.; Eapen, S.; Mills, E. 2014: Sa1108 Cost-Effectiveness of Golimumab Versus Infliximab and Adalimumab for the Treatment of Moderate to Severe Ulcerative Colitis. Gastroenterology 146(5): S-202

Kotlyar, D.; Lewis, J.D.; Tierney, A.; Blonski, W.; Gisbert, J.P.; Chaparro, M.; Lichtenstein, G.R. 2014: Sa1109 Meta-Analysis of Duration of Exposure to Thiopurines in Association With Development of Lymphoma in Patients With Inflammatory Bowel Disease. Gastroenterology 146(5): S-202

Stidham, R.W.; Lee, T.; Higgins, P.D.; Deshpande, A.R.; Sussman, D.A.; Singal, A.G.; Elmunzer, B.J.J.; Saini, S.D.; Vijan, S.; Waljee, A.K. 2014: Sa1110 Comparing the Effectiveness of Anti-Tnf Agents for the Treatment of Crohn's Disease: a Bayesian Network Meta-Analysis. Gastroenterology 146(5): S-202

Pallotta, N.; Vincoli, G.; Candeloro, L.; Calarco, R.; Corazziari, E. 2014: Sa1112 Pre-Operative Diarrhea and Length of Distal/Terminal Ileal Resection Do Not Predict Post-Operative Diarrhea in Crohn's Disease Patients. Gastroenterology 146(5): S-203

Pallotta, N.; Vincoli, G.; Candeloro, L.; Calarco, R.; Corazziari, E. 2014: Sa1113 In Crohn's Disease (Cd) Patients Small Bowel Prestenotic Dilatation Is Not Related to Severity Degree of Stricture. Gastroenterology 146(5): S-203

Burisch, J.; Pedersen, N.; Cukovic-Cavka, S.; Kaimakliotis, J.; Duricova, D..; Shonova, O.; Vind, I.; Thorsgaard, N.; Andersen, V.; Dahlerup, J.F.; Salupere, R.; Nielsen, K.R.; Manninen, P.; Tsianos, E.V.; Ladefoged, K. 2014: Sa1114 The Cost of Medical Management, Surgery and Clinical Investigations in a European Population-Based Inception Cohort From the Biological Era An Ecco-Epicom Study. Gastroenterology 146(5): S-203

Borges, L.F.; Lucci, M.; Cao, B.; Collins, E.; Vogel, B.; Arthur, E.; Emmons, D.; Korzenik, J.R. 2014: Sa1116 Co-Morbid Psychiatric Disease and Chronic Pain Highly Correlate With Repeat Hospitalization in Inflammatory Bowel Disease Patients. Gastroenterology 146(5): S-204

Govani, S.M.; Waljee, A.K.; Stidham, R.W.; Higgins, P.D. 2014: Sa1117 Increased Ultraviolet Light Exposure Protects Against Inpatient Mortality in Patients With a Primary Diagnosis of Clostridium difficile Infection. Gastroenterology 146(5): S-204

Lördal, M.; Cars, T.; Wettermark, B. 2014: Sa1118 Gender Differences of Ibd Care in the Healthcare Region of Stockholm. Gastroenterology 146(5): S-204

Hatoum, H.T.; Patel, H.; Lin, S.-J.; Mody, R. 2014: Sa1119 Indicators of Inadequate Response to Biologic Therapies in Patients With Crohn's Disease From Real-World Practice Settings. Gastroenterology 146(5): S-204-S-205

Hatoum, H.T.; Patel, H.; Lin, S.-J.; Mody, R. 2014: Sa1120 Indicators of Inadequate Response to Anti-Tumor Necrosis Factor Therapies in Patients With Ulcerative Colitis From Real-World Practice Settings. Gastroenterology 146(5): S-205

de Castro, F.D.; Magalhães, J.; Carvalho, P.; Moreira, M.J.; Cotter, J. 2014: Sa1121 Predictive Factors of the Course of Crohn's Disease Can We Treat in Anticipation?. Gastroenterology 146(5): S-205

Siegel, C.A.; Thompson, K.D.; Walls, D.; Connor, S.J.; Stewart, S.K.; Bewtra, M.; Rubin, D.T.; Baumblatt, G.L.; Holubar, S.D.; Greenup, A.-J.; Sechi, A.; Girgis, A.; Gollins, J. 2014: Sa1122 Patients With Ulcerative Colitis Are More Concerned About Complications of Their Disease Than Side Effects of Medications. Gastroenterology 146(5): S-205

Yokoyama, Y.; Kawai, M.; Kamikozuru, K.; Iimuro, M.; Hida, N.; Miwa, H.; Nakamura, S. 2014: Sa1124 A Report on the Prevalence and Reactivation Rate of Hepatitis B Virus in Patients With Inflammatory Bowel Disease in Japan. Gastroenterology 146(5): S-206

Van Deen, W.K.; Zand, A.; Ha, C.Y.; Kane, E.; Choi, J.M.; Roth, B.E.; Centeno, A.; Esrailian, E.; Homme, D.W. 2014: Sa1125 Challenges in the Work Place: Decreased Work Productivity and Job-Lock in Ibd Patients. Gastroenterology 146(5): S-206

Abdullah, B.; Murphy, T.; Langer, S.L.; Romano, J.; Levy, R. 2014: Sa1126 Physician Measures of Disease Severity Significantly Predict Health-Related Quality of Life in Children With Ibd. Gastroenterology 146(5): S-206

Yassin, N.A.; Dibley, L.; Sim, H.-L.; Phillips, R.K.; Hart, A.L.; Norton, C. 2014: Sa1128 The Anal Fistula Journey: Effects on Patients' Life Experiences. Gastroenterology 146(5): S-207

Flor, L.; Minguez, M.; Tosca, J.; Anton, R.; Bosca-Watts, M.M.; Mora, F. 2014: Sa1129 Fecal Incontinence (Fi) in Patients With Inflammatory Bowel Disease (Ibd). Probably As Important As Prevalent. Gastroenterology 146(5): S-207

Magalhães, J.; de Castro, F.D.; Carvalho, P.; Leite, S.; Moreira, M.J.; Cotter, J. 2014: Sa1130 Validation of a Portuguese Version of the Inflammatory Bowel Disease Disability Score. Gastroenterology 146(5): S-207

Chan, F.K.L.; Cheong, P.K.; Ching, J.; Tse, Y.K.; Lee, V.W.; Wu, J.C.; Arakawa, T. 2014: Sa1132 Proton-Pump Inhibitor (Ppi) Versus Histamine-2 Receptor Antagonist (H2Ra) for the Prevention of Recurrent Upper Gastrointestinal Bleeding (Ugi) in High-Risk Users of Low-Dose Aspirin (Asa): An Interim Analysis. Gastroenterology 146(5): S-208

Chan, F.K.L.; Kee, K.M.; Lee, V.W.; Ching, J. 2014: Sa1133 Rabeprazole for the Prevention of Gastroduodenal Injury Associated With Nonsteroidal Anti-Inflammatory Drugs (Nsaids): A Double-Blind Randomized Trial. Gastroenterology 146(5): S-208

Jasnos, K.; Magierowski, M.; Strzalka, M.; Surmiak, M.; Ptak-Belowska, A.; Kwiecien, S.; Brzozowski, T. 2014: Sa1135 Acceleration of Gastric Ulcer Healing by Carbon Monoxide Releasing Molecule-2 (Corm-2), a Carbon Monoxide Donor. Role of Heme Oxygenase-1, Endogenous Prostaglandins and Lipid Peroxidation. Gastroenterology 146(5): S-209

Bang, C.S.; Baik, G.H.; Kim, J.B.; Suk, K.T.; Yoon, J.H.; Kim, Y.S.; Kim, D.J. 2014: Sa1136 Peptic Ulcer Disease in Liver Cirrhosis and Chronic Hepatitis: Impact of Portal Hypertension. Gastroenterology 146(5): S-209

Kim, B.W.; Kim, J.S.; Yeum, S.C.; Park, S.M. 2014: Sa1138 Comparison of Four Scoring Systems for Predicting Clinical Outcomes in Patients With Non-Variceal Upper Gastrointestinal Bleeding. Gastroenterology 146(5): S-210

Lau, J.Y.; Sung, J.J.Y.; Lind, T.; Persson, T.; Eklund, S. 2014: Sa1139 High-Dose Intravenous Proton Pump Inhibitors for Prevention of Recurrent Peptic Ulcer Bleeding in Chinese and Western Populations: Rebleeding Is Not Influenced by Ethnicity. Gastroenterology 146(5): S-210

Lim, Y.J.; Lee, C.G.; Yang, C.H.; Lee, J.H.; Park, S.J.; Cho, J.Y.; Kim, Y.-T.; Chun, H.J.; Song, S.Y. 2014: Sa1140 The Clinical Features and Treatment Modality of Esophageal Neuroendocrine Tumors: Nationwide Multicenter Study in Korea. Gastroenterology 146(5): S-210

Linghu, E.; Meng, M.; Zhao, P. 2014: Sa1142 Prognosis Analysis of Rectal Neuroendocrine Neoplasm With Different Pathological Grade. Gastroenterology 146(5): S-211

Voellinger, M.T.; Forbes, J.; Trivedi, A.; Joy, G.; Chou, J.; Zhao, X.; Feng, J.; Lim, R.M.; Hughes, M.S.; Millo, C.; Chen, C.C.; Wank, S. 2014: Sa1143 Comparison of Gallium-68 Dotatate With 18-Fdopa Pet/Ct in Patients With Familial Midgut Carcinoid Tumor. Gastroenterology 146(5): S-211

Kim, J.H.; Moon, W.; Park, S.J.; Park, M.I.; Kim, S.E. 2014: Sa1144 Clinical Impact of Endoscopic Ultrasonography for Small Diameter Rectal Neuroendocrine Tumors. Gastroenterology 146(5): S-211

Amin, S.; Kim, M.K.; Lucas, A.L.; Frucht, H. 2014: Sa1146 Increased Survival Over Time of Individuals With Gastrinomas: A Population Based Analysis. Gastroenterology 146(5): S-212

Huba, M.; Taggart, M.W.; Abraham, S.C. 2014: Sa1147 Metastatic Gastrointestinal Neuroendocrine Tumors: Problematic Issues in Diagnosis and Grading. Gastroenterology 146(5): S-212

Cassani, L.S.; Gilger, M.; Lindsey, E.; Shi, C.; Liu, E.H. 2014: Sa1148 Duodenal Carcinoids: A Longitudinal Tertiary Care Experience. Gastroenterology 146(5): S-212

Ruszniewski, P.; Caplin, M.; Valle, J.; Lombard-Bohas, C.; Poston, G.; Perros, P.; Holubec, L.; Fave, G.D.; Smith, D.; Niccoli, P.; Maisonobe, P.; Atlan, P. 2014: Sa1149 Possible Predictors of Patient-Reported Satisfaction With Diarrhea Control Associated With Lanreotide Depot (Lan) Treatment for Carcinoid Syndrome (Cs) in Gastroenteropancreatic Neuroendocrine Tumor (Net) Patients. Gastroenterology 146(5): S-212

Griffiths, A.M.; Crandall, W.; Colletti, R.B.; Ruemmele, F.; Faubion, W.A.; Hyams, J.S.; Lazar, A.; Li, Y.; Eichner, S.; Thakkar, R. 2014: Sa1151 Steroid-Free Remission in Adalimumab-Treated Pediatric Patients With Moderately to Severely Active Crohn's Disease in the ImagIne 1 Trial. Gastroenterology 146(5): S-213

Hyams, J.S.; Ruemmele, F.; Colletti, R.B.; Kierkus, J.; Rosh, J.R.; Eichner, S.; Lazar, A.; Li, Y.; Thakkar, R. 2014: Sa1153 Impact of Concomitant Immunosuppressant Use on Adalimumab Efficacy in Children With Moderately to Severely Active Crohn's Disease: Results From ImagIne 1. Gastroenterology 146(5): S-214

Shavrov, A.; Kharitonova, A.; Claggett, B.; Shavrov, A.; Liu, J.J. 2014: Sa1154 The Predictive Value of Probe-Based Confocal Laser Endomicroscopy (pCle) Findings in Pediatric Inflammatory Bowel Disease Patients. Gastroenterology 146(5): S-214

Béhal, H.; Ley, D.; Gower-Rousseau, C.; Duhamel, A.; Fumery, M.; Vasseur, F.; Michaud, L.; Rousseau, I.; Savoye, G.; Turck, D. 2014: Sa1155 Growth Pattern and Growth Failure in Paediatric Crohn's Disease Are Related to Inflammatory Status but Not to Duration of Steroid Therapy. Gastroenterology 146(5): S-214

Granados, H.; Draghi, A.; Sylvester, F.A.; Vella, A. 2014: Sa1157 Normal Programmed Death-1 Expression in Peripheral Blood T-Cells, but Not Monocytes in Children With New Onset Crohn Disease. Gastroenterology 146(5): S-215

Granados, H.; Draghi, A.; Vella, A.; Sylvester, F.A. 2014: Sa1158 Increased Serum Lipopolysaccharide in Crohn's Disease Is Associated With Alterations in Toll-Like Receptor Expression in Peripheral Blood. Gastroenterology 146(5): S-215

Badalyan, V.; Sebastian, T.; Behrle, A.; Alston, M.; Clore, E.; Conklin, L.; Snyder, J. 2014: Sa1160 Laboratory Evaluation for Patients on Regular Infliximab Infusions: What Frequency Is Required?. Gastroenterology 146(5): S-216

Otley, A.R.; Grant, A.; Johanns, J.; Padgett, L.; Blank, M.; Hyams, J.S. 2014: Sa1161 Impact-Iii Demonstrates Excellent Sensitivity in Reflecting Clinical Change in the T72 Trial of Infliximab for Pediatric Ulcerative Colitis. Gastroenterology 146(5): S-216

Kaplan, J.L.; Bhasin, M.; Moran, C.J.; Libermann, T.A.; Winter, H. 2014: Sa1162 Transcriptional Profiling of Peripheral Blood Mononuclear Cells Identifies Genes and Gene Pathways Associated With Pediatric Ibd and That Differentiate Crohn's Disease and Ulcerative Colitis. Gastroenterology 146(5): S-216

Albenberg, L.; Chehoud, C.; Judge, C.; Grunberg, S.; Bittinger, K.; Baldassano, R.; Lewis, J.D.; Bushman, F.D.; Wu, G.D. 2014: Sa1163 Its Gene Sequencing Reveals a Unique Fungal Signature in the Gut Microbiota of Pediatric Patients With Inflammatory Bowel Disease. Gastroenterology 146(5): S-217

Giffin, N.; Grant, A.; Mahdi, G.; Rashid, M.; Otley, A.R. 2014: Sa1164 Exclusive Enteral Nutrition Optimizes Growth Outcomes Versus Corticosteroid Therapy for Pediatric Crohn's Disease. Gastroenterology 146(5): S-217

Draghi, A.; Ramanarasimhaiah, R.; Fernandez, M.L.; Vella, A.T.; Sylvester, F.A. 2014: Sa1165 Colonic Osteoprotegerin: Higher Expression in Children With Ulcerative Colitis Than Crohn's Disease. Gastroenterology 146(5): S-217

Lin, C.-H.; Parkman, R. 2014: Sa1167 Effect of Anti-Tumor Necrosis Factor (Tnf) - Therapy on Regulatory T Lymphocytes in a Child With Severe Crohn's Disease. Gastroenterology 146(5): S-218

Varela, B.R.; Shin, D.; Perl, D.; Zhou, E.; Lee, M.H.; Protano, M.-A.; Richards-Kortum, R.; Gaisa, M.; Anandasabapathy, S. 2014: Sa1168 High-Resolution Microendoscopy (Hrme) in the Detection of Anal Intraepithelial Neoplasia: A Quantitative Approach to Optimize Diagnostic Accuracy. Gastroenterology 146(5): S-218

Rastogi, A.; Gupta, N.; Sinh, P.; Sharma, P.; Wani, S.; Bansal, A. 2014: Sa1169 Performance of Gastroenterology (Gi) Trainees in Real-Time Characterization of Diminutive Polyp (Dp) Histology With Narrow Band Imaging (Nbi) -Results From a Prospective Trial. Gastroenterology 146(5): S-218

David, W.J.; Qumseya, B.J.; Bartel, M.J.; Badillo, R.J.; Bhalla, R.; Brahmbhatt, B.; Melendez-Rosado, J.; Moris, M.; Kröner, T.; Wolfsen, H.C.; Wallace, M.B. 2014: Sa1171 Interobserver Agreement for Differentiating Normal vs. Barrett's Esophagus and Erosive vs. Non Erosive Esophagitis Using Volumetric Laser Endomicroscopy Imaging Technique. Gastroenterology 146(5): S-219

Arsenescu, R.; Yearsley, M.M.; Arsenescu, V.; Frankel, W.L. 2014: Sa1172 Probe-Based Confocal Laser Endomicroscopy (pCle) Provides Reliable, Real Time Assessment During Colonoscopy in Patients With Inflammatory Bowel Disease. Gastroenterology 146(5): S-219

Riba, A.; Olier, M.; Lencina, C.; Bacquie, V.; Harkat, C.; Gillet, M.; Cartier, C.; Baron, M.; Sommer, C.; Mallet, V.; Theodorou, V.; Ménard, S. 2014: Sa1173 Early Maternal Separation Induced Commensal E. Coli Overgrowth Associated With Specific Immune Response in Mice At Adulthood. Gastroenterology 146(5): S-219

Kasir, R.; Zakko, S.F.; Lee, A.; Zakko, P.; Dhingra, S.; Adler, M. 2014: Sa1174 Criteria of a Lactulose Breath Test Predictive of Response to Antibiotic Therapy in Patients With the Irritable Bowel Syndrome. Gastroenterology 146(5): S-219-S-220

Jakobsson, S.; Björkman, I.; Ung, E.J.; Törnblom, H.; Simren, M. 2014: Sa1175 Fatigue: A Distressing Symptom in Patients With Irritable Bowel Syndrome (Ibs). Gastroenterology 146(5): S-220

Opekun, A.R.; Balesh, A.M.; Hernandez, K.; Shelby, H.T.; Graham, D.Y. 2014: Sa1176 Sucrase-Insufficiency-Related Irritable Bowel Syndrome. Gastroenterology 146(5): S-220

Wouters, M.M.; Dooley, J.; Van Wanrooij, S.; Loan, A.N.T.; Franckaert, D.; Liston, A.; Boeckxstaens, G.E. 2014: Sa1177 Study on the Mechanism of Action Underlying the Therapeutic Effect of the Histamine 1 Receptor Antagonist Ebastin in Ibs. Gastroenterology 146(5): S-220

Jung, K.W.; Cho, Y.H.; Park, Y.-O.; Yoon, S.Y.; Lee, J.; Kim, J.W.; Yang, D.-H.; Yoon, I.J.; Seo, S.Y.; Lee, H.J.; Park, S.H.; Kim, K.-J.; Ye, B.D.; Byeon, J.-S.; Jung, H.-Y. 2014: Sa1179 Prevalence of Fructose Malabsorption in Patients With Irritable Bowel Syndrome After Excluding Small Intestinal Bacterial Overgrowth. Gastroenterology 146(5): S-221

Dahlstrom, A.K.; Ashwood, P. 2014: Sa1180 Epstein Barr Virus (Ebv) Infection -A Common Cause of Functional Abdominal Pain (Fap) in Children With and Without Autism. Gastroenterology 146(5): S-221

Guo, X.-W.; Zhang, F.-C.; Liang, L.-X.; Huang, D.; Zhao, Y.-Z.; Ye, H.-L.; Zhang, G. 2014: Sa1182 Evaluation of Micro Rnas Expression in Irritable Bowel Syndrome: A Pilot Study. Gastroenterology 146(5): S-222

Freede, M.; Proskin, H.M.; McRorie, J.; Leasure, A.R.; Miner, P.B.; Hatch, D.A. 2014: Sa1184 A Comparison of Rectal and Esophageal Sensitivity in Women With Functional Heartburn. Gastroenterology 146(5): S-223

Fourie, N.H.; Wang, D.; Smyser, P.A.; Abey, S.; Sherwin, L.; Rahim-Williams, B.; Henderson, W.A. 2014: Sa1185 Dysbiosis of the Mucosa-Adherent Microbiome in Patients With Irritable Bowel Syndrome. Gastroenterology 146(5): S-223

Li, L.; Xiong, L. 2014: Sa1186 Meta-Analysis: Cognitive-Behavioral Therapy for Irritable Bowel Syndrome. Gastroenterology 146(5): S-223

Horie, H.; Handa, O.; Kishimoto, S.; Onozawa, Y.; Horii, Y.; Suzuki, K.; Uehara, Y.; Fukuda, W.; Inada, Y.; Iida, T.; Qin, Y.; Higashimura, Y.; Mizushima, K.; Okayama, T.; Yoshida, N. 2014: Sa1187 The Role of Serotonin in the Regulation of Intestinal Epithelial Cell Permeability. Gastroenterology 146(5): S-224

Uchida, E.; Uchiyama, S.; Yamada, E.; Sakai, E.; Ohkubo, H.; Higurashi, T.; Endo, H.; Takahashi, H.; Inamori, M.; Maeda, S.; Nakajima, A. 2014: Sa1188 Location of Diverticular Disease and Irritable Bowel Syndrome: A Multicenter Prospective Study in Japan. Gastroenterology 146(5): S-224

Rios, J.D.; Becker, F.; Jordan, P.A.; Sheth, A.; Wang, Y.; Castor, J.L.P.; Castor, T.P.; Al-Kofahi, M. 2014: Sa1189 Zindol Inhibits 5-Ht Induced Contraction of Human Intestinal Smooth Muscle, Mechanistic Implications for Ibd/Ibs Therapy. Gastroenterology 146(5): S-224

Hassan, S.A.; Lee, E.L.; Shokrani, B.; Laiyemo, A.O.; Panchal, H.J.; Brim, H.; Paydar, M.; Haidary, T.; Nouraie, M.; Ashktorab, H. 2014: Sa1190 Ulcerative Colitis and Risk of Adenoma in African Americans. Gastroenterology 146(5): S-224

Gudleski, G.D.; Li, X.; Ma, C.; Dunlap, L.J.; Baweja, V.; Satchidanand, N.; Keefer, L.; Lackner, J.M. 2014: Sa1191 Modeling Health Care Utilization in Irritable Bowel Syndrome Patients: Distinguishing Factors That Influence the Decision to Consult a Doctor From Those That Influence Frequency of Doctor Visits. Gastroenterology 146(5): S-224

Mosli, M.H.; Feagan, B.G.; Zou, G.; Geboes, K.; Langner, C.; Peterson, M.R.; Pai, R.; Sandborn, W.; D'Haens, G.R.; Vandervoort, M.K.; Behling, C.; Kaplan, K.J.; Shackelton, L.M.; Jones, J.; Khanna, R. 2014: Sa1192 Agreement of Central Readers in the Evaluation of Histopathological Disease Activity in Ulcerative Colitis. Gastroenterology 146(5): S-225

Ali, T.; Zhao, D.; Crosby, A.; Orr, W.C.; Madhoun, M.F.; Rubin, D.T. 2014: Sa1193 Daytime Dysfunction in Patients With Inflammatory Bowel Disease Associated With Mucosal Inflammation: A Cross Sectional Study. Gastroenterology 146(5): S-225

Khanna, R.; D'Haens, G.R.; Feagan, B.G.; Sandborn, W.; Vandervoort, M.K.; Zou, G.; Rolleri, R.L.; Paterson, C.; Forbes, W.P.; Bortey, E.; Levesque, B.G. 2014: Sa1195 Patient Reported Outcome Measures Derived From the Crohn's Disease Activity Index: Correlation Between Pro2 and Pro3 Scores and Cdaidefined Clinical Thresholds. Gastroenterology 146(5): S-226

Goren, I.; Yahav, L.; Tulchinsky, H.; Dotan, I. 2014: Sa1197 Ulcerative Colitis Patients After Pouch Operation Are Serologically More Comparable to Crohn's Disease Patients. Gastroenterology 146(5): S-227

Gecse, K.; Lowenberg, M.; Bossuyt, P.; Rutgeerts, P.J.; Vermeire, S.; Stitt, L.; Vandervoort, M.K.; Sandborn, W.; Feagan, B.G.; Samaan, M.A.; Khanna, R.; Dubcenco, E.; Levesque, B.G.; D'Haens, G.R. 2014: Sa1198 Agreement Among Experts in the Endoscopic Evaluation of Postoperative Recurrence in Crohn's Disease Using the Rutgeerts Score. Gastroenterology 146(5): S-227

Lockton, S.; Shah, D.; Princen, F.; Hauenstein, S.; Singh, S.; Levesque, B.G.; Sandborn, W.; Feaga, B.G. 2014: Sa1200 Presence and Concentration of OmpC As a Risk Factor for Developing Antibodies to Infliximab (Ati): Implications for Selecting Patients With Inflammatory Bowel Disease (Ibd) for Combination Therapy. Gastroenterology 146(5): S-228

Schoepfer, A.; Schaffer, T.; Seibold, F. 2014: Sa1202 Serum Ficolin-2 Correlates Worse Than Fecal Calprotectin and Crp With Endoscopic Crohn's Disease Activity. Gastroenterology 146(5): S-229

van Deen, W.K.; Choi, J.M.; Zand, A.; Ha, C.Y.; Inserra, E.K.; Eimers, L.; Centeno, A.; Roth, B.E.; Cole, D.; Getzug, T.; Kane, E.; Connolly, L.S.; Ovsiowitz, M.; Ho, A.D.; van Oijen, M.G. 2014: Sa1203 The Development of e-Health Tools for the Management of Inflammatory Bowel Diseases. Gastroenterology 146(5): S-229

Chongthammakun, V.; Lopez, R.; She, B. 2014: Sa1204 Correlation of Rutgeerts Score and Postoperative Recurrence of Crohn's Disease in Patients With End Ileostomy. Gastroenterology 146(5): S-229

Horst, S.; Schwartz, D.A.; Wang, S.; Johnson, S.J.; Thakkar, R.; Eichner, S.; Skup, M.; Chao, J.; Mulani, P. 2014: Sa1205 Association Between Disease Activity and Depression Among Patients With Moderate to Severe Crohn's Disease. Gastroenterology 146(5): S-230

Lukas, M.; Kasalicky, M.; Duricova, D..; Lukas, M.; Machkova, N.; Hruba, V.; Bortlik, M. 2014: Sa1206 Risk of Short-Term Endoscopic Recurrence of Crohn's Disease After Ileo-Colonic Resection: Results From a Single, Tertiary Ibd Center. Gastroenterology 146(5): S-230

Brandse, J.F.; Bennink, R.J.; Van Eeden, S.; Baars, P.A.; Lowenberg, M.; Ponsioen, C.; van den Brink, G.R.; D'Haens, G.R. 2014: Sa1207 Leukocyte Scintigraphy As a Tool to Measure Inflammatory Load in Ulcerative Colitis. Gastroenterology 146(5): S-230

Nuij, V.J.; Fuhler, G.; Peyrin-Biroulet, L.; van der Woude, C.J. 2014: Sa1208 Predicting Undesirable Disease in Newly Diagnosed Ibd Patients, Results From the Delta Cohort. Gastroenterology 146(5): S-230

Naganuma, M.; Matsuoka, K.; Hisamatsu, T.; Hosoe, N.; Kashiwagi, K.; Kanai, T.; Ogata, H. 2014: Sa1209 Mr Enterography Is Useful to Detect Intestinal Lesions of Crohn's Disease in Patients Who Are Treated With Biologics. Gastroenterology 146(5): S-231

Kucharzik, T.; Maaser, C.; Nurwakagari, P.; Rath, S.; Wittig, B.M.; Schwarz, M. 2014: Sa1210 Bowel Ultrasound Is Useful in Crohn's Disease Monitoring: Preliminary Results From the Trust Study in Germany. Gastroenterology 146(5): S-231

Kanaoka, S.; Kuriyama, S.; Iwaizumi, M.; Yamada, T.; Sugimoto, M.; Osawa, S.; Sugimoto, K.; Hosoda, Y.; Sato, Y.; Yamada, M.; Shigeto, Y.; Kawakami, K.; Nakai, K.; MIyajima, H. 2014: Sa1211 Fecal Hemoglobin As a Marker for Mucosal Inflammation of Ulcerative Colitis: Usefulness of Combination With Rachmilewitz's Clinical Activity Index. Gastroenterology 146(5): S-231

Mikolajczyk, A.E.; Watson, S.; Ackerman, M.T.; Goeppinger, S.R.; Hart, J.; Turner, J.R.; van Rubin, D.T. 2014: Sa1213 Assessment of the Degree of Variation of Histologic Inflammation in Ulcerative Colitis. Gastroenterology 146(5): S-232

Magnusson, M.K.; Strid, H.; Isaksson, S.; Lasson, A.; Ung, K.-A.; Bajor, A.; Ohman, L. 2014: Sa1214 Reduced Monocyte Activation and Recruitment Two Weeks After Treatment Start Reflect Early Infliximab Therapy Response in Patients With Ulcerative Colitis. Gastroenterology 146(5): S-232

Mooiweer, E.; Severs, M.; Schipper, M.E.; Fidder, H.; Siersema, P.D.; Laheij, R.; Oldenburg, B. 2014: Sa1215 Fecal Calprotectin Can Predict Relapse in Inflammatory Bowel Disease Patients in Endoscopic Remission: A Plea for Extreme Deep Remission?. Gastroenterology 146(5): S-233

Buisson, A.; Barnich, N.; Goutte, M.; Vazeille, E.; Minet-Quinard, R.; Pereira, B.; Bommelaer, G. 2014: Sa1216 Faecal Lipocalin-2 As Biomarker in the Evaluation of Crohn's Disease Activity. Gastroenterology 146(5): S-233

Wong, C.; Kalra-Lall, A.; Rubinov, J.; Amoruso, L.; Singh, S.; Gluckman, C.; Hudesman, D. 2014: Sa1217 Pre-Infliximab Infusion Serum Vitamin D3 Levels in Moderate to Severe Inflammatory Bowel Disease Patients Predicts Higher Infliximab Dose Requirements and Hospitalization Rates. Gastroenterology 146(5): S-233

Rodrigues, S.; Cardoso, H.; Rosa, B.; Marques, M.; Lopes, S.; Albuquerque, A.; Magro, F.; Carvalho, P.; Moreira, M.J.; Cotter, J.; Macedo, G. 2014: Sa1218 Predictive Factors of Proximal Small Bowel Crohn's Disease Detected At Capsule Endoscopy. Gastroenterology 146(5): S-233

Targownik, L.; Sexton, K.A.; Bernstein, M.T.; Walker, J.R.; Graff, L.A.; Miller, N.; Rogala, L. 2014: Sa1220 The Effect of Psychological Distress and Perceived Stress on Change in Symptom Activity and Inflammation Over Time in Crohn's Disease. Gastroenterology 146(5): S-234

Daperno, M.; Comberlato, M.; Bossa, F.; Bonanomi, A.G.; Lombardi, G.; Biancone, L.; Cosintino, R.; D'Inca, R.; Cassinotti, A.; Mangiarotti, R.; Papa, A.; Pica, R.; Rizzello, F.; Armuzzi, A.; Orlando, A. 2014: Sa1221 Increasing Interobserver Agreement on Ibd Endoscopic Scoring Systems: Results From the Igibdendo Educational Program. Gastroenterology 146(5): S-234

Langhorst, J.; Boone, J.H.; Lauche, R.; Rueffer, A.; van Dobos, G.J. 2014: Sa1222 Fecal Lactoferrin, Calprotectin, Pmn-Elastase, Crp and White Blood Count As Indicator for Clinical Course of Disease and Mucosal Healing in Patients With Ulcerative Colitis: A Prospective 12-Month Monitoring Study. Gastroenterology 146(5): S-234

Mañosa, M.; Calafat, M.; de Francisco, R.; Caparrós, C.G.; Casanova, M.J.; Huelín, P.; Calvo, M.; Salazar, L.F.; Minguez, M.; Ruiz-Cerulla, A.; Zabana, Y.; Bastida, G.; Hinojosa, J.; Marquez, L.; Acosta, M.B. 2014: Sa1223 Phenotypic Characteristics and Use of Therapeutic Resources in Elderly-Onset Inflammatory Bowel Disease: A Multicentre, Case-Control Study. Gastroenterology 146(5): S-235

García-Planella, E.; Mañosa, M.; Chaparro, M.; Acosta, M.B.; Beltran, B.; Ricart, E.; García-Sánchez, V.; Esteve, M.; Piqueras, M.; Bermejo, F.; López-SanRomán, A.; Taxonera, C.; Llao, J.; Gisbert, J.P.; Cabré, E. 2014: Sa1224 Usefulness of a Faecal Calprotectin Rapid Semiquantitative Test in Predicting Relapse in Patients With Ulcerative Colitis in Remission. Gastroenterology 146(5): S-235

Lin, J.-F.; Chen, J.-M.; Nie, B.; Jiang, B. 2014: Sa1225 Meta-Analysis: Faecal Calprotectin for Assessment of Inflammatory Bowel Disease Activity. Gastroenterology 146(5): S-235

Ramos Rivers, C.M.; Regueiro, M.; Dunn, M.A.; Szigethy, E.; Schwartz, M.; Barrie, A.; Hashash, J.G.; Swoger, J.M.; Baidoo, L.; van Binion, D.G. 2014: Sa1227 Clinical Characteristics of Inflammatory Bowel Disease (Ibd) Patients Who Call After Hours. Gastroenterology 146(5): S-236

Ramos Rivers, C.M.; Regueiro, M.; Dunn, M.A.; Szigethy, E.; Hashash, J.G.; Schwartz, M.; Barrie, A.; Baidoo, L.; Swoger, J.M.; van Binion, D.G. 2014: Sa1228 Association of Telephone Activity With Clinical Features in Inflammatory Bowel Disease (Ibd): A Prospective Validation Study. Gastroenterology 146(5): S-236

Godskesen, L.; Mortensen, J.H.; Klinge, L.; Jensen, M.D.; Krag, A.; Karsdal, M.A.; Kjeldsen, J.; Bay-Jensen, A.-C. 2014: Sa1230 Specific Fragments of Extracellular Matrix Proteins Reflect Disease Activity in Ulcerative Colitis. Gastroenterology 146(5): S-237

Abhyankar, A.; Ham, M.; Bai, A.; Cheifetz, A.S.; Robson, S.C.; Moss, A.C. 2014: Sa1231 Elevated Serum Il-17 Levels in Crohn's Disease Correlate With Disease Activity but Do Not Predict Response to Infliximab. Gastroenterology 146(5): S-237

Bodini, G.; Savarino, V.; Dulbecco, P.; Baldissarro, I.; Savarino, E. 2014: Sa1233 Tnf- Levels Strongly Correlated With Disease Activity Based on Hbi and Cdeis in Patients With Crohn's Disease in Maintenance Treatment With Adalimumab. Gastroenterology 146(5): S-238

Kevans, D.; Kabakchiev, B.; Qiang, J.; Stempak, J.M.; Croitoru, K.; Nguyen, G.C.; Steinhart, A.H.; Silverberg, M.S. 2014: Sa1234 Rna-Seq Derived Whole Blood Gene Expression Signature As a Biomarker for Differential Diagnosis and Intestinal Inflammation in Inflammatory Bowel Disease. Gastroenterology 146(5): S-238

Marin, R.; Khalili, H.; Ananthakrishnan, A.N.; Sauk, J.; Yajnik, V.; Gupta, N.; Xavier, R.J.; van Nguyen, D.D. 2014: Sa1235 Pkm2 As a Novel Serum Biomarker of Ibd Activity, A Early Pilot Study. Gastroenterology 146(5): S-238

Frederiksen, M.T.; Ainsworth, M.A.; Brynskov, J.; Thomsen, O..; Bendtzen, K.; Steenholdt, C. 2014: Sa1236 Antibodies Against Infliximab Are Associated With Increased Risk of Anti-Adalimumab Antibody Development in Patients With Inflammatory Bowel Disease. Gastroenterology 146(5): S-238

Billiet, T.; de Bruyn, M.; Ballet, V.; Claes, K.; Liu, X.; Kirkland, R.; Drake, K.; Lockton, S.; Princen, F.; Singh, S.; Ferrante, M.; van Assche, G.A.; Rutgeerts, P.J.; Cleynen, I.; Vermeire, S. 2014: Sa1237 Prediction of Primary Response to Infliximab in Crohn's Disease: A Matrix-Based Prediction Model. Gastroenterology 146(5): S-239

Juillerat, P.; Andrew, P.M.; Macpherson, J.; Slack, E.; Cahenzli, J.; Seibold, F.; McCoy, K.D.; van Macpherson, A.J. 2014: Sa1238 Cd62L (L-Selectin) Shedding for Assessment of Functional Blockade of Tnfalpha in Anti-Tnf Treated Inflammatory Bowel Disease Patients: Clinical Feasibility and Perspectives. Gastroenterology 146(5): S-239

Fiorino, G.; Allocca, M.; Bonifacio, C.; Naccarato, P.; Sposta, F.M.; Spinelli, A.; Balzarini, L.; Danese, S. 2014: Sa1240 LMann Index Assessment Overtime in Crohn's Disease Patients Treated With Anti Tnfs: A Pilot Observational Cohort Study. Gastroenterology 146(5): S-240

Looney, C.; Fuh, F.; Tang, M.T.; Wei, X.; Keir, M.E.; Tew, G.W.; Eastham-Anderson, J.; Diehl, L.; Salas, A.; DeHertogh, G.; Francom, S.; Gilbert, H.; Luca, D.; Egen, J.G.; Vermeire, S. 2014: Sa1241 Pharmacology of Etrolizumab in a Phase 2 Study in Moderate-to-Severely Active Ulcerative Colitis. Gastroenterology 146(5): S-240

Merkley, S.A.; Horst, S.N.; Beaulieu, D.B.; Duley, C.; Annis, K.; Nohl, A.J.; van Schwartz, D.A. 2014: Sa1242 The Use of Ivig in Ibd Patients With Contraindications or Who Are Unresponsive to Conventional Treatment for Inflammatory Bowel Disease. Gastroenterology 146(5): S-240

Steenholdt, C.; Bendtzen, K.; Brynskov, J.; Thomsen, O..; Ainsworth, M.A. 2014: Sa1243 Clinical Implications of Measuring Drug and Anti-Drug Antibodies by Different Assays When Optimizing Infliximab Treatment Failure in Crohn's Disease. Gastroenterology 146(5): S-240

Maranville, J.C.; Hanauer, S.B.; DiRienzo, A.; Kupfer, S. 2014: Sa1244 In Vitro Sensitivity Assays and Clinical Response to Glucocorticoids in Patients With Inflammatory Bowel Disease. Gastroenterology 146(5): S-241

Pedersen, N.; Vinding, K.K.; Vegh, Z.; Casén, C.; Ankersen, D.V.; Carlsen, K.; Petersen, A.M.; Burisch, J.; Munkholm, P. 2014: Sa1245 Gut Microbiota in Ibd Patients With Ibs Before and After 6 Weeks of Low Fodmap Diet. Gastroenterology 146(5): S-241

Baert, F.J.; Lockton, S.; Hauenstein, S.; Singh, S.; Gils, A.; Vermeire, S. 2014: Sa1247 Antibodies to Adalimumab Predict Inflammation in Crohn's Patients on Maintenance Adalimumab Therapy. Gastroenterology 146(5): S-242

Casteele, N.V.; Peeters, M.; Compernolle, G.; Ferrante, M.; van Assche, G.A.; Vermeire, S.; Gils, A. 2014: Sa1248 Tnf-Responsive Cellular Based Assay Reveals Neutralizing Capacity of Anti-Adalimumab Antibodies in Crohn's Disease and Ulcerative Colitis Patients. Gastroenterology 146(5): S-242

Casteele, N.V.; Drake, K.; Hauenstein, S.; Levesque, B.G.; Singh, S.; Sandborn, W. 2014: Sa1249 Infliximab and Antibody to Infliximab Concentrations in 7,613 Patients Shows Indication for Testing, Association With Loss of Response and Provides New Insights Into Binding Characteristics of Anti-Drug Antibodies. Gastroenterology 146(5): S-242

Dotan, I.; Yanai, H.; Ron, Y.; Kariv, R.; Fishman, S.; Yahav, L.; Ben-Yehoyada, M.; Santo, E.; van Mould, D.R. 2014: Sa1250 Population Pharmacokinetic Evaluation of Adlimumab Reveals Patient Factors That Increase Adalimumab Clearance and Shorten Half-Life in Inflammatory Bowel Disease Patients. Gastroenterology 146(5): S-243

Arranz, M.D.M.ín; Arranz, E.M.; Salcedo, D.P.; DeDiego, C.; Senent, S.G.; Cordon, J.P.; Garcia, B.B.; Parga, J.M.S. 2014: Sa1251 Infliximab Trough Levels and Antibodies: Relationship With Infusion Reaction, Immunomodulators and Biological Parameters. Gastroenterology 146(5): S-243

Willrich, M.A.V.; Murray, D.L.; Barnidge, D.R.; Ladwig, P.M.; Snyder, M. 2014: Sa1252 Serum Infliximab Quantitation by Lc-Ms/Ms in Patients Treated for Inflammatory Disorders. Gastroenterology 146(5): S-243

Yarur, A.; Drake, K.; Kubiliun, M.; Dauer, R.M.; Sussman, D.A.; Hauenstein, S.; Quintero, M.A.; Singh, S.; Barkin, J.S.; van Abreu, M.T. 2014: Sa1254 Anti-Tumor Necrosis Factor Levels Are Not Associated With Intestinal Extent of Mucosal Inflammation in Patients With Inflammatory Bowel Diseases. Gastroenterology 146(5): S-244

Krajcovicova, A.; Hlavaty, T.; Killinger, Z.; Miznerova, E.; Toth, J.; Cierny, D.; Koller, T.; Letkovsky, J.; Zelinkova, Z.; Huorka, M.; Payer, J. 2014: Sa1256 Combined Immunosuprpession, Corticoids and Menopause Have Significant Influcence on Bone Mineral Density in Ibd Patients. A Prospective Study. Gastroenterology 146(5): S-245

Leclerc, M.; Marotte, H.; Paul, S.; Del Tedesco, E.; Phelip, J.M.; Peyrin-Biroulet, L.; Roblin, X. 2014: Sa1257 Persistence of Antibodies to Infliximab for More Than Two Months Predicts Loss of Response to Infliximab in Inflammatory Bowel Diseases. Gastroenterology 146(5): S-245

Ungar, B.; Anafy, A.; Kopylov, U.; Ron, Y.; Yanai, H.; Dotan, I.; Chowers, Y.; Eliakim, A.R.; Ben-Horin, S. 2014: Sa1258 The Clinical and Immunological Significance of Low Level of Infliximab in the Absence of Anti-Infliximab Antibodies in Patients With Ibd. Gastroenterology 146(5): S-245

Maldonado-Perez, B.; Vázquez-Gámez, M.A.; Castro-Laria, L.; Montoya-Garcia, M.J.; Perez-Cano, R.; Herrerias, J.M. 2014: Sa1259 Prospective Study of Prevalence an Incidence of Vertebral Fractures in Long-Term Anti-Tnf Alpha Maintenance Therapy Treatment for Inflammatory Bowel Disease. Gastroenterology 146(5): S-246

Lasch, K.; Glauser, T.A.; Ursos, L.; Erickson, J.; Nevins, P.H.; Salinas, G. 2014: Sa1260 Practice Patterns in the Management of Patients With Inflammatory Bowel Disease: Results of a National Survey of Gastroenterologists. Gastroenterology 146(5): S-246

Annunziata, M.L.; Papparella, L.G.; Sansoni, I.; Balestrieri, P.; Cicala, M. 2014: Sa1261 Normalized Wall Thickness At Mre Predicts Clinical Remission in Crohn's Disease After Infliximab Discontinuation: A 5 Years' Follow-Up Study. Gastroenterology 146(5): S-246

Blaker, P.A.; Fong, S.C.; Smith, M.A.; Kariyawasam, V.C.; Marinaki, A.M.; Irving, P.M.; van Sanderso, J.D. 2014: Sa1262 The Impact of Thiopurine Hypermethylation on Clinical Outcomes in Patients With Inflammatory Bowel Disease. Gastroenterology 146(5): S-246

Vadan, R.; Gheorghe, L.; Diculescu, M.; Iacob, R.; Bancila, I.; Cotruta, B.; Greere, M.; Mateescu, B.; Gheorghe, C. 2014: Sa1263 Endoscopic Follow Up of Patients With Ibd and Biological Treatment: Achievement and Persistence of Mucosal Healing in Patients With Clinical Remission. Gastroenterology 146(5): S-247

Echarri, A.; Ferreiro, R.; Fraga-Iriso, R.; Acosta, M.B.; Cid, J.; De-Castro, L.; Pereira, S.; Fernández-Villaverde, A.; Soto, S.; Carpio, D.; Gonzalez, B.; Castro, E.; Ollero, V.; Campos, A.C. 2014: Sa1264 Drug Trough Levels and Primary Nonresponse to antiTnf Therapy in Moderate-Severe Crohn Disease. Results of the Optimiza Study. Gastroenterology 146(5): S-247

Gisbert, J.P.; Marin, A.C.; McNicholl, A.G.; Chaparro, M. 2014: Sa1265 Meta-Analysis on the Efficacy of a Second-Line Anti-Tnf in Inflammatory Bowel Disease Patients With Failure to a Previous Anti-Tnf Treatment. Gastroenterology 146(5): S-247

Johnson, H.E.; Weaver, S.; van McLaughlin, S.D. 2014: Sa1266 Low Dose Azathioprine and Allopurinol in Azathioprine Intolerant Patients: Is It Tolerated and Is It Effective in Ibd?. Gastroenterology 146(5): S-247

Balsanek, J.; Willrich, M.A.V.; Murray, D.L.; Snyder, M. 2014: Sa1268 Clinical Development of an Electrochemiluminescent Immunoassay to Measure Antibodies-to-Infliximab. Gastroenterology 146(5): S-248

Hester, K.D.; Liu, X.; Salbato, J.; Lockton, S.; Hauenstein, S.; Singh, S. 2014: Sa1269 Improved Homogeneous Mobility Shift Assay (Hmsa) for the Detection of Neutralizing Antibodies (Nab) in Ibd Patients Treated With Infliximab or Adalimumab. Gastroenterology 146(5): S-248

Mantzaris, G.J.; Karatzas, P.; Kyriakos, N.; Archavlis, E.J.; Papamichael, K.; Tzannetakou, X.; Internos, I.; Anastasiadis, S.; Tsironikos, D.; Drougas, I. 2014: Sa1270 Can We Increase the Dose Interval of Infliximab to 10 Weeks Without Risking Loss of Response in Patients With Crohn's Disease? Prospective, Single-Center Pilot Study Based on Successive Measurements of Fecal Calprotectin. Gastroenterology 146(5): S-248

Eross, B.M.; Johnson, H.E.; Weaver, S.; van McLaughlin, S.D. 2014: Sa1271 Low Dose Aza and Allopurinol Co-Therapy: Is It Safe to Use Without Metabolite Monitoring?. Gastroenterology 146(5): S-248

Sze, K.C.; Siriwardana, A.; Sechi, A.; Watson Ng, W.S.; Connor, S.J. 2014: Sa1272 Thiopurine Prescribing and Monitoring Behavior, Including Metabolites Testing and Allopurinol Co-Therapy: An Australian Perspective From 2008 to 2013. Gastroenterology 146(5): S-249

Christophorou, D.; Funakoshi, N.; Duny, Y.; Valats, J.-C.; Bismuth, M.; Daures, J.-P.; Blan, P. 2014: Sa1273 Infliximab Versus Combination Infliximab and Immunosuppressant Therapy for Patients With Active Ulcerative Colitis: A Meta-Analysis. Gastroenterology 146(5): S-249

Rubin, D.T.; Coarse, J.; Kosutic, G.; Spearman, M.; Ambarkhane, S.; Jojic, N. 2014: Sa1274 Prior Use of Infliximab As a Predictor of Long-Term Outcomes of Treatment With Certolizumab Pegol for Active Crohn's Disease: Analyses From the Precise 3 7-Year Study. Gastroenterology 146(5): S-249

Kamata, N.; Watanabe, K.; Morimoto, K.; Noguchi, A.; Miyazaki, T.; Sogawa, M.; Yamagami, H.; Nagami, Y.; Sugimori, S.; Tanigawa, T.; Shiba, M.; Tominaga, K.; Watanabe, T.; Fujiwara, Y.; Arakawa, T. 2014: Sa1275 Clinical Impact of Evaluating Suitable Timing for Switching From Infliximab to Adalimumab According to Precise Endoscopic Monitoring in Patients With Crohn's Disease. Gastroenterology 146(5): S-249

Engevik, M.A.; Yacyshyn, M.B.; Yacyshyn, B.; Hassett, D.J.; Worrell, R.T. 2014: Sa1276 Altered Mucus Oligosaccharide Composition in Human C. difficile Infection. Gastroenterology 146(5): S-250

Serrao, S.; Jackson, C.S.; Ibrahim, D.; Juma, D.; Randhawa, M.; Soret, S.; Ing, M. 2014: Sa1279 Exploring the Risk of Septicemia Among Patients Diagnosed With Clostridium difficile. Gastroenterology 146(5): S-250

Staelens, D.; Van de Wouwer, M.; Brouwers, E.; Caluwaerts, S.; Rottiers, P.; Vanhoenacker, P.; Geukens, N.; Declerck, P.J.; Ferrante, M.; Vermeire, S.; Rutgeerts, P.J.; Van Assch, G.A. 2014: Sa1280 Prevention of Recurrent Clostridium difficile Infection by Neutralizing Monoclonal Antibodies in a Hamster Relapse Model. Gastroenterology 146(5): S-250

El-Zaatari, M.; Chang, Y.-M.; Zhang, M.; Shreiner, A.; Young, V.B.; Huffnagle, G.B.; Kao, J.Y. 2014: Sa1281 Tryptophan Catabolism Restricts Clostridium difficile Immunopathology. Gastroenterology 146(5): S-250

Lingala, S. 2014: Sa1283 Fecal Microbiota Transplantation in Critically Ill Patient With Severe Clostridium difficile Colitis. Gastroenterology 146(5): S-251

Saffouri, G.; Pardi, D.S.; Khanna, S. 2014: Sa1285 Outcomes From Vancomycin Administration Per Rectum After Colectomy for Clostridium difficile Infection. Gastroenterology 146(5): S-252

Ewelukwa, O.; Cheema, B.; Metzger, S.; Markert, R.J.; Akram, S. 2014: Sa1286 The Effect of Statins on the Risk of Developing Clostridium difficile Diarrhea: A Case-Control Study. Gastroenterology 146(5): S-252

Atkins, K.A.; Kao, D. 2014: Sa1287 Potential Cost Savings Associated With Timely Fecal Microbiota Transplantation (Fmt) for Recurrent Clostridium difficile Infection (Rcdi). Gastroenterology 146(5): S-252

Etienne-Mesmin, L.; Chassaing, B.; Edwards, A.N.; Miles, J.P.; McBride, S.; Gewirtz, A.T. 2014: Sa1289 Culture-Independent Quantitation of Clostridium difficile in C57Bl/6 Mice Aids Mechanistic Study of Disease Pathophysiology and Protective Immunology. Gastroenterology 146(5): S-253

Shah, M.; Rajan, D.; Shen, H.; Rashid, S.; Lipka, S.; Cohen, I.; Mustacchia, P. 2014: Sa1290 The Impact of Physician Education on Prescribing Patterns of Gastric Acid Suppression Therapy in Hospitalized Patients With Clostridium difficile-Associated Diarrhea. Gastroenterology 146(5): S-253

Patel, I.J.; Villafuerte-Galvez, J.A.; Theethira, T.G.; Leffler, D.; Kell, C.P. 2014: Sa1291 Evaluation of Adherence to Treatment Guidelines and Outcomes of Clostridium difficile Infection At a Large Teaching Institution. Gastroenterology 146(5): S-253

Villafuerte-Galvez, J.A.; Patel, I.J.; Xu, H.; Yang, X.; Chen, X.; Kelly, C.P. 2014: Sa1293 Serum Cytokine Profiles in Patients With C. difficile Associated-Diarrhea and Non-C. difficile Antibiotic Associated Diarrhea. Gastroenterology 146(5): S-254

Witherspoon, J.; Powell-Chandler, A.; Aslanyan, A.; Brown, C.; Karran, A.; Thomas, C.E.; Lewis, W.G.; Coakley, M. 2014: Sa1294 Prognostic Significance of Deprivation in Patients Undergoing Emergency Laparotomy. Gastroenterology 146(5): S-254

Weissert, J.; Siegler, K.; Hernandez, L.V.; Ananthakrishnan, A.N.; Tonellato, P. 2014: Sa1296 Emergent Gastrointestinal Diagnosis and Procedures: A Nationwide Longitudinal Study of Emergency Department and Inpatient Stays. Gastroenterology 146(5): S-255

Treeprasertsuk, S.; Phaosawasdi, K.; Thepsuthammarat, K.; Chirawatkul, A. 2014: Sa1297 Duration of Hospital Stay and Mortality Rate of the Appendectomy As an Indicator for Quality of Medical Care: The 2010 Nationwide Study. Gastroenterology 146(5): S-255

Ji, Y.; Wang, L.S.; Shi, H.; Luo, R.; Wong, C.; Bohdenheimer, H.C.; Theise, N.D. 2014: Sa1298 A Comparison of Histopathology of Liver Biopsy of Chronic Hepatitis B Patients Between Chinese-Americans in New York and Chinese in Shanghai. Gastroenterology 146(5): S-256

Diehl, T.M.; Nylund, C.M. 2014: Sa1299 Self-Grown Produce Is Associated With Seropositivity for Hepatitis E. Gastroenterology 146(5): S-256

Cordero-Ruiz, P.; Carmona-Soria, I.; Caunedo-Alvarez, A.; Herrerias, J.M.; Vilches-Arenas, A. 2014: Sa1300 Long-Term Impact of Antiviral Therapy in the Natural History of Chronic Hepatitis C. Gastroenterology 146(5): S-256

Gara, N.; Tana, M.M.; Fryzek, N.; Zhao, X.; Doo, E.; Heller, T.; Liang, J.; Hoofnagle, J.; Ghany, M. 2014: Sa1302 Prospective Study of Withdrawal of Oral Antiviral Therapy in Chronic Hepatitis B Patients After Prolonged Virological Response. Gastroenterology 146(5): S-257

Judd, S.; Liubakka, A.M.; Antaki, F. 2014: Sa1303 Are Primary Care Providers' (Pcps) Beliefs and Attitudes Impacting Patients' Perceptions of Chronic Hepatitis C Virus (Hcv) and Treatment Decisions?. Gastroenterology 146(5): S-257

Magalhães, J.; de Castro, F.D.; Carvalho, P.; Leite, S.; Marinho, C.M.; Cotter, J. 2014: Sa1305 Assessment of Liver Fibrosis in Patients With Chronic Hepatitis B -Diagnostic Accuracy of Four Noninvasive Tests. Gastroenterology 146(5): S-258

Miranda, E.I.; Quiñones-Badillo, Y.; Morales-Vásquez, L.; Rodríguez-Medina, J.R.; Lespier, J.M.; Muñoz-Acabá, J.; Pastrana, R.; Pérez-Cardona, C.M.; Yamamura, Y.; Torres, E.A. 2014: Sa1306 Pharmacogenetics in Hepatitis C Virus Infected Hispanics: Genetic Prevalence and Associations of Single Nucleotide Polymorphisms of Infl4 and Ifnl3 With Sustained Virological Response. Gastroenterology 146(5): S-258

Rosenblatt, L.; Engel-Nitz, N.M.; Becker, L.K.; Buikema, A.; Quadri, S. 2014: Sa1308 Hepatitis B (Hbv) Viral Suppression Among Patients Treated With Entecavir and With Previous Treatment With Lamivudine or Other Antiviral Medications: Real-World Outcomes in a Us Insured Population. Gastroenterology 146(5): S-259

Cardoso, H.; Vilas-Boas, F.; Coelho, R.; Rodrigues, S.; e Vale, A.H.; Araújo, F.; Macedo, G. 2014: Sa1309 Real-Life Experience in Chronic Hepatitis B Treatment With Tenofovir and Entecavir. Gastroenterology 146(5): S-259

Cardoso, H.; Albuquerque, A.; Moura, M.C.; Marques, M.; e Vale, A.H.; Vilas-Boas, F.; Araújo, F.; Macedo, G. 2014: Sa1310 The Impact of Cirrhosis in Genotype 3 Hepatitis C Treatment Outcome. Gastroenterology 146(5): S-259

DeFelice, K.M.; Markovic, S.; Kottschade, L.A.; Finnes, H.D.; Kamath, P.S.; Raffals, L.H. 2014: Sa1312 Systemic Corticosteroids Required Only for Moderate-to-Severe Ipilimumab-Induced Hepatitis. Gastroenterology 146(5): S-260

Gill, U.S.; Peppa, D.; Micco, L.; Singh, H.D.; Foster, G.; Maini, M.; Kennedy, P.T. 2014: Sa1313 Sequential Nuc Therapy Following Pegylated Interferon-Alpha Exposure Restores Innate Immune Responses Conferring a Treatment Advantage Over Nuc Monotherapy in Chronic Hepatitis B. Gastroenterology 146(5): S-260

Bhattacharya, P.; Patel, D.; Goyal, A.; Patel, S.; John, S.; Danilewitz, M. 2014: Sa1314 Triple Therapy for Chronic Hepatitis C (Hcv) Infection: Experience in an Urban Community Setting. Gastroenterology 146(5): S-260

Katoonizadeh, A.; Ostovaneh, M.R.; Esmaili, S.; Shayanrad, A.; Poustchi, H.; Malekzadeh, R. 2014: Sa1315 Long Term Immune Response 10-18 Years After Active Neonatal Hepatitis B Immunization: Results of a Big Population Based Study in Iran. Gastroenterology 146(5): S-260-S-261

Bhullar, M. 2014: Sa1316 Interferon Induced Interstitial Pneumonitis: A Systematic Review Including an Illustrative Patient. Gastroenterology 146(5): S-261

McNamara, K.M.; Jamal, M.M.; Vega, K.J. 2014: Sa1317 does Race Impact Hcv Knowledge among Oklahomans?. Gastroenterology 146(5): S-261

Kanata, R.; Goto, T.; Miura, K.; Ohshima, S.; Shibuya, T.; Sato, W.; Kamada, K.; Chiba, M.; Sakai, T.; Minami, S.; Sugimoto, Y.; Fujiwara, J.; Ishioka, M.; Ohnishi, H. 2014: Sa1318 Improvement of Liver Stiffness Measured by Arfi During Telaprevir-Based Triple Therapy for Chronic Hepatitis C. Gastroenterology 146(5): S-261

Hassanein, T.; Box, T.D.; Tong, M.J.; Pozza, R.; Rossaro, L.; Glenn, J.; Cheung, R.C.; Hemaidan, A.; He, Y.; Sheng, Y.; Barakat, F.; Behling, C.; Liu, C.; Liu, P.; Vierling, J.M. 2014: Sa1319 A Phase Ii, Randomized, Placebo-Controlled, Double-Blind, Multi-Center Study to Assess the Antifibrotic Activity of Fuzheng Huayu in Chronic Hepatitis C Patients With Hepatic Fibrosis (S-Usiit-01). Gastroenterology 146(5): S-261

Li, S.; Yin, J.; Chen, J. 2014: Sa1321 Vagal Mechanism Involved in the Anti-Emetic Effect of Electroacupuncture in Rats. Gastroenterology 146(5): S-262

Cengia, B.T.; Stuart, P.S.; Weinberg, R.B.; Koch, K.L. 2014: Sa1322 Bull's-Eye Nausea: Glucose-Hydrogen Breath Test Parameters Associated With Chronic Nausea Perceived in a Periumbilical Location. Gastroenterology 146(5): S-262

Tanaka, F.; Tominaga, K.; Fujikawa, Y.; Tanigawa, T.; Watanabe, T.; Fujiwara, Y.; Arakawa, T. 2014: Sa1324 Chronic Psychological Stress Down-Regulates the Expressions of Glial Cell Line-Derived Neurotrophic Factor and E-Cadherin, Which Are Associated With Duodenal Mucosal Barrier Dysfunction in Mice. Gastroenterology 146(5): S-263

McCullough, R.W. 2014: Sa1325 Mucosa-Centric Clinical Effects of High Potency Sucralfate: 28 Day 83% Resolution of Undifferentiated Dyspepsia, 28 Day 83% Reversal of Sign & Symptoms of Co-Morbid Ibs and 1 Week 80% Healing of Gerd Erosions -Results of Two Randomized Clinical Trials. Gastroenterology 146(5): S-263

Witte, A.-B.; Hilsted, L.; Holst, J.J..; Schmidt, P.T. 2014: Sa1326 Glp-1 and Glucose Homeostasis in Functional Dyspepsia Relation to Dyspeptic Symptoms and Satiety Measures. Gastroenterology 146(5): S-263

Amano, T.; Ariga, H.; Yamato, S.; Kanazawa, M.; Fukudo, S. 2014: Sa1327 Effect of 5-Ht4 Agonist Mosapride on Human Gastric Accommodation. Gastroenterology 146(5): S-263

Hamid, F.; Likhitsup, A.; Sanchez-Fermin, P.A. 2014: Sa1329 Rapid Gastric Emptying; a Possible Cause of Unexplained Upper Gastrointestinal Symptoms in Hospitalized Patients. Gastroenterology 146(5): S-264

Fikree, A.; Aktar, R.; Farmer, A.D.; Grahame, R.; Knowles, C.H.; Aziz, Q. 2014: Sa1330 The Joint Hypermobility Syndrome Is Associated With Functional Dyspepsia and Gastro-Oesophageal Reflux Disorders and Identifies A Subgroup With Multiple Extra-Intestinal Symptoms and Worse Quality of Life. Gastroenterology 146(5): S-264

Suzuki, H.; Matsuzaki, J.; Fukushima, Y.; Suzaki, F.; Kasugai, K.; Nishizawa, T.; Naito, Y.; Hayakawa, T.; Kamiya, T.; Ando, T.; Yoshida, H.; Tokura, Y.; Nagata, H.; Kobayakawa, M.; Mori, M. 2014: Sa1331 Efficacy and Safety of Rikkunshito, a Japanese Herbal Medicine, on the Treatment of Functional Dyspepsia: A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study. Gastroenterology 146(5): S-265

Kedar, A.; McElmurray, L.; Abell, T.L. 2014: Sa1332 Bloating and Abdominal Pain Symptoms May Be Important Indicators of Disease Status in Patients With Severe Dyspepsia or Gastroparesis. Gastroenterology 146(5): S-265

Oshima, T.; Koseki, J.; Shan, J.; Ikeo, K.; Fukui, H.; Watari, J.; Hattori, T.; Kase, Y.; Miwa, H. 2014: Sa1334 Serotonin 2B Receptor Is Involved in the Stress-Induced Inhibition of Gastric Accommodation in Conscious Guinea Pigs. Gastroenterology 146(5): S-266

Palsson, O.S.; Van Tilburg, M.A.; Spiegel, B.M.; Tack, J.F.; Spiller, R.C.; Walker, L.S.; Yang, Y.; Whitehead, W.E. 2014: Sa1335 Uninvestigated Dyspepsia in the U.S. General Population: Results From the Rome Normative Gastrointestinal Symptoms Survey (Rngss). Gastroenterology 146(5): S-266

Kamal, A.N.; Sayuk, G.S.; Gyawali, C.P. 2014: Sa1336 The Clinical and Therapeutic Profile of a Large Cyclic Vomiting Syndrome Cohort At a Tertiary Gastroenterology Center. Gastroenterology 146(5): S-266

Kang, H.W.; Yang, J.N.; Kim, J.H.; Lim, Y.J. 2014: Sa1337 Visceral Abdominal Obesity Measured by Ct Scan Is Associated With an Increased Risk of Functional Dyspepsia. Gastroenterology 146(5): S-266

Paik, C.N.; Chung, W.C.; Lee, K.M. 2014: Sa1338 The Chracteristics of Positivity to Glucose Breath Test in Patients With Cholecystectomy. Gastroenterology 146(5): S-267

Bures, J.; Kvetina, J.; Pavlik, M.; Kunes, M.; Kuca, K.; Kopacova, M.; Rejchrt, S.; Tacheci, I. 2014: Sa1339 Effect of Different Doses of Atropine on the Gastric Myoelectric Activity in Experimental Pigs. Gastroenterology 146(5): S-267

Omer, E.; McElmurray, L.; Kedar, A.; Hughes, M.G.; Cacchione, R.; Abell, T.L. 2014: Sa1340 Proximal Gastric Measurements May Predict Clinical Response in Patients With Nausea and Vomiting Undergoing Temporary Endoscopic Gastric Electrical Stimulation. Gastroenterology 146(5): S-267

Mion, F.; Roman, S.; Marjoux, S.; Pellissier, P.E.; Damon, H. 2014: Sa1341 Prevalence of Functional Dyspepsia in a Tertiary Digestive Motility Center: A Strong Positive Association With Gerd and Ibs. Gastroenterology 146(5): S-267

Jung, D.H.; Choi, E.J.; Jeon, H.H.; Lee, Y.H.; Park, H. 2014: Sa1343 Effects of Gc7101, a Novel Prokinetic Agent on Gastric Motor Function: In Vitro Study. Gastroenterology 146(5): S-268

Bruno, G.; Lopetuso, L.R.; Ianiro, G.; Laterza, L.; Gerardi, V.; Petito, V.; Poscia, A.; D'Angelo, G.; DiRienzo, T.A.; Tesori, V.; Franceschi, F.; Scaldaferri, F.; Gasbarrini, A. 2014: Sa1344 Study of Gastric Emptying and Digestive Function With 13C Octanoic Acid Breath Test in Non Dyspeptic Healthy Volunteers. Gastroenterology 146(5): S-268

Randall, C.W.; Zaga-Galante, J.; Suarez, A.V.; Vizuete, J.; Randall, F.; Taboada, C.M. 2014: Sa1345 Electrogastrography Provides Diagnostic Accuracy and Therapeutic Options in Patients With Non-Ulcer Dyspepsia: A 12 Year Study. Gastroenterology 146(5): S-268

Ortiz, A.M.; Cooper, C.J.; Gomez, Y.; Sarosiek, I.; McCallum, R.W. 2014: Sa1346 Clinical Experience and Cardiovascular Safety Profile of Domperidone Therapy for Nausea and Vomiting. Gastroenterology 146(5): S-268

Rejchrt, S.; Koupil, I.; Kopacova, M.; Seifert, B.; Fendrichova, M.S.; Douda, T.; Spirkova, J.; Vorisek, V.; Bures, J.; Tacheci, I. 2014: Sa1348 Prevalence and Socio-Demographic Determinants of Uninvestigated Dyspepsia in the Czech Republic. Gastroenterology 146(5): S-269

Tacheci, I.; Kvetina, J.; Pavlik, M.; Kunes, M.; Rejchrt, S.; Kopacova, M.; Bures, J. 2014: Sa1349 Impact of Water Load Test on the Gastric Myoelectric Activity in Experimental Pigs. Gastroenterology 146(5): S-269

de Bortoli, N.; Guidi, G.; Savarino, E.; Bertani, L.; Franchi, R.; Martinucci, I.; Macchia, L.; Ceccarelli, L.; Russo, S.; Furnari, M.; Bellini, M.; Savarino, V.; March, S. 2014: Sa1351 Voluntary and Controlled Weight Loss Can Reduce Symptoms and Allow a Lowering of Proton Pump Inhibitor Dosage in Patients With Gastroesophageal Reflux Disease. A Case-Control Study. Gastroenterology 146(5): S-270

Gomez, V.; Florit, P.T.K.öner; Bhalla, R.; Heckman, M.; Diehl, N.; Rawal, B.; Lynch, S.A.; Loeb, D.S. 2014: Sa1352 Routine Screening Endoscopy before Bariatric Surgery -Is it Necessary?. Gastroenterology 146(5): S-270

Gutzwiller, J.-P.; Beglinger, C. 2014: Sa1354 Effect of a Test Meal on Insulin Sensitivity and Meal Responses of Satiety Hormones and Their Association to Insulin Resistance in Obese and Normal Weight Adolescents. Gastroenterology 146(5): S-271

Gupta, A.; Mayer, E.A.; Sanmiguel, C.P.; Dinov, I.D.; Tillisch, K.; Labus, J.S. 2014: Sa1355 Morphological Imaging-Based Brain Signatures Discriminate Overweight from Lean Subjects: Examining Central Mechanisms with Obesity. Gastroenterology 146(5): S-271

Chung, S.J.; Kim, D.; Park, M.J.; Kim, J.S. 2014: Sa1356 Visceral Obesity As Risk Factor of Progression of Reflux Esophagitis: A Longitudinal 5 Year Cohort Study. Gastroenterology 146(5): S-271

Estep, J.M.; Greer, A.; Mehta, R.; Elsheikh, E.; Jeffers, T.; Goodman, Z.D.; Elarainy, H.A.; Moazez, A.H.; Younossi, Z.M. 2014: Sa1357 Histologic Nash Is Associated Lack of Improvement of Metabolic Conditions Post Bariatric Surgery. Gastroenterology 146(5): S-271

Shin, A.; Vazquez-Roque, M.I.; Acosta, A.; Iturrino, J.; Carlson, P.; Vella, A.; Eckert, D.J.; O'Neill, J.; Burton, D.D.; Zinsmeister, A.R.; Camilleri, M. 2014: Sa1358 Comparison of Gastric Motor Functions and Satiation in Overweight and Obese Adults With Allelic Variants At the Tcf7l2 Locus to Adults With Common Alleles. Gastroenterology 146(5): S-272

Marcil, V.; Amre, D.K.; Mayeur, S.; Spahis, S.; Lamarche, B.; Pouliot, Y.; Seidman, E.G.; Levy, E. 2014: Sa1359 Lactoferrin Polymorphism Associated With Metabolic Syndrome in Children and Adolescents. Gastroenterology 146(5): S-272

Kilpatrick, L.A.; Gupta, A.; Labus, J.S.; Istrin, J.J.; Sanmiguel, C.P.; Tillisch, K.; Mayer, E.A. 2014: Sa1360 Sex Commonalities and Differences in Bmi-Related Alterations in Intrinsic Brain Activity and Connectivity. Gastroenterology 146(5): S-272

Jacobs, D.M.; Fayad, J.M.; Monte, S.V.; Toale, A.; Perna, A.F.; Bryniarski, M.; Schentag, J.J. 2014: Sa1362 Comparison of Weight and Metabolic Profiles in Patients Treated With an Oral Mimetic of the Roux-en-Y Gastric Bypass Effect. Gastroenterology 146(5): S-273

Argonz, J.; Puentes, E.; Matos, P.; Vázquez, H.; Bolino, C.; Argonz, J. 2014: Sa1363 Utility of Intragastric Balloon in 385 Obese Patients: Experience in a Single Centre in Buenos Aires, Argentina. Gastroenterology 146(5): S-273

Lin, E.C.; Massey, B.T. 2014: Sa1365 The Presence of Methanogenic Bacteria Is Not Associated With a Higher Body Mass Index in a Us Midwestern Population. Gastroenterology 146(5): S-274

Egnatios, J.; Rutledge, T.; Kenyon, M.L.; Liao, P.S.; Frankwich, K.A.; Herbst, K.L.; Zarrinpar, A. 2014: Sa1366 Ankk1 Predicts Improvement in Lipid Profile, Glycemic Control, and Favorable Changes in Tfeq Score in Participants Engaged in a Dietary and Lifestyle Modification Program. Gastroenterology 146(5): S-274

Carabotti, M.; Liguori, A.; Ridolfi, M.; Rizzello, M.; Capoccia, D.; Scirocco, A.; Leonetti, F.; Corazziari, E.; Silecchia, G.; Severi, C. 2014: Sa1367 Are Gastrointestinal Symptoms Useful to Require Esophago-Gastro-Duodenoscopy (Egds) in Obese Patients Before Bariatric Surgery? Prevalence of Gastrointestinal Symptoms and Upper Endoscopic Findings. Gastroenterology 146(5): S-274

Nguyen, N.Q.; Ruszkiewicz, A.; Chang, D.; Bambrick, J.E.; Biankin, A.V. 2014: Sa1369 Biomarker Assessment From Eus Guided Biopsy Predicts Survival Outcomes and Surgical Treatment in Pancreatic Carcinoma. Gastroenterology 146(5): S-275

Watt, J.; Siddiqui, I.; Radon, T.; Dowe, T.; Crnogorac-Jurcevic, T.; Allavena, P.; Kocher, H. 2014: Sa1371 Pentraxin3 Is a Stromal Biomarker in Pancreatic Ductal Adenocarcinoma. Gastroenterology 146(5): S-276

George, K.; Patel, N.M.; Mawri, S.; Hachey, B.; Michaels, A.; Willens, D.; Parekh, R. 2014: Sa1372 What Risk Factors in Patients With New Onset Diabetes Mellitus Increase the Likelihood of Developing Pancreatic Cancer?. Gastroenterology 146(5): S-276

Momi, N.; Subramanian, H.; Bowen, L.; DeLaCruz, M.; Weinstein, J.; Wali, R.K.; Backman, V.; Roy, H.K. 2014: Sa1374 Paracrine Signaling Between Pancreatic Cancer and Small Intestinal Cells As the Biological Underpinnings of Duodenal Alterations in Field Carcinogenesis: Implications for Screening. Gastroenterology 146(5): S-277

Harinck, F.; Boersma, F.; Konings, I.C.; Van Hooft, J.E.; Dijkgraaf, M.G.; Dinjens, W.; Fockens, P.; Biermann, K.; Bruno, M.J. 2014: Sa1375 Clinicopathological Characteristics of Pancreatic Resection Specimens of Inherited/Familial Versus Sporadic Pancreatic Ductal Adenocarcinoma. Gastroenterology 146(5): S-277

Halasi, M.; Gartel, A.L. 2014: Sa1376 Foxm1 As a Potential Target in Pancreatic Cancer. Gastroenterology 146(5): S-277

Desai, S.V.; Watson, J.B.; Spaete, J.; Philcox, S.; Heacock, M.; Jowell, P.; Obando, J.V.; Burbridge, R. 2014: Sa1378 Repeat Endoscopic Ultrasound-Guided Fine Needle Aspiration in Patients With Suspected Pancreatic Neoplasm. Gastroenterology 146(5): S-278

Kanzaki, H.; Edderkaoui, M.; Pandol, S.; Murali, R. 2014: Sa1379 Osteoprotegerin, an Inhibitor of Trail-Induced Cancer Cell Death, Is Stimulated in a Smoking Model of Pancreatic Cancer. Gastroenterology 146(5): S-278

Kim, B.; Chung, M.J.; Park, J.Y.; Bang, S.; Park, S.W.; Song, S.Y.; Chung, J.B. 2014: Sa1381 The Association of Visceral Obesity and Poor Prognosis in Pancreatic Cancer. Gastroenterology 146(5): S-279

Banim, P.R.; Luben, R.; Khaw, K.-T.; Hart, A. 2014: Sa1382 Dietary Saturated Fatty Acids Are Positively Associated With the Development of Pancreatic Cancer -Data From a Uk Prospective Study (Epic) Using 7-Day Food Diaries. Gastroenterology 146(5): S-279

Gasiorowska, A.; Talar-Wojnarowska, R.; Kaczka, A.; Borkowska, A.; Czupryniak, L.; Malecka-Panas, E. 2014: Sa1383 Assessment of Glucose Tolerance, Inflammatory Cytokines and Endothelial Dysfunction in Patients With Chronic Pancreatitis and Newly Diagnosed Pancreatic Cancer. Gastroenterology 146(5): S-279

Singh, J.; Parikh, D.A.; Urayama, S. 2014: Sa1385 Potential for New-Onset Diabetes Mellitus As a Marker of Resectable Pancreatic Cancer From Eus Registry. Gastroenterology 146(5): S-280

Benesova, L.; Belsanova, B.; Cuperkova, R.; Bunganic, B.; Dvorakova, T.; Zavoral, M.; Minarik, M. 2014: Sa1386 Eus-Guided Biopsies for Molecular Testing of Pancreatic Cancer: Optimization of Experimental Parameters for Dna and miRna Extraction and Analysis. Gastroenterology 146(5): S-280

Gazouli, M.; Dervenis, C.; Liakakos, T. 2014: Sa1387 Genetic Polymorphisms of Inflammatory Response Gene Tnf-A and Its Influence on Sporadic Pancreatic Neuroendocrine Tumors Predisposition Risk. Gastroenterology 146(5): S-280

Buchen, B.; Günther, C.; Stürzl, M.; Cesarman, E.; Neurath, M.F.; Ballon, G.; Becker, C. 2014: Sa1719 A Single Viral Protein Is Able to Disrupt Intestinal Immune Homeostasis. Gastroenterology 146(5): S-281

Soroosh, A.; West, G.; Albeiroti, S.; Fiocchi, C.; de la Motte, C. 2014: Sa1720 Crohn's Disease Fibroblasts Selectively Overexpress the Novel Kiaa1199 Protein That Cleaves Hyaluronan and Generates Pro-Inflammatory Fragments. Gastroenterology 146(5): S-281

Lopez-Posadas, R.; Bergo, M.O.; Becker, C.; de Medina, F.S.; Amann, K.; Tenzer, S.; Atreya, R.; Neurath, M.F.; Atreya, I. 2014: Sa1721 Spontaneous Intestinal Inflammation in Mice Lacking Geranylgeranylation in Epithelial Cells Due to RhoA-Mediated Cytoskeleton Alterations and Breakdown of Gut Homeostasis. Gastroenterology 146(5): S-281

Bettenworth, D.; Fröhling, M.; Brückner, M.; Mennigen, R.; Nowacki, T.M.; Lügering, A.; Thomas, P.; Stratis, A. 2014: Sa1724 Loss of Proteoglycan Syndecan-4 Aggravates Intestinal Inflammation Due to Impaired Epithelial Wound Healing. Gastroenterology 146(5): S-282

Bettenworth, D.; Stegemann, A.; Tepasse, P.R.; Rijcken, E.; Apel, M.; Böhm, M. 2014: Sa1725 Human Intestinal Fibroblasts Are Novel Target Cells for Alpha-Melanocyte-Stimulating Hormone -Possible Implications for the Treatment of Stricturing Crohn's Disease With Melanocortin Peptides and Derivatives. Gastroenterology 146(5): S-282

Shimodaira, Y.; Takahashi, S.; Kinouchi, Y.; Endo, K.; Kakuta, Y.; Shimosegaw, T. 2014: Sa1726 Autophagy Is Induced by Er Stress Through Ire1 and Chop in Human Colon Cancer Cells. Gastroenterology 146(5): S-282

Dahan, S. 2014: Sa1727 Notch-1 Signaling Is Required for Mucosal Homeostasis and Epithelial Repair. Gastroenterology 146(5): S-282

Stanzel, C.; Terhalle, A.; Scharl, M.; Rogler, G. 2014: Sa1729 Er Stress Leads to Epithelial to Mesenchymal Transition (Emt) in Intestinal Epithelial Cells in a Jnk-and Src-Dependent Manner. Gastroenterology 146(5): S-283

Monteleone, I.; Zorzi, F.; Marafini, I.; Caruso, R.; Colantoni, A.; Pallone, F.; Monteleone, G. 2014: Sa1730 Aryl Hydrocarbon Receptor-Driven Signals Down-Regulate Intestinal Fibrosis. Gastroenterology 146(5): S-283

Zhu, X.; Messer, J.S.; Wang, Y.; Lin, F.; Cham, C.M.; Chang, J.; Billiar, T.; Lotze, M.T.; Boone, D.L.; Chang, E.B. 2014: Sa1731 Hmgb1 Controls the Intestinal Epithelial Autophagy/Apoptosis Checkpoint During Mucosal Inflammation and Ibd. Gastroenterology 146(5): S-283

Tang, R.; Yang, G.; Zhang, S.; Chen, M. 2014: Sa1732 Tnf- Inhibits Mucosal Protection Effects of Osteopontin in Crohn's Disease via Irf1. Gastroenterology 146(5): S-283

Terc, J.D.; Hansen, A.; Alston, L.; Hirota, S.A. 2014: Sa1734 Pregnane X Receptor Agonists Enhance Intestinal Epithelial Wound Healing and Repair of the Intestinal Barrier Following the Induction of Experimental Colitis. Gastroenterology 146(5): S-284

Friedrich, M.; Diegelmann, J.; Brand, S. 2014: Sa1735 Il-17A Modulates the Tnf--Induced Expression of Inflammatory Bowel Disease Susceptibility Genes in Intestinal Epithelial Cells. Gastroenterology 146(5): S-284

Lissner, D.; Schumann, M.; Batra, A.; Kredel, L.I.; Kuehl, A.A.; Siegmund, B. 2014: Sa1736 Macrophage Subtypes Disrupt the Epithelium via Deregulated Tight Junctions and Induction of Apoptosis. Gastroenterology 146(5): S-284

Ramanarasimhaiah, R.; Fernandez, M.L.; Vella, A.; Sylvester, F.A. 2014: Sa1737 Osteoprotegerin: A Novel Alarmin in Colonic Epithelial Cells?. Gastroenterology 146(5): S-284

Hahne, H.; Schmoeller, I.R.; Sans, M.; Vetrano, S.; Sala, E.; Danese, S.; Kuster, B.; Haller, D. 2014: Sa1739 Comparative Proteome Profiling of Intestinal Epithelial Cells in Mice and Ibd Patients. Gastroenterology 146(5): S-285

Halloran, B.P.; Chang, J.J.; McGovern, D.P.; Targan, S.; Thiesen, A.; Shih, D.Q.; Fedorak, R.N.; Halloran, P.F. 2014: Sa1740 Microarray Analysis of Ulcerative Colitis and Correlation With Conventional Clinical and Histologic Features. Gastroenterology 146(5): S-285

Edelman, M.; Rowehl, L.M.; Gathungu, G. 2014: Sa1741 Bacterial Antigens and Food Additives Alter Membrane Integrity and Induce Intestinal Inflammation In Vitro. Gastroenterology 146(5): S-285

Nagy-Szakal, D.; Mir, S.; Harris, R.A.; Dowd, S.E.; Yamada, T.; Lacorazza, D.; Tatevian, N.; Kellermayer, R. 2014: Sa1742 Microbiome and Host Factors Communicate Protection Against Acute Murine Colitis Following Omega-6 Fatty Acid Induced Transient Pediatric Obesity. Gastroenterology 146(5): S-286

In, J.; Foulke-Abel, J.; Cole, R.N.; Kovbasnjuk, O. 2014: Sa1743 Ehec Virulence Factor Espp Cleaves Actin Binding Protein Fodrin to Induce Macropinocytosis of Shiga Toxins. Gastroenterology 146(5): S-286

McLean, L.; Smith, A.; Cheung, L.; Sun, R.; Grinchuk, V.; Zhao, A.; Raufman, J.-P.; Shea-Donohue, T. 2014: Sa1744 Type 3 Muscarinic Receptor Activity Facilitates Clearance of Citrobacter Rodentium. Gastroenterology 146(5): S-286

Chassaing, B.; Gewirtz, A.T. 2014: Sa1745 Food Additives Promote Intestinal Inflammation in Susceptible Hosts. Gastroenterology 146(5): S-286

Singh, K.; Coburn, L.A.; Druce, J.P.; Asim, M.; Barry, D.P.; Chaturvedi, R.; Wilson, K.T. 2014: Sa1746 Cationic Amino Acid Transporter 2 and L-Arginine Availability Are Required for Talin-1-Dependent Adherence of the Colonic Pathogen Citrobacter Rodentium and Subsequent Pro-Inflammatory Responses. Gastroenterology 146(5): S-287

Ho, S.; Bakirtzi, K.; Isaacson, R.E.; Pothoulakis, C.; Koon, H.W. 2014: Sa1747 Antimicrobial Peptide Cathelicidin Inhibits Salmonella Mediated Intestinal Inflammation and Fibrosis. Gastroenterology 146(5): S-287

Vazeille, E.; Buisson, A.; Goutte, M.; Ouchchane, L.; Hugot, J.-P.; de Vallée, A.; Bommelaer, G.; Darfeuille-Michaud, A. 2014: Sa1748 Comparative Behaviour of Macrophages Isolated From Patients With Crohn's Disease or Ulcerative Colitis and Controls in Response to Adherent-Invasive or Non-Pathogenic E. Coli Infection. Gastroenterology 146(5): S-287

Yan, M.; Wang, H.; Zhu, Y.; Joo, J.; Sun, J.; Xu, C.; Yan, S.; Morse, H.C.; Coleman, W.G. 2014: Sa1749 Investigating the Role of Interferon Regulatory Factor 8 in Helicobacter pylori-Induced Inflammatory Responses. Gastroenterology 146(5): S-287

Yan, M.; Liu, W.; Xu, C.; Joo, J.; Yu, C.; Zhu, Y.; Yan, S.; Rodgers, G.; Coleman, W.G. 2014: Sa1750 Olfactomedin 4 Deletion Enhances Host Pro-Inflammatory Immune Responses Against Helicobacter pylori Infection Through a MyD88 Dependent Mechanism. Gastroenterology 146(5): S-287-S-288

Kamada, N. 2014: Sa1751 Monocyte-Derived Intestinal Macrophages Control Enteric Pathogen Eradication via Eliciting Innate and Adaptive Lymphocyte Responses. Gastroenterology 146(5): S-288

Ocvirk, S.; Sava, I.; Steck, N.; Roh, J.H.; Tchaptchet, S.Y.; Hansen, J.J.; Huebner, J.; Murray, B.E.; Sartor, R.B.; Haller, D. 2014: Sa1752 Colitogenic Activity of Enterococcus Faecalis Requires Lipoprotein-Mediated Activation of Innate Immune Effector Functions in Il-10-/-Mice. Gastroenterology 146(5): S-288

Brand, M.W.; Jergens, A.; Proctor, A.; Phillips, G.; Hostetter, J.M.; Wannemuehler, M.J. 2014: Sa1753 Vertical Transmission of Aiec Pathobiont Increases Severity of Dss-Induced Colitis in Offspring. Gastroenterology 146(5): S-288

Riba, A.; Lencina, C.; Bacquie, V.; Harkat, C.; Gillet, M.; Cartier, C.; Baron, M.; Sommer, C.; Mallet, V.; Olier, M.; Theodorou, V.; Ménard, S. 2014: Sa1754 Early Maternal Separation Leads to Abnormal Immune Response Against Commensal Microbiota in Adult Mice. Gastroenterology 146(5): S-288

Basic, M.; Keubler, L.M.; Buettner, M.; Smoczek, A.; Bleich, A. 2014: Sa1755 Norovirus Infection Support Mucosal Inflammation in Germfree Mice After Schaedler Flora Colonization. Gastroenterology 146(5): S-289

Su, L.; Su, C.; Zhang, M.; Cherayil, B.J.; Shi, H.N. 2014: Sa1756 Co-Infection With an Intestinal Helminth Exacerbates Salmonella Enterocolitis in Mice. Gastroenterology 146(5): S-289

Tran-Minh, M.-L.; Quévrain, E.; Brot, L.; Grill, J.-P.; Thomas, G.; Trugnan, G.; Seksik, P. 2014: Sa1757 Gut Microbiota Can Induce Autophagy in Intestinal Epithelial Cells, A Concern for Crohn's Disease. Gastroenterology 146(5): S-289

Xu, C.; Yan, M.; Joo, J.; Zhu, Y.; Yan, S.; Chen, W.; Coleman, W.G. 2014: Sa1758 Nlrp3 Inflammasome Is Activated in Mice by Helicobacter pylori Infection. Gastroenterology 146(5): S-289

Aguilera, M.; Pla, J.; Martinez, V. 2014: Sa1760 Stimulation of Colonic Tlr4-and Tlr7-Mediated Bacterial-Host Interaction Systems Leads to a Distinct Local Immune Activation in Rats. Gastroenterology 146(5): S-290

Chang, Y.-M.; Zhang, M.; El-Zaatari, M.; McDermott, A.; Huffnagle, G.B.; Young, V.B.; Kao, J.Y. 2014: Sa1761 Cd11c+ Myeloid Cells Suppress Host Immunity Against Acute Clostridium difficile Infection in Mice. Gastroenterology 146(5): S-290

Spalinger, M.R.; Chassard, C.; Kasper, S.; Biedermann, L.; Vavricka, S.R.; Frey-Wagner, I.; Atrott, K.; Lacroix, C.; Fried, M.; Rogler, G.; Scharl, M. 2014: Sa1762 T Cell Specific Loss of Ptpn2 Leads to Miss-Balanced T Helper Cell Differentiation Resulting in Aggravated Intestinal Inflammation. Gastroenterology 146(5): S-290

Jones, G.-R.; Cook, P.; MacDonald, A. 2014: Sa1763 Epigenetic Control of Colonic Inflammation via the Methyl-Binding Protein Mbd2. Gastroenterology 146(5): S-290

Tomkovich, S.E.; Kanther, M.; Sun, X.; Grosser, M.R.; Koo, J.S.; Flynn, E.J.; Jobin, C.; Rawls, J.F. 2014: Sa1764 Commensal Microbiota Stimulate Systemic Neutrophil Migration Through Induction of Serum Amyloid A. Gastroenterology 146(5): S-291

Homer, C.R.; Nickerson, K.P.; Corridoni, D.; Kabi, A.; Cominelli, F.; McDonald, C. 2014: Sa1765 Defective Autophagy Contributes to Impaired Bacterial Clearance of Samp1/Yitfc Mice. Gastroenterology 146(5): S-291

Dalmasso, G.; Nguyen, H.T.; Goulème, L.; Cougnoux, A.; Gibold, L.; Delmas, J.; Darfeuille-Michaud, A.; Bonnet, R. 2014: Sa1766 Crohn's Disease-Associated Adherent-Invasive Escherichia coli Manipulate Host Autophagy by Impairing Sumoylation. Gastroenterology 146(5): S-291

Backert, I.; Koralov, S.B.; Wirtz, S.J.; HIldner, K.; Neurath, M.F.; Becker, C.; Neufert, C. 2014: Sa1767 Stat3 Activation in Cd4+ Lymphocytes Shapes Epithelial Host Defense During Infectious Colitis. Gastroenterology 146(5): S-291

Nguyen, H.T.; Carrier, J.; Dalmasso, G.; Maurin, A.-C.; Bruhat, A.; Darfeuille-Michaud, A. 2014: Sa1768 The Gcn2/eIf2/Atf4 Signaling Pathway Is Necessary for Autophagy Response to Infection With Crohn's Disease-Associated Adherent-Invasive Escherichia coli. Gastroenterology 146(5): S-291-S-292

Kanagavelu, S.kumar; Flores, C.; Ruiz, J.R.; Singh, G.; Fukata, M. 2014: Sa1769 Trif Confers Expansion of Unique Innate Lymphoid Cell Populations During Enteric Infection With Gram-Negative Bacteria. Gastroenterology 146(5): S-292

DiGiovangiulio, M.; Gomez-Pinilla, P.J.; Stakenborg, N.; Farro, G.; Matteoli, G.; Boeckxstaens, G.E. 2014: Sa1770 The Vagus Nerve As Modulator of Intestinal Immune Homeostasis. Gastroenterology 146(5): S-292

Lopez-Posadas, R.; Bergo, M.O.; Becker, C.; Neurath, M.F.; Atreya, I.; de Medina, F.S. 2014: Sa1771 Ggtase-1 Deficient T-Lymphocytes Are Predominantly Directed to the Gut and Reveal High Colitogenic Potency. Gastroenterology 146(5): S-292

Fan, T.-J.; Tchaptchet, S.; Goeser, L.E.; Sartor, R.B.; Hansen, J.J. 2014: Sa1773 Caspase-11 Enhances Killing of Colitogenic Escherichia coli by Macrophages, but Does Not Affect Development of Experimental Colitis. Gastroenterology 146(5): S-293

Mukherjee, S.; Venkatesh, M.; Wang, H.; Phillips, R.S.; Kortagere, S.; Khanna, K.M.; Mani, S. 2014: Sa1774 Regulation of Intestinal Mucosal Barrier Function by Specific Microbial Metabolites. Gastroenterology 146(5): S-293

Qiu, Y.; Xiao, W.; Chen, G.; Sun, L.; Yu, M.; Zhang, C.; Yang, H. 2014: Sa1775 Tcr+ Intraepithelial Lymphocytes Protect Intestinal Mucosa Injuryby Il-22 Production Through Aryl Hydrocarbon Receptor Signaling in a Ischemia/Reperfusion Mouse Model. Gastroenterology 146(5): S-293

Li, J.; Luider, J.; Ueno, A.; Chan, R.; Gasia, M.F.; Murdoch, T.B.; Hirota, C.; Iacucci, M.; Kaplan, G.; Panaccione, R.; Deane, M.; Wang, T.; Qian, J.M.; Gui, X.; Ghosh, S. 2014: Sa1777 Novel Regulatory T Cell Population Co-Expressing Ror T+ or Gata3+ Is Increased in Intestinal Lamina Propria of Ibd Patients. Gastroenterology 146(5): S-293

Konijeti, G.G.; Boylan, M.R.; Song, Y.; Arora, P.; Harrell, F.E.; Newton-Cheh, C.; ONeill, D.; Korzenik, J.R.; Wang, T.J.; Chan, A.T. 2014: Sa1779 Vitamin D Modulates T Cell-Mediated Immunity: Results From a Randomized Controlled Trial of Low-Dose and High-Dose Vitamin D3. Gastroenterology 146(5): S-294

Garber, J.; Mallick, E.; Scanlon, K.M.; Donnenberg, M.S.; Leong, J.M.; Snapper, S.B. 2014: Sa1780 The Attaching-and-Effacing Pathogen Effector EspF Exploits Tight Junction Regulatory Activities of N-Wasp and Snx9 to Induce Intestinal Barrier Disruption. Gastroenterology 146(5): S-294

Song, J.H.; Zhao, Y.; Chiang, H.-S.; Liu, S.; Wang, N.; Terhorst, C.; Basavappa, M.G.; Jeffrey, K.L.; Reinecker, H.-C. 2014: Sa1781 Gef-H1 Is Required for Antiviral Host Defense. Gastroenterology 146(5): S-294

Kuo, W.-T.; Yang, H.-Y.; Chen, C.-Y.; Lee, T.-C.; Lu, Y.-Z.; Wu, L.-L.; Ni, Y.-H.; Wei, S.-C.; Yu, L.C.H. 2014: Sa1782 Opposing Roles of Cd14 and Tlr4 in Bacterial Lps-Induced Colonocytic Apoptosis. Gastroenterology 146(5): S-294

Maruta, K.; Hozumi, H.; Yasutake, Y.; Narimatsu, K.; Sato, H.; Kurihara, C.; Okada, Y.; Usui, S.; Watanabe, C.; Komoto, S.; Tomita, K.; Nagao, S.; Miura, S.; Hokari, R. 2014: Sa1783 Nicotine Ameliorates Colonic Inflammation via Down-Regulation of Vascular Endothelial Cell Adhesion Molecules. Gastroenterology 146(5): S-295

Kok, K.; Curciarello, R.; Giuffrida, P.; Joshi, N.; Biancheri, P.; Thomas, M. 2014: Sa1784 Interactions Between Neutrophil Elastase and Biologics in Ibd. Gastroenterology 146(5): S-295

Tanner, S.M.; Lorenz, R.G.; Martin, C.A. 2014: Sa1785 Aryl Hydrocarbon Receptor Disrupts B1 Cell Populations and Antibody Production in Intestinal Tissue. Gastroenterology 146(5): S-295

Luaces-Regueira, M.; Castiñeira-Alvariño, M.; Dominguez-Munoz, E. 2014: Sa1786 Activation of the Inflammatory Response in Pancreatic Acinar Cells in Response to Tobacco Compared to Alcohol: An In Vitro Study. Gastroenterology 146(5): S-295

Ashat, M.; Tashkandi, N.; Sreekumar, B.; Patel, V.; Chowdhury, A.B.; Shugrue, C.; Messenger, S.; Groblewski, G.E.; Thrower, E.C. 2014: Sa1788 Tobacco Toxin Nnk (4-[Methylnitrosamino]-1-[3-Pyridyl]-1-Butanone) Mediates Zymogen Activation in Murine and Human Pancreatic Acini. Gastroenterology 146(5): S-296

Mareninova, O.A.; Shalbueva, N.; Elperin, J.M.; Lee, G.E.; Lotshaw, E.M.; French, S.W.; Gukovsky, I.; Gukovskaya, A.S. 2014: Sa1789 Block of Mannose-6-Phosphate Mediated Pathway of Hydrolase Delivery From the Golgi to Lysosomes Causes Spontaneous Pancreatitis. Gastroenterology 146(5): S-296

Foss, C.; Liu, L.; Mease, R.C.; Wang, H.; Pomper, M.; Pasricha, P.J. 2014: Sa1790 Imaging Macrophage-Specific Inflammation in an Experimental Model of Chronic Pancreatitis. Gastroenterology 146(5): S-296

Singh, V.; Patel, K.; Durgampudi, C.; Noel, P.; Trivedi, R.N.; Lee, K.; Papachristou, G.I.; Slivka, A.; Yadav, D.; Chennat, J.; Khalid, A.; Brand, R.; Murad, F.; Acharya, C.; Navina, S. 2014: Sa1791 Biliopancreatic Duct Ligation in Rats Is More Representative of Human Biliary Acute Pancreatitis (Ap) Than Bile Acid Infusion. Gastroenterology 146(5): S-296

Garg, S.K.; Dawra, R.; Barlass, U.; Yuan, Z.; Dixit, A.K.; Saluja, A. 2014: Sa1792 Development of a New Mouse Model of Chronic Pancreatitis Induced by Administration of L-Arginine. Gastroenterology 146(5): S-297

Shahid, R.A.; Davis, S.J.; Vigna, S.R.; Liddle, R.A. 2014: Sa1793 Bile Acid-Induced Acute Pancreatitis in Mice Is Caused by Acinar Cell Leukotriene B4 Secretion Through a Calcium-Independent Pathway. Gastroenterology 146(5): S-297

Mrazek, A.A.; Bhatia, V.; Falzon, M.; Bohanon, F.; Chao, C.; Hellmich, M.R. 2014: Sa1794 Apigenin Attenuates Cerulein-Induced Parathyroid Hormone-Related Protein (PthrP) and Il-6 in a Model of Murine Pancreatitis. Gastroenterology 146(5): S-297

Sumimoto, K.; Uchida, K.; Mitsuyama, T.; Fukui, Y.; Kusuda, T.; Miyoshi, H.; Fukata, N.; Koyabu, M.; Sakaguchi, Y.; Ikeura, T.; Shimatani, M.; Fukui, T.; Matsushita, M.; Takaoka, M.; Nishio, A. 2014: Sa1795 Regulatory B Cells in Type 1 Autoimmune Pancreatitis. Gastroenterology 146(5): S-297

Lee, L.; Ito, T.; Nakamura, T.; Hijioka, M.; Niina, Y.; Igarashi, H.; Jensen, R.T.; Takayanagi, R. 2014: Sa1796 Saturated Fatty Acid Inhibits Fibrogenesis of Chronic Pancreatitis via Er Stress Response in Pancreatic Stellate Cells. Gastroenterology 146(5): S-297-S-298

Malecki, E.; Castellanos, K.J.; Cabay, R.J.; Fantuzzi, G. 2014: Sa1798 Repeated Administration of Il-12 and Il-18 Causes Fatty Replacement of the Pancreas in Mice. Gastroenterology 146(5): S-298

Park, S.W.; Chung, M.J.; Oh, T.G.; Park, J.Y.; Bang, S.; Park, S.W.; Song, S.Y. 2014: Sa1799 Intramuscular Diclofenac for the Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Randomized, Double-Blind, Placebo-Controlled Trial. Gastroenterology 146(5): S-298

Sharma, S.K.; Rana, S.V.; Rana, S.S.; Nada, R.; Bhasin, D.K. 2014: Sa1800 Triticum Aestivum Inhibits Tgf--Induced Pancreatic Stellate Cell Activation, Oxidative Stress and Extracellular Matrix Formation. Gastroenterology 146(5): S-298

Utomo, W.K.; Parikh, K.; de Vries, M.; Van Goor, H.; Bruno, M.J.; Braat, H.; Peppelenbosch, M.P. 2014: Sa1801 Potential Mechanisms of Therapeutic Cannabis Use in Chronic Pancreatitis. Gastroenterology 146(5): S-298

Ding, Z.; Hou, X. 2014: Sa1802 Induction of M2 Polarization in Primary Culture Liver Macrophages From Rats With Acute Pancreatitis. Gastroenterology 146(5): S-298

Bayrer, J.R.; Mukkamala, S.; Sablin, E.; Fletterick, R. 2014: Sa1803 Dissecting the Oncogenic Activity of the Nuclear Receptor Lrh-1 in the Colon. Gastroenterology 146(5): S-299

Lyros, O.; Moore, T.; Medda, R.; Nie, L.; Otterson, M.F.; Gockel, I.; Lang, H.; Shaker, R.; Rafiee, P. 2014: Sa1804 Dysregulation of Wnt5A/Ror2 Signaling Pathway Characterizes the Progression of Barrett's-Associated Esophageal Adenocarcinoma. Gastroenterology 146(5): S-299

Wang, Q.; Zhou, Y.; Weiss, H.L.; Evers, B.M. 2014: Sa1805 An mTor-Sirtuin Axis in the Intestinal Cell Differentiation Network. Gastroenterology 146(5): S-299

Ahluwalia, A.; Jones, M.K.; Tarnawski, A.S. 2014: Sa1806 Upregulation of Importins Is a Novel Key Mechanism for Aberrant, Increased Vegf Expression in Colon Cancer Cells and Sustained Proliferation of These Cells via an Autocrine Pathway. Gastroenterology 146(5): S-299

Loomans, H.A.; LeBras, G.F.; Andl, C.D. 2014: Sa1807 Fibroblast-Secreted Activin a Inhibits Invasion and Angiogenesis in Esophageal Squamous Cell Carcinoma. Gastroenterology 146(5): S-299

Goretsky, T.; Bradford, E.; Barrett, T.A. 2014: Sa1809 Tnf and Nicotine Flexibly Utilize Common Signaling Pathways, Which Synergize to Increase Proliferation and -Catenin-Mediated Transcription in Intestinal Epithelial Cells. Gastroenterology 146(5): S-300

Sugimoto, S.; Hotta, K.; Shimoda, T.; Imai, K.; Yamaguchi, Y.; Kakushima, N.; Takizawa, K.; Tanaka, M.; Matsubayashi, H.; Ono, H. 2014: Sa1810 Venous Permeation and Ki-67 Labeling Index Are Reliable Factors to Predict the Metastatic Potential of Rectal Neuroendocrine Tumors. Gastroenterology 146(5): S-300

Todt, J.; Tsao, A.C.; Hayes, M.M.; Veniaminova, N.A.; Saqui-Salces, M.; Merchant, J.L. 2014: Sa1811 Generation of Gastric Carcinoids in Mice After Targeted Deletion of Men1 and Somatostatin Gene Loci. Gastroenterology 146(5): S-300

Uchida, D.; Shiraha, H.; Kato, H.; Nagahara, T.; Iwamuro, M.; Kataoka, J.; Horiguchi, S.; Watanabe, M.; Nasu, Y.; Kumon, H.; Yamamoto, K. 2014: Sa1813 The Efficacy of Reic/Dkk-3 Gene Therapy for Pancreatic Cancer. Gastroenterology 146(5): S-301

Feng, Y.; Dempsey, P.J.; Frey, M.R.; Tsai, Y.-H.; Xiao, W.; Ralls, M.W.; Wolforth, J.; Rakshit, S.; Teitelbaum, D.H. 2014: Sa1814 Intestine-Specific ErbB4 Deficiency Exacerbates Tpn Associated Intestinal Atrophy. Gastroenterology 146(5): S-301

Thota, P.N.; Sanaka, M.R.; Singh, P.; Pagadala, M.R.; Lopez, R. 2014: Sa1816 Influence of Body Mass Index (Bmi) on the Prevalence of Dysplasia in Barrett's Esophagus (Be). Gastroenterology 146(5): S-302

Thota, P.N.; Sanaka, M.R.; Singh, P.; Pagadala, M.R.; Lopez, R. 2014: Sa1817 Effect of Body Mass Index on Progression of Dysplasia in Barrett's Esophagus. Gastroenterology 146(5): S-302

Kim, D.; Oh, D.S.; DeMeester, S.R.; Greene, C.L.; Worrell, S.G.; Hagen, J.A. 2014: Sa1819 Computer-Assisted Analysis of Esophageal Brush Biopsies Increase the Effectiveness of Screening and Surveillance for Short Segment Barrett's Esophagus. Gastroenterology 146(5): S-303

Yellore, V.; Meltzer, S.J.; Cheng, Y.; Stover, J. 2014: Sa1820 Analytical Validation of a Novel Multi-Gene Assay for Patients With Barrett's Esophagus. Gastroenterology 146(5): S-303

Shakhatreh, M.H.; Katz, L.H.; Elfaramawi, M.; El-Serag, H.; Fischbach, L.A. 2014: Sa1821 The Association of Obesity and Barrett's Esophagus, A Meta-Analysis. Gastroenterology 146(5): S-303

Yachimski, P.S.; Wani, S.; Givens, T.; Howard, E.; Higginbotham, T.; Price, A.; Berman, K.; Hosford, L.; Menard-Katcher, P.; Perzan, K.; Hur, C. 2014: Sa1822 Patient Preferences for Prevention of Esophageal Adenocarcinoma in Barrett's Esophagus, Endoscopic Ablation Versus Chemoprevention: A Prospective Multicenter Study. Gastroenterology 146(5): S-304

Canipe, A.; Slaughter, J.C.; Yachimski, P.S. 2014: Sa1823 Endoscopic Mucosal Resection or Radiofrequency Ablation for Barrett's Esophagus Containing High-grade Dysplasia: Agreement Among Expert, Non-Expert, and Trainee Gastroenterologists. Gastroenterology 146(5): S-304

Davelaar, A.; Calpe, S.; Lau, C.T.; Meijer, S.L.; Krishnadath, K.K. 2014: Sa1824 A Sequence of Genetic Events for P53 Is Associated With Increasing Neoplasia Stage in Barrett's Esophagus. Gastroenterology 146(5): S-304

Sun, X.; Chak, A.; Falk, G.W.; Grady, W.M.; Kinnard, M.F.; mittal, sumeetK.; Canto, M.I.; Shaheen, N.J.; Wang, J.S.; Iyer, P.G.; Abrams, J.A.; Willis, J.; Markowitz, S.; Barnholtz-Sloan, J.; Brock, W. 2014: Sa1826 Predicting Barrett's Esophagus in Families of Patients With Barrett's Esophagus: A Betrnet Model Fitting Clinical Data to a Genetic Paradigm. Gastroenterology 146(5): S-305

Genta, R.M.; Spechler, S.J. 2014: Sa1827 Barrett's Esophagus Is Not Rare in Asian Patients Who Have Endoscopy With Esophageal Biopsies Taken in the United States. Gastroenterology 146(5): S-305

Uno, K.; Leggett, C.L.; Anderson, M.; Lutzke, L.S.; Wang, K.K. 2014: Sa1829 Irregular Submucosal Glands Imaged on Volume Laser Endomicroscopy in Barrett's Esophagus Are Associated With the Transformed Microenvironment. Gastroenterology 146(5): S-306

Bidari, K.; McGorisk, T.; Kahrilas, P.J.; Pandolfino, J.E.; Krishnan, K.; Keefer, L.; Komanduri, S. 2014: Sa1830 Efficacy, Durability and Safety of Radiofrequency Ablation for Nondysplastic Barrett's Esophagus At a University Referral Center. Gastroenterology 146(5): S-306

Nguyen, T.; Alsarraj, A.; El-Serag, H. 2014: Sa1832 The Length of Newly Diagnosed Barrett's Esophagus Has Been Decreasing Over Time. Gastroenterology 146(5): S-307

Westra, W.; Wang, K.K.; Krishnadath, K.K.; Lutzke, L.S.; Roes, A.L. 2014: Sa1835 Tobacco Chewing and Smoking Are Risk Factors for Barrett's Esophagus in Caucasian Gerd Patients. Gastroenterology 146(5): S-308

Davelaar, A.; Straub, D.; Fockens, P.; Buttar, N.; Krishnadath, K.K. 2014: Sa1836 Active Metalloproteases Are Expressed Early on During the Esophagitis-Metaplasia Sequence and Are High in Barrett's Esophagus and Esophageal Adenocarcinoma. Gastroenterology 146(5): S-308

Masclee, G.; Coloma, P.M.; Kuipers, E.J.; Sturkenboom, M.C. 2014: Sa1837 Does Use of Nsaids, Statins and Proton Pump Inhibitors Prevent Development of Esophageal Adenocarcinoma Among Patients With Barrett's Esophagus? -Results From a Multinational Population Based Case-Control Study. Gastroenterology 146(5): S-308

Tamagawa, Y.; Ishimura, N.; Tiwari, A.; Ding, P.; Uno, G.; Aimi, M.; Oshima, N.; Ishihara, S.; Kinoshita, Y.; Spechler, S.J.; Souza, R.F.; Wang, D.H. 2014: Sa1839 Atonal Homolog 1 (Atoh1) Upregulates Gastric-and Intestinal-Type Protein Expression in Esophageal Squamous Cells, and Increases Proliferation in Barrett's Cells: Potential Roles for Atoh1 in Barrett's Pathogenesis and Carcinogenesis. Gastroenterology 146(5): S-309

Hong, J.; Chen, Z.; Peng, D.; Belkhiri, A.; El-Rifai, W. 2014: Sa1840 Ape1 Suppresses Acidic Bile Salts-Induced Cell Death Through Regulation of Jnk/p38 Pathways in Esophageal Adenocarcinoma. Gastroenterology 146(5): S-309

Majewski, M.; Skoczylas, T.; Wallner, G.; Sarosiek, J. 2014: Sa1841 Increased Esophageal Transforming Growth Factor Secretion in Patients With Barrett's Esophagus: Repair of Excessive Injury or Promotion of Cancerogenesis?. Gastroenterology 146(5): S-309

Elliott, D.R.F.; Ross-Innes, C.S.; Eldridge, M.D.; Fitzgerald, R. 2014: Sa1843 The Toll-Like Receptor Pathway Is Recurrently Mutated in Esophageal Adenocarcinoma. Gastroenterology 146(5): S-310

Gupta, M.; Schleck, C.D.; Zinsmeister, A.R.; Katzka, D.A.; Dunagan, K.T.; Johnson, M.L.; Iyer, P.G. 2014: Sa1844 Erosive Esophagitis As a Potential Precursor of Barrett's Esophagus -Findings From a Population Based Cohort. Gastroenterology 146(5): S-310

Devanna, S.; Singh, S.; Dunagan, K.T.; Johnson, M.L.; Iyer, P.G. 2014: Sa1845 Association Between Serum Adipokines, Insulin and Risk of Barrett's Esophagus: A Systematic Review and Meta-Analysis. Gastroenterology 146(5): S-310

Stevens, S.C.; Abrams, J.A.; LeFave, C.; Lightdale, C.J.; Gonda, T.A. 2014: Sa1846 Global and Gene Specific Dna Methylation Changes in Barrett's Epithelium and Adjacent Normal Mucosa. Gastroenterology 146(5): S-311

Mokrowiecka, A.; Kacprzak, D.; Wieczfinska, J.; Pawliczak, R.; Malecka-Panas, E. 2014: Sa1847 Adiponectin and Leptin Receptors Activation in Barrett's Esophagus and Esophageal Adenocarcinoma Patients Could Not Be Explained by Obesity Status. Gastroenterology 146(5): S-311

Davelaar, A.; Calpe, S.; Lau, C.T.; Meijer, S.L.; Visser, M.; Fockens, P.; Krishnadath, K.K. 2014: Sa1848 Aberrant P53 by P53 Immunohistochemistry Combined With Dna Fish, Is Excellent for Risk Stratification of Barrett's Esophagus Patients: Results From a Prospective Long Term Follow-Up Study. Gastroenterology 146(5): S-311

Kestens, C.; Leenders, M.; Offerhaus, J.; Van Baal, J.W.; Siersem, P.D. 2014: Sa1849 The Risk of Malignant Progression in Patients With Barrett's Esophagus and a Histologic Diagnosis of Indefinite for Dysplasia: A Dutch Nationwide Cohort Study. Gastroenterology 146(5): S-311

Pietro, M.di; Bird-Lieberman, E.L.; Liu, X.; ODonovan, M.; Fitzgerald, R. 2014: Sa1852 Autofluorescence-Targeted Optical Biopsy Accurately Diagnoses Dysplasia in Barrett's Esophagus and Can Detect the Field of Molecular Change. Gastroenterology 146(5): S-312

Desai, V.; Greenspan, M.; Dhanekula, R.; Mobarhan, S.M.; Losurdo, J.; Jakate, S.M.; Melson, J.E. 2014: Sa1853 Negative Surveillance Endoscopy Occurs Frequently in Patients With Ultrashort Segment Barrett's Esophagus. Gastroenterology 146(5): S-312

Van Olphen, S.H.; Kastelein, F.; Steyerberg, E.W.; Looman, C.W.; Spaander, M.C.; Bruno, M.J.; de Grob, E.W.B. 2014: Sa1855 Cost-Effectiveness of Barrett's Esophagus Surveillance in a Prospective Followed Cohort in the Netherlands. Gastroenterology 146(5): S-313

Brown, C.S.; Lapin, B.; Wang, C.; Goldstein, J.; Linn, J.G.; Denham, W.; Haggerty, S.P.; Carbray, J.; Talamonti, M.; Ujiki, M.B. 2014: Sa1856 Predicting Progression in Barrett's Esophagus Results From a Retrospective Cohort of 1834 Patients. Gastroenterology 146(5): S-313

Spaander, M.C.; Van Beelen, N.W.; Dandrieu, E.; Gottrand, F.; Michaud, L.; Biermann, K.; Bruno, M.J.; Wijnen, R.M.; IJsselstijn, H. 2014: Sa1858 High Prevalence of Barrett's Esophagus and Histological Inflammatory Changes in Patients With Esophageal Atresia. Gastroenterology 146(5): S-314

Chak, A.; Buttar, N.; Foster, N.R.; Seisler, D.K.; Marcon, N.E.; Schoen, R.E.; Cruz-Correa, M.R.; Falk, G.W.; Sharma, P.; Hur, C.; Sharma, A.N.; Baruah, A.; Chowdhury, S.; Kossak, S.; Rodriguez, L.M. 2014: Sa1859 Randomized Double Blind Placebo Controlled Phase Ii Trial of Barrett's Esophagus Chemoprevention With Metformin. Gastroenterology 146(5): S-314

Venerito, M.; Radünz, M.; Reschke, K.; Mertens, P.R.; DiMario, F.; Malfertheiner, P. 2014: Sa1860 Serum Pepsinogens for Detection of Fundic Gastric Atrophy in Subjects With Autoimmune Thyroid Disease. Gastroenterology 146(5): S-314

Pazos, A.J.; Bravo, L.E.; Figueroa, M. 2014: Sa1861 Antimicrobial Susceptibility and Virulence Factors in Two Populations in Contrast With Gastric Cancer Risk in Southwestern Colombia. Gastroenterology 146(5): S-314

Hellström, P.M.; Hendolin, P.H.; Kaihovaara, P.; Kronberg, L.; Meierjohann, A.; Millerhovf, A.; Paloheimo, L.I.; Sundelin, H.; Syrjänen, K.J.; Webb, D.-L.; Salaspuro, M. 2014: Sa1863 L-Cysteine Slow-Release Capsule Formulation in Prevention of Gastric Carcinogenesis Associated With Atrophic Gastritis. Gastroenterology 146(5): S-315

Buttar, N.; Falk, G.W.; Sharma, A.N.; Foster, N.R.; Chowdhury, S.; Baruah, A.; Kossak, S.; Chandra, R.; Singh, I.; Iyer, P.G.; Ziegler, K.A.; Romero, Y.; Marcon, N.E.; Schnell, T.G.; Corley, D.A. 2014: Sa1864 Aspirin Downregulates Cell Survival and mTor Effector pS6K in Barrett's Esophagus Patients: Data From a Randomized, Double-Blind, Phase Ii Chemoprevention Trial. Gastroenterology 146(5): S-315

Aloor, S.; Tamariz, L.; Deshpande, A.R.; Sussman, D.A. 2014: Sa1865 Barrett's Esophagus and Serum Adipokines: A Meta-Analysis. Gastroenterology 146(5): S-315

Zhang, S.; Lee, D.S.; Morrissey, R.; Aponte-Pieras, J.R.; Rogers, A.B.; Moss, S.F. 2014: Sa1866 Timing of Antibiotics to Prevent Gastric Cancer in a Mouse Model of H. pylori Infection. Gastroenterology 146(5): S-315

Derakhshan, M.H.; Harvey, T.; Ferrier, R.K.; Robertson, E.V.; Orange, C.; Forshaw, M.; Going, J.J.; McColl, K.E. 2014: Sa1867 Evidence of Two Aetiologies of Gastroesophageal Junctional Cancers Based on Gastric Parietal Cell Density. Gastroenterology 146(5): S-316

Lee, H.J.; Kim, G.H.; Lee, B.E.; Baek, D.H.; Song, G.A. 2014: Sa1868 Is Endoscopic Submucosal Dissection Safe for Papillary Adenocarcinoma of Stomach?. Gastroenterology 146(5): S-316

Nielsen, J.A.; Lager, D.; Roberts, C.A.; Lewin, M. 2014: Sa1870 Fundic Gland Polyps with Dysplasia. Gastroenterology 146(5): S-317

Kawai, T.; Yanagisawa, K.; Fukuzawa, M.; Kusano, C.; Gotoda, T.; Moriyasu, F. 2014: Sa1871 Evaluation of Gastric Cancer Diagnosis Using Ultrathin Transnasal Endoscopy With Narrow-Band Imaging. Gastroenterology 146(5): S-317

Kwon, H.J.; Park, M.I.; Park, S.J.; Moon, W.; Kim, S.E. 2014: Sa1872 Hyperglycemia and Dyslipidemia Is Positively Correlated With Development of Gastric Adenoma: Retrospective Uni-Center Case Control Study. Gastroenterology 146(5): S-317

Quiel, L.A.; Alderuccio, J.P.; Adekunle, A.; Fernandez, I.; Harley, J. 2014: Sa1874 Incidence of Gastric Intestinal Metaplasia in Patients With Negative Helicobacter pylori. Gastroenterology 146(5): S-318

Correa, P. 2014: Sa1875 the Gastric Precancerous Cascade. Gastroenterology 146(5): S-318

Arisawa, T.; Fukuyama, T.; Tahara, T.; Yamada, K.; Yamada, H.; Nomura, T.; Hayashi, R.; Matsunaga, K.; Kawada, N.; Otsuka, T.; Nakamura, M.; Shimasaki, T.; Toshikuni, N.; Shiroeda, H.; Shibata, T. 2014: Sa1876 Genetic Polymorphisms of Dnmt3A Are Associated With the Aberrant Dna Methylation of Cdh1 in Japanese Subjects. Gastroenterology 146(5): S-318

Link, A.; Steponaitiene, R.; Kupcinskas, L.; Langner, C.; Skieceviciene, J.; Balaguer, F.; Kupcinskas, L.; Malfertheiner, P. 2014: Sa1877 Methylation of miR-137 Is a Frequent and Early Event in Gastric Carcinogenesis. Gastroenterology 146(5): S-318

Livovsky, D.M.; Skarzhinsky, G.; Peretz, A.; Pappo, O.; Ackerman, Z. 2014: Sa1878 Individuals With Portal Hypertension Have an Increased Propensity to Develop Hyperplastic Gastric Polyps. Gastroenterology 146(5): S-319

Petersen, J.; Hallas, J.; de Muckadell, O.B.S.; Dall, M.; Hansen, J.M. 2014: Sa1879 A Model to Assess the Risk for Asa/Nsaid-Related Ulcer Bleeding for the Individual Patient Based on the Number of Risk Factors. Gastroenterology 146(5): S-319

Wang, J.H.; Basseri, R.J.; Jackson, C.S. 2014: Sa1880 Somatostatin Analogs Can Decrease Hospitalizations and Gastrointestinal Bleeding in Patients With Small Bowel Angioectasia. Gastroenterology 146(5): S-319

Serrao, S.; Jackson, C.S.; Juma, D.; Ibrahim, D.; Randhawa, M.; Soret, S.; Gerson, L.B. 2014: Sa1882 Exploring Predictors of in-Hospital Mortality in Dieulafoy's Lesions of the Stomach and Intestine. Gastroenterology 146(5): S-320

Taha, A.S.; McCloskey, C.; Craigen, T.; Angerson, W.J. 2014: Sa1883 Antithrombotic vs. Ulcer Effects in Non-Variceal Bleeding in Users of Antithrombotic Drugs. Gastroenterology 146(5): S-320

Thandassery, R.B.; Sharma, M.; Kaabi, S.A. 2014: Sa1884 Validation of a New Bedside Prognostic Score (Aims65) in Upper Gastrointestinal Bleed. Gastroenterology 146(5): S-320

Liang, P.S.; Saltzman, J.R. 2014: Sa1885 The Initial Management of Upper Gastrointestinal Bleeding: A National Survey. Gastroenterology 146(5): S-320

Calo, N.C.; Arguero, M.J.; Gonzalez, M.L.; Mahler, M.A.; Manazzoni, D.; DePaula, J.A.; Serra, M.M. 2014: Sa1887 Gastrointestinal Bleeding in Patients With Hemorrhagic Hereditary Telangiectasia: a Cross Sectional Study. Gastroenterology 146(5): S-321

Lee, J.M.; Chun, H.J.; Lee, J.S.; Kim, S.H.; Nam, S.J.; Choi, H.S.; Kim, E.S.; Keum, B.; Jeen, Y.T.; Lee, H.; Um, S.H.; Kim, C.D.; Ryu, H.S.; Park, J.-J.; Lee, S.W. 2014: Sa1888 Target Level for Hemoglobin Correction in Patients With Acute Non-Variceal Upper Gastrointestinal Bleeding. Gastroenterology 146(5): S-321

Lee, J.M.; Lim, S.U.; Ki, H.-S.; Jun, C.; Park, C.-H.; Kim, H.-S.; Choi, S.-K.; Rew, J.-S.; Park, S.-Y. 2014: Sa1889 Clinical Characteristics of Upper Gastrointestinal Bleeding After Percutaneous Coronary Intervention: A Single-Center Study. Gastroenterology 146(5): S-321

Matei, D.; Cruciat, C.; Furnea, B.; Levi, C.; Groza, I.; Puie, L.; Bocsan, C.; Vesa, S.C.; Tantau, M. 2014: Sa1890 The Impact of Comorbidities on 30-Day Mortality in Peptic Ulcer Bleeding. Gastroenterology 146(5): S-321

Stefanova, M.; Pelikanova, M.; Burian, M.; Erhart, D.; Spacek, R. 2014: Sa1892 Dabigatran -Risk Factor of Severe Bleeding in Distal Esophagus in Elderly Women. Gastroenterology 146(5): S-322

Goldis, A.; Ratiu, I.; Diaconescu, R.; Lazar, D.E. 2014: Sa1893 Non-Variceal Upper Digestive Bleeding-Predictive Factors for Rebleeding and Mortality. Gastroenterology 146(5): S-322

Lachar, J.; Christopher, S.; Flattery, M.; Shah, K.; Tang, D.G.; Smallfield, M.C.; Cooke, R.H.; Kasirajan, V.; Cheng, J.; Smallfield, G. 2014: Sa1894 Gastrointestinal Bleeding in Ventricular Assist Device and Total Artificial Heart Implantations. Gastroenterology 146(5): S-322

Amal, H.; Leja, M.; Funka, K.; Skapars, R.; Liepniece-Karele, I.; Kikuste, I.; Vanags, A.; Tolmanis, I.; Haick, H. 2014: Sa1896 Nanomaterial-Based Sensor Technology Can Detect Gastric Cancer and Peptic Ulcer Disease With a High Accuracy From an Exhaled Air Sample. Gastroenterology 146(5): S-323

Pérez-Carbonell, L.; Egoavil, C.M.; Rojas, E.; Alenda, C.; Rodriguez-Soler, M.; Guarinos, C.; Juarez-Quesada, M.; Andreu, M.; Llor, X.; Castells, A.; Jover, R.; Boland, C.R.; Goel, A. 2014: Sa1897 Novel Evidence for Interleukin-8 (Il-8) As a Predictive Biomarker of Response to 5fluorouracil Based Chemotherapy in Colorectal Cancer. Gastroenterology 146(5): S-323

Hur, K.; Xu, G.; Okugawa, Y.; Toiyama, Y.; Chang, A.N.; Boland, C.R.; Goel, A. 2014: Sa1898 Next Generation Sequencing (Ngs)-Based Transcriptomic Approaches for the Identification of Novel Colorectal Cancer (Crc)-Specific miRna Biomarkers. Gastroenterology 146(5): S-323

Mori, H.; Suzuki, H.; Matsuzaki, J.; Tsugawa, H.; Okada, S.; Fukuhara, S.; Masaoka, T.; Kanai, T.; Saya, H. 2014: Sa1900 Cd44v9 Results in Resistance to Trastuzumab via Induction of Ros Resistance. Gastroenterology 146(5): S-324

Barták, B.K.; Spisak, S.; Ittzés, P.; Bodor, A.; Kondor, D.; Vattay, G.; Nagy, Z.B.; Kalmár, A.; Tulassay, Z.; Csabai, I.; Molnár, B. 2014: Sa1901 Bacterial Dna and Methylated Host Dna Sequences in Plasma Samples of Healthy and Colorectal Cancer Patients: A Whole-Metagenome Analysis. Gastroenterology 146(5): S-324

Barták, B.K.; Wasserkort, R.; Kalmár, A.; Valcz, G.; Tóth, K.; Tulassay, Z.; deVos, T.; Molnár, B. 2014: Sa1902 Sept9 and Sfrp1 Dna Hypermethylation in Colorectal Cancer: Restriction to a Single CpG Island and Expansion to the Gatekeeper Myofibroblasts. Gastroenterology 146(5): S-324

Calpe, S.; Davelaar, A.; Lau, C.T.; Meijer, S.L.; Fockens, P.; Krishnadath, K.K. 2014: Sa1904 Her-2 Amplifications Correlate With Genetic Instability and Appear Late During Malignant Progression of Barrett's Esophagus. Gastroenterology 146(5): S-325

Satherley, L.; Ye, L.; Hargest, R.; Jian, W.G. 2014: Sa1905 Psoriasin Expression in Human Colorectal Cancer. Gastroenterology 146(5): S-325

Chen, H.; Nayak, S.S.; Liu, H.; Engen, P.; Ai, J.; Li, Y.; Melson, J.E.; Deng, Y. 2014: Sa1906 Circulating Plasma MicroRna As Markers in the Early Detection of Colorectal Cancer. Gastroenterology 146(5): S-325

Jiménez-Pérez, J.; Borda, A.; Zozaya, J.M.; Rubio, E.; Urman, J.; Borda, F. 2014: Sa1908 Onodera Index Independently Predicts Survival in Surgically Treated Colorectal Carcinoma. Gastroenterology 146(5): S-326

Thomaidis, T.; Maderer, A.; Kornmann, M.; Bauer, S.L.; Trautmann, M.; Schwarz, M.; Neumann, W.; Formentini, A.; Lyros, O.; Schad, A.; Galle, P.R.; Moehler, M. 2014: Sa1909 Predictive Value of Proteins Related With the Vegfr and Egfr Pathways in Patients With Stage Ii/Iii Colorectal Cancer Receiving Adjuvant Treatment With Fluorouracil, Leucovorin +/ Irinotecan: Translational Results of the Fogt-4 Trial. Gastroenterology 146(5): S-326

Gleeson, F.C.; Kipp, B.R.; Voss, J.S.; Campion, M.B.; Henry, M.; Sciallis, A.P.; Graham, R.; Lazaridis, K.; Vasmatzis, G.; Levy, M.J. 2014: Sa1911 Eus Fna Cytology Next-Generation Sequencing: the Fbxw7 Gene Pathogenic Alteration Profile in Treatment Naive Locally Advanced Rectal Cancer. Gastroenterology 146(5): S-327

Bishehsari, F.; Celistan, M.; Bauer, J.; Sporn, J.; Jung, B.H. 2014: Sa1912 Bard1 Splice Variant Status Can Predict Sensitivity to Parp-1 Inhibitor Therapy in Colon Cancer. Gastroenterology 146(5): S-327

Song, S.-E.; Park, S.-J.; Park, M.-I.; Moon, W.; Kim, S.E.; Kwon, H.J.; Ku, K.H.; Choi, Y.J.; Yoo, C.H.; Lee, G.W.; Cheon, J.H.; Kim, J.H. 2014: Sa1913 Diagnostic Value of Ascitic Fluid Cea in Advanced Colorectal Cancer With Peritoneal Carcinomatosis. Gastroenterology 146(5): S-327

Seo, K.; Cho, S.-J.; Kook, M.-C.; Ryu, K.W.; Kim, Y.-W.; Kim, C.G.; Choi, I.J. 2014: Sa1914 Prognostic Value of Tumoral Expression of Galectin-9 in Gastric Cancer. Gastroenterology 146(5): S-328

Kachaamy, T.; Adam, J.D.; Cheng, J.; Puri, P. 2014: Sa1915 How Solid Are Iron Indices for Risk Stratification in Suspected Iron Deficiency Anemia?. Gastroenterology 146(5): S-328

Li, J.; Glover, S.C.; Gjymishk, A. 2014: Sa1916 Increased Expression of Rock I and Met in Colorectal Cancer Is Associated With Decreased Patient Survival. Gastroenterology 146(5): S-328

Cui, M.; Wang, Z.; Tong, W.; Zhang, D.; Ye, F. 2014: Sa1917 Detection of Mutations in Kras, Braf and Pik3Ca Genes in Colorectal Cancer Patients Using Allele Specific Primer Extension on Luminex Platform. Gastroenterology 146(5): S-328

Yoo, E.J.; Park, J.C.; Kim, E.H.; Park, C.H.; Shim, C.N.; Lee, H.J.; Chung, H.; Lee, H.; Shin, S.K.; Lee, S.K.; Lee, Y.C. 2014: Sa1919 Prognostic Value of Neutrophil to Lymphocyte Ratio in Patients Treated With Concurrent Chemoradiation Therapy for Locally Advanced Esophageal Cancer. Gastroenterology 146(5): S-329

Lim, H.; Lee, J.H.; Ahn, J.Y.; Choi, K.-S.; Kim, D.H.; Choi, K.D.; Song, H.J.; Lee, G.H.; Jung, H.-Y.; Kim, J.-H. 2014: Sa1920 Clinical Significance of Epstein-Barr Virus Involvement in Gastric Lymphoepithelioma-Like Carcinoma. Gastroenterology 146(5): S-329

Mitsuhashi, K.; Nosho, K.; Igarashi, H.; Ito, M.; Naito, T.; Sukawa, Y.; Okuda, H.; Yoshii, S.; Kusumi, T.; Hosokawa, M.; Yamamoto, E.; Suzuki, H.; Yamamoto, H.; Imai, K.; Shinomura, Y. 2014: Sa1921 MicroRna-31 May Predict Response in Patients With Metastatic Colorectal Cancer Treated With Anti-Egfr Therapy. Gastroenterology 146(5): S-329-S-330

Elliott, J.A.; O'Farrell, N.J.; Halpenny, D.; King, S.; Muldoon, C.; Johnston, C.; Reynolds, J.V. 2014: Sa1922 Lack of Clinical Value of a Second Ct-Pet Scan Following Neoadjuvant Chemoradiotherapy for Adenocarcinoma of the Esophagogastric Junction. Gastroenterology 146(5): S-330

Shichijo, S.; Hirata, Y.; Yamaji, Y.; Sakitani, K.; Yamamoto, S.; Yoshida, S.; Yamada, A.; Koike, K. 2014: Sa1923 Histological Findings of Intestinal Metaplasia in the Gastric Corpus Is a Predictive Factor for the Development of Gastric Cancer. Gastroenterology 146(5): S-330

Wolf, W.A.; Lao-Sirieix, P.; Duits, L.C.; Chak, A.; Shaheen, N.J.; Fitzgerald, R.; Bergman, J.J. 2014: Sa1924 Utility of a Biomarker Panel to Predict Progression to Esophageal Adenocarcinoma in Barrett's Esophagus. Gastroenterology 146(5): S-330

Molnár, B.; Patai, Ã.V.; Valcz, G.; Wichmann, B.; Barták, B.K.; Tulassay, Z. 2014: Sa1925 Early and Universal Aberrant Dna Hypermethylation Changes in Colorectal Adenomas and Cancers. Gastroenterology 146(5): S-331

Mihalache, A.; Gosset, P.; Ringot, B.; Nunes, B.; Fleurisse, L.; Léonard, R.; Groux-Degroote, S.; Robbe-Masselot, C. 2014: Sa1926 Mucin O-Glycans As Potential Prognosis and Recurrence Markers of Colorectal Cancer. Gastroenterology 146(5): S-331

Weinstein, J.; DeLaCruz, M.; Wali, R.K.; Momi, N.; Roy, H.K. 2014: Sa1927 Sirt 6: Linking Metabolic and Microvascular Alterations in Early Colon Carcinogenesis. Gastroenterology 146(5): S-331

Majumdar, A.; Chen, J.; Lin, S.-H.; Katz, L.H.; Raju, G.S.; Shetty, K.; White, J.; Wu, X.; Rashid, A.; McMurray, J.S.; Shaw, K.R.; Su, X.; Weston, B.R.; Thirumurthi, S.; He, A.R. 2014: Sa1928 Whole Genome Analysis of Colon Adenomas Reveals Novel Prognostic and Therapeutic Targets. Gastroenterology 146(5): S-331

Cook, R.W.; Lassen, N.; Bierman-Harrar, Y.; Johnson, C.E.; Oelschlager, K.; Maetzold, D.; Saxena, R.; Shan, W.; Rosen, D.G. 2014: Sa1929 A Novel, Multi-Analyte Assay With the Potential to Predict Responses to Neoadjuvant Chemoradiation in Rectal Adenocarcinoma Patients. Gastroenterology 146(5): S-332

Chhatrala, R.; Warren, G.; Tan, W.; Iyer, R. 2014: Sa1930 Correlation Between Cotinine -A Smoker's Signature and Erlotinib Exposure and Clinical Outcomes in Pancreatic Cancer. Gastroenterology 146(5): S-332

Tahara, T.; Okubo, M.; Shibata, T.; Sumi, K.; Ishizuka, T.; Ichikawa, Y.; Kawamura, T.; Nakamura, M.; Nagasaka, M.; Nakagawa, Y.; Ohmiya, N.; Arisawa, T.; Hirata, I. 2014: Sa1931 Association Between Common Genetic Variants in Pre-Micro Rnas and Prognosis of Advanced Gastric Cancer Treated Chemotherapy. Gastroenterology 146(5): S-332

Rahmani, S.; Burke, D.; Howel, S.J. 2014: Sa1932 The Effect of Adjuvant Pre-Operative Therapy (Apt) on Patients With Colorectal Cancer Awaiting Surgical Resection. Gastroenterology 146(5): S-332

Rossi, R.E.; Garcia-Hernandez, J.; Martin, N.; Meyer, T.; Thirlwell, C.; Watkins, J.; Caplin, M.; Toumpanakis, C. 2014: Sa1934 Chromogranin a As a Predictor of Radiological Disease Progression in Neuroendocrine Tumors. Gastroenterology 146(5): S-333

Rossi, R.E.; Garcia-Hernandez, J.; Mandair, D.; Martin, N.; Toumpanakis, C.; Caplin, M. 2014: Sa1935 Variation and Utility Ofchromogranin a Assays for Gastric Carcinoid Type 1. Gastroenterology 146(5): S-333

Solaini, L.; Jamieson, N.B.; Tamburrini, R.; Spoletini, G.; Hilal, M.A.; Johnson, C.D.; Soonawalla, Z.; Davidson, B.; McKay, C.; Koche, H. 2014: Sa1937 Uk Multicentre Surgical Experience with Primary Duodenal Adenocarcinoma. Gastroenterology 146(5): S-334

Ince, A.T.; Yildiz, K.; Baysal, B.; Danalioglu, A.; Kocaman, O.; Tozlu, M.; Gangarapu, V.; Kemik, A.S.; Uysal, Ã.; Senturk, H. 2014: Sa1939 Role of Serum and Biliary Cea, Ca19-9, Vegfr-3 and Tac for Differentation of Malignant and Benign Biliary Obstruction. Gastroenterology 146(5): S-334

Nanjo, S.; Ando, T.; Terao, S.; Sugiyama, T. 2014: Sa1941 The Candidate Molecular Markers for Evaluating the Risk of Gastric Cancer After Helicobacter pylori Eradication. Gastroenterology 146(5): S-335

Chung, K.H.; Ryu, J.K.; Park, J.M.; Lee, J.M.; Lee, S.H.; Kim, Y.-T. 2014: Sa1942 MicroRna Expression in Unresectable Pancreatic Cancer As a Prognostic Marker in Eus-Fna Cytology Specimens. Gastroenterology 146(5): S-335

Li-Chang, H.H.; Mitrovic, B.; Handley, K.; Gray, R.; Assarzadegan, N.; Hutchins, G.; Quirke, P.; Riddell, R.H.; Kirsch, R. 2014: Sa1943 Histopathologic Grading Using Poorly-Differentiated Clusters Predicts Outcome in Colorectal Carcinoma. Gastroenterology 146(5): S-335

Guarinos, C.; Hernandez-Illan, E.; Juarez-Quesada, M.; Rodriguez-Soler, M.; Egoavil, C.M.; Pérez-Carbonell, L.; Salas-Rico, R.; Cubiella, J.; Rodriguez-Moranta, F.; De-Castro, L.; Bujanda, L.; Serradesanferm, A.; Nicolás-Pérez, D.; Herraiz, M.; Fernández-Bañares, F. 2014: Sa1944 Patients With Multiple Adenomatous Polyps: Causes, Characteristics and Management Recommendations. Gastroenterology 146(5): S-336

Juarez-Quesada, M.; Egoavil, C.M.; Rodriguez-Soler, M.; Guarinos, C.; Hernandez-Illan, E.; Pérez-Carbonell, L.; Andreu-Martinez, L.; Castaño-Soler, L.; Martínez, J.; Ruiz, F.; Compañy, L.; Aparicio, J.R.; Casellas, J.A.; Barberá, V.M.; Castillejo, A. 2014: Sa1945 Molecular Characterization of Serrated Polyps Can Differentiate More Advanced Lesions. Gastroenterology 146(5): S-336

Geng, X.; Minacapelli, C.D.; Cheng, C.L.; Das, K.M. 2014: Sa1946 Effects of Mesalamine on Cyp Expressionin Colon: a Novel Pathway for Chemoprevention of Mesalamine in Ulcerative Colitis. Gastroenterology 146(5): S-336

Urayama, S. 2014: Sa1947 Discriminant Identifiable Plasma Metabolites in Pancreatic Cancer-Associated Diabetes -Candidate Early-Detection Biomarkers. Gastroenterology 146(5): S-336

Amiriani, T.; Kelarijani, F.N.; Besharat, S.; Roshandel, G. 2014: Sa1949 Validity of Serum Markers As Non-Endoscopic Screening Method for Gastric Cancer. Gastroenterology 146(5): S-337

Cherciu, I.F.; Margaritescu, C.; Pirici, D.; Barbalan, A.; Cartana, T.; Saftoiu, A. 2014: Sa1950 Prom1/Alcam/Ki-67 Triple Immunofluorescence Assessment for Putative Cancer Stem Cells in Colorectal Carcinoma. Gastroenterology 146(5): S-337

Ito, M.; Nosho, K.; Igarashi, H.; Naito, T.; Matsunaga, Y.; Mitsuhashi, K.; Takahashi, T.; Tanuma, T.; Kurihara, H.; Yamamoto, K.; Okahara, S.; Takahashi, H.; Hosokawa, M.; Takenouchi, T.; Yamamoto, H. 2014: Sa1951 Molecular Characterization of Superficial Esophageal Adenocarcinoma Obtained From Endoscopic Submucosal Dissection (Esd). Gastroenterology 146(5): S-337

Lee, J.yup; Kim, N.; Choi, Y.J.; Yoon, H.; Shin, C.M.; Park, Y.S.; Lee, D. 2014: Sa1952 The Role of Serum Pepsinogen Test for the Detection of Atrophy, Intestinal Metaplasia and Gastric Cancer in Korea. Gastroenterology 146(5): S-337

Konda, V.J.; Dougherty, U.; Valuckaite, V.; Mustafi, R.; Almoghrabi, A.; Sadiq, F.; Fichera, A.; Joseph, L.J.; Hart, J.; Bissonnette, M. 2014: Sa1953 Docosahexaenoic Acid (Dha) Inhibits Vegf Induction and Aom/Dss Tumorigenesis. Gastroenterology 146(5): S-338

Minacapelli, C.D.; Bajpai, M.; Geng, X.; Das, K.M. 2014: Sa1954 Benzo[a]Pyrene-Induced Cyp 1A1/1B1 Genes May Promote Development of Esophageal Adenocarcinoma While Curcumin Attenuates Such Induction. Gastroenterology 146(5): S-338

Jeon, S.; Kwon, Y. 2014: Sa1956 Old Age Is Another Independent Risk Factor for Metachronous Gastric Cancer Irrespective of H. pylori Eradication; Retrospective, Single Tertiary Center Study. Gastroenterology 146(5): S-339

Gómez, E.J.; Pereyra, L.; González, R.; Fischer, C.; Mella, J.M.; Omodeo, M.; Panigadi, G.N.; Amante, M.F.; Casas, G.; Cimmino, D.G.; Pedreira, S.C.; Boerr, L.A. 2014: Sa1958 Serrated Polyposis Syndrome: Pushing Through Prevalence and Clinicopathological Features. Gastroenterology 146(5): S-340

O'Connell, M.R.; Sarkar, S.; Kantara, C.; Singh, P. 2014: Sa1959 Curcumin Induces Autophagic Survival of Dclk1+Ve Colon Cancer Stem Cells (Cscs), While Co-Treatment With Curcumin and Dclk1-siRna Eliminates Cscs: Role of Long and Short Isofoms of Dclk1. Gastroenterology 146(5): S-340

Geng, X.; Seril, D.N.; Poplin, E.; Ferges, W.; Bajpai, M.; Chen, C.; Chen, C.; Cheng, J.; Das, K.M. 2014: Sa1960 Carcinogenesis-Genes Identified in Colon Tissue As Possible Targets for Chemo Preventive Effect of Mesalamine in Patients With Chronic Ulcerative Colitis. Gastroenterology 146(5): S-340

Cheah, K.Y.; Howarth, G.S.; Bindon, K.A.; Kennedy, J.A.; Mashtoub, S.; Bastian, S.E. 2014: Sa1963 Low Molecular Weight Procyanidins From Grape Seeds Enhance the Impact of 5-Fluorouracil Chemotherapy on Colon Cancer Cells. Gastroenterology 146(5): S-341

Øverby, A.; Zhao, C.-M.; Wang, T.C.; Bones, A.; Chen, D. 2014: Sa1964 Gastric Cancer Chemoprevention by Phenethyl Isothiocyanate-Containing Diet in Chemically but Not Genetically Induced Gastric Cancer in Mice. Gastroenterology 146(5): S-341

Sharma, A.N.; Kossak, S.; Chowdhury, S.; Chandra, R.; Singh, I.; Baruah, A.; DeMars, C.J.; Iyer, P.G.; Urrutia, R.A.; Wang, K.K.; Krishnadath, K.K.; Buttar, N. 2014: Sa1965 Garcinol Interferes With Oncogenic Il1b-Stat3 and Facilitates Tumor Suppressive Klf11-Sin3A to Down-Regulate Akt1 Expression and Cell Growth in Barrett's Epithelium. Gastroenterology 146(5): S-341

Quainoo, C.E.; DeAlwis, S.; Huang, C.-H.; Golla, V.; Haynes, M.; Aytaman, Y.; Ndzengue, A.; Caguiat, K.; Aytaman, A.; Martinez, M.; Lawlo, G. 2014: Sa1966 Predictors of Right-Sided Polyp Growth in a Veteran Population. Gastroenterology 146(5): S-341

Khare, V.; Asboth, M.; Gasche, C. 2014: Sa1968 Mesalamine Exhibits a Protective Dna Damage Response in Normal Colon Epithelial Cells Under Oxidative Stress. Gastroenterology 146(5): S-342

Mallipeddi, M.K.; Speicher, P.J.; Ganapathi, A.M.; Englum, B.R.; Migaly, J.; Mantyh, C.R. 2014: Sa1969 Effects of Neoadjuvant and Adjuvant Therapy for Rectal Cancer on Long Term Survival. Gastroenterology 146(5): S-342

Xiao, B.; Viennois, E.; Zhang, Y.; Ayyadurai, S.; Laroui, H.; Merlin, D. 2014: Sa1970 Cd98 As a Ligand for Colitis-Targeted Delivery of Nanoparticle. Gastroenterology 146(5): S-342

Lin, Z.; Mogni, B.; Nicodème, F.; Lipowska, A.; Lin, C.-Y.; Kahrilas, P.J.; Pandolfino, J.E. 2014: Sa1972 Bolus Flow Time Calculated From High-Resolution Impedance and Manometry (Hrim) Data Correlates With Timed Barium Esophagram Measures. Gastroenterology 146(5): S-343

Kaneshiro, M.; Kaiser, W.; Russell, M.M.; Patel, A.; Tashjian, V.C.; Zegarski, V.; Singh, D.; Cohen, S.E.; Reid, M.W.; Whitman, C.B.; Talley, J.; Martinez, B.M.; Spiegel, B.M. 2014: Sa1974 Characterizing Gastrointestinal (Gi) Motility With a Computer-Aided, Non-Invasive Acoustic Sensor: Proof-of-Concept Testing in Normal Controls vs. Postoperative Patients. Gastroenterology 146(5): S-344

Gargallo, C.J.; Ferrandez, A.; Carrera, P.; Ducons, J.; Simon, M.A.; Lanas, A. 2014: Sa1977 Clinical Outcomes and Survival After Self-Expandable Colon Stents (Ses) in Colorectal Obstruction. Gastroenterology 146(5): S-345

Saxena, P.; Akshintala, V.S.; Simons, B.W.; Gabrielson, K.; Kumbhari, V.; Pasricha, P.J.; Kalloo, A.N.; Khashab, M.; Singh, V.K. 2014: Sa1978 A Novel Flexible Endoscopy-Capable Oxygen Probe Can Detect Pancreatic Ischemia in a Rat Model of Chronic Pancreatitis. Gastroenterology 146(5): S-345

Choi, M.-G.; Kim, I.-W.; Kim, J.H.; Park, J.M. 2014: Sa1979 New Evaluation Method of Singlet Oxygen Production in Photodynamic Therapy With Photomultiplier-Tube-Based Singlet Oxygen Detection System. Gastroenterology 146(5): S-345

de Leon, E.D.; Robinson, L.; Euhus, D.; Burstein, E.; Sarode, V.R. 2014: Sa1981 Evaluation of Lynch Syndrome by Immunohistochemistry and Quantitative Scoring by Digital Image Analysis As a Screening Tool for the Diagnosis of Hereditary Colon Cancer and Correlation With Genetic Analysis. Gastroenterology 146(5): S-346

Zhou, S.-Y.; Zhang, G.; Zhou, H.; Lu, Y.; Owyang, C. 2014: Sa1982 High Fat Diet Induced Upregulation of Ep2 Receptor in Small Intestine Paneth Cells Is Responsible for the Activation of Unfolded Protein Response and Reduction of, Defensins in Rats. Gastroenterology 146(5): S-346-S-347

Albenberg, L.; Esipova, T.V.; Judge, C.; Bittinger, K.; Chen, J.; Grunberg, S.; Baldassano, R.; Lewis, J.D.; Li, H.; Bushman, F.D.; Vinogradov, S.; Wu, G.D. 2014: Sa1983 Radial Partitioning of the Gut Microbiota Associated With Tolerance to Oxygen and Asaccharolytic Metabolism. Gastroenterology 146(5): S-347

Turco, F.; Palumbo, I.; Andreozzi, P.; Buonfantino, C.; Baldoni, T.; Sarnelli, G.; Cuomo, R. 2014: Sa1984 Probiotic and Postbiotic Effects of Lactobacillus Casei Dg on Enteroglial-Derived S100B and Nitric Oxide Production in Human Intestinal Biopsies. Gastroenterology 146(5): S-347

de Meij, T.; Budding, A.E.; de Groot, E.; Kneepkens, C.M.; Savelkoul, P.; Van Bodegraven, A.A. 2014: Sa1985 Short-Term and Long-Term Stability of the Intestinal Microbiota in Healthy Children. Gastroenterology 146(5): S-347

Rossen, N.; Fuentes, S.; D'Haens, G.R.; Heilig, H.; Zoetendal, E.G.; de Vos, W.M.; Ponsioen, C. 2014: Sa1987 Does the Ileocecal Valve Functionally Separate Ileal and Right-Sided Colon Microbiota Compositions?. Gastroenterology 146(5): S-348

Shobar, R.M.; Keshavarzian, A.; Losurdo, J.; Swanson, G.B.; DeMeo, M.; Melson, J.E.; Engen, P.; Velineni, S.; Mutlu, E. 2014: Sa1988 The Effect of Bowel Preparation on the Colonic Microbiota in Healthy Subjects and in Patients With Inflammatory Bowel Disease. Gastroenterology 146(5): S-348

Zanini, B.; Marullo, M.; Ricci, C.; Lanzarotto, F.; Lanzini, A. 2014: Sa1989 Non Celiac Gluten Sensitivity (Ncgs) Is Outnumbered by Fodmaps Sensitivity in Patients Spontaneously Adhering to Gluten Free Diet (Gfd): A Two Stage Double Blind Prospective Study. Gastroenterology 146(5): S-348

Victor, Z.; Raker, V.; Maxeiner, J.H.; Kahn, M.; Schuppan, D. 2014: Sa1991 Nutritional Wheat Alpha-Amylase/Trypsin Inhibitors (Atis) Worsen Allergic Airway Inflammation in Mice. Gastroenterology 146(5): S-349

Nordyke, K.; Rosén, A.; Emmelin, M.; Ivarsson, A. 2014: Sa1992 Internalizing the Threat of Risk-A Qualitative Study on Adolescents' Experience Living With Screening-Detected Celiac Disease Five Years After Diagnosis. Gastroenterology 146(5): S-349

Shetty, S.A.; Dhotre, D.P.; Bhatia, K.; Verma, A.K.; Mishra, A.; Ahuja, V.; Makharia, G.K.; Shouche, Y.S. 2014: Sa1993 Constitutional and Functional Small Intestinal Microbiome of Patients With Celiac Disease, First Degree Relatives and Effect of Gluten Free Diet on Them. Gastroenterology 146(5): S-349

Zanini, B.; Marullo, M.; Ricci, C.; Lanzarotto, F.; Lanzini, A. 2014: Sa1995 Self-Prescribed Gluten Free Diet (Gfd) in Non Celiac Patients With Perceived Gluten Sensitivity Is More Balanced in Macro-and Micro-Nutrients Than in Patients With Celiac Disease (Cd) and in Healthy Controls (Hc). Gastroenterology 146(5): S-350

Nijeboer, P.; de Baaij, L.R.; Visser, O.; Mulder, C.J.; Cillessen, S.A.; Bouma, G. 2014: Sa1996 Treatment Response of Eatl Patients in Amsterdam. Gastroenterology 146(5): S-350

Marafini, I.; Monteleone, I.; Cupi, M.L.; Paoluzi, O.A.; Colantoni, A.; Ortenzi, A.; Sica, G.; Pallone, F.; Monteleone, G. 2014: Sa1998 Innate Lymphoid Cells Are Increased in Celiac Disease Intestinal Mucosa and Have a Pathogenic Role in a Mouse Model of Small Intestine Atrophy. Gastroenterology 146(5): S-351

van de Water, J.M.; Nijeboer, P.; Zegers, J.; Mulder, C.J.; van der Peet, D.L. 2014: Sa1999 Surgery for Celiac Disease. Gastroenterology 146(5): S-351

Mooney, P.D.; Wong, S.H.; Sander, D.S. 2014: Sa2000 Predicting Histological Remission in Patients With Coeliac Disease on a Gluten Free Diet. Gastroenterology 146(5): S-351

Adelman, D.; Gribben, D.J.; Marcantonio, A.; Wu, T.-T.; Murray, J.A. 2014: Sa2001 Celiac Disease Patients Attempting Adherence to a Gluten-Free Diet Who Continue to Have Moderate or Severe Symptoms Have Clinically Significant Mucosal Injury. Gastroenterology 146(5): S-351

Khayyal, M.T.; Abdel-Aziz, H.; El-Ghazaly, M.A.; Abdel-Naby, D.H.; El-Hazek, R. 2014: Sa2002 Therapeutic Usefulness of an Herbal Preparation, Stw 5, in Protecting Against Radiation-Induced Intestinal Mucositis. Gastroenterology 146(5): S-352

Bhol, K.C.; Erlich, E.; Keane, D.M.; Lemos, B.; Lasko, D.; Tracey, D.E.; Fox, B.S.; Hartman, D. 2014: Sa2004 Effects of Avx-470m, an Oral Polyclonal Anti-Tnf Antibody, on Survival and Biomarkers in a Murine Model of Gastrointestinal Acute Radiation Syndrome. Gastroenterology 146(5): S-352

Jain, A.; Lipson, E.J.; Sharfman, W.; Lazarev, M. 2014: Sa2005 Clinical Features and Treatment of Immune Mediated Colitis in Metastatic Melanoma Patients Treated With Ipilimumab: Retrospective Review of a Single-Center Experience. Gastroenterology 146(5): S-352

Chen, J.-H.; Yu, Y.; Yang, Z.; Yu, W.-Z.; Huizinga, J.D. 2014: Sa2007 Colonic Motor Patterns in Patients With Chronic Constipation Assessed by High Resolution Manometry. Gastroenterology 146(5): S-353

Lacy, B.E.; Lembo, A.; Schey, R.; Lavins, B.J.; Eng, P.F.; Fox, S.M.; Jia, X.D.; Hao, X.; Currie, M.G.; Kurtz, C.B.; Johnston, J.; Shiff, S.J. 2014: Sa2008 Efficacy and Safety of Linaclotide in Chronic Idiopathic Constipation Patients With Abdominal Bloating: Phase 3b Trial Results. Gastroenterology 146(5): S-353

Koloski, N.A.; Jones, M.P.; Young, M.; Talley, N.J. 2014: Sa2010 Differentiation of Functional Constipation (Fc) and Irritable Bowel Syndrome-Constipation Predominant (Ibs-C) Based on Rome Iii Criteria. A Population Based Study. Gastroenterology 146(5): S-354

Haya-Hidalgo, J.R.; de Lemos, I.; Martín, I.; Tejero, M.; Royo, I.; Munteis, E.; Castillo, M.; del Amo, E.; Zafón, I.A.I.ñez; Bory, F.; Delgado-Aros, S. 2014: Sa2011 Neurogenic Bowel Dysfunction: Prevalence, Clinical Characteristics and Impact on Perceived Quality of Life in Spinal Cord and Brain Injury Patients. Gastroenterology 146(5): S-354

Dinning, P.G.; Wklendt, L.; Gibbins, I.; Maslen, L.; Lewis, H.; Arkwright, J.W.; Brookes, S.J.; Bampton, P.A.; Costa, M. 2014: Sa2012 High-Resolution Fiber-Optic Manometry Study of Myogenic and Neurogenic Motor Patterns of the Healthy Human Colon. Gastroenterology 146(5): S-354

Nusrat, S.; Farooq, M.A.; Bielefeldt, K. 2014: Sa2014 The Burden of Functional Disease. Gastroenterology 146(5): S-355

Burgell, R.; Knowles, C.H.; Scot, S.M. 2014: Sa2015 A Case Control Study Assessing the Symptomatic Impact of Rectal Hyposensitivity in Patients With Disordered Defecatory Function. Gastroenterology 146(5): S-355

Kumar, L.; Gosling, J.; Alam, A.; Raeburn, A.J.; Emmanue, A. 2014: Sa2016 Rectal Hyposensitivity to Balloon Distension Is Influenced by Rate of Inflation. Gastroenterology 146(5): S-355

Kumar, L.; Butt, S.; Alam, A.; Chatoor, D.; Emmanuel, A. 2014: Sa2018 Use of Consensus Definition of Failure of a Treatment to Provide Adequate Relief (F-Par) for Chronic Functional Constipation in Clinical Practice. Gastroenterology 146(5): S-356

Kunze, W.; Yan, R.M.; Min, K.K.; Pasyk, M.; Stanisz, A.; Zasloff, M. 2014: Sa2019 Squalamine Reverses Age and Loperamide Associated Dysmotility in a Mouse Biomarker Model of Constipation. Gastroenterology 146(5): S-356

Jamal, M.M.; Cryer, B.L.; Losch-Beridon, T.; Ueno, R. 2014: Sa2020 Lubiprostone for Treatment of Opioid-Induced Constipation: Analysis of Response by Opioid Class. Gastroenterology 146(5): S-356

Gatta, L.; Scarpignato, C. 2014: Sa2022 Does Prucalopride Have a Pro-Arrhythmic Potential? Lessons From Randomized Clinical Trials in Chronic Constipation. Gastroenterology 146(5): S-357

Ron, Y.; Safadi, R.; Dickman, R.; Halpern, Z. 2014: Sa2023 Vibrating Capsule for the Treatment of Chronic Idiopathic Constipation (Cic) and Constipation Predominant Irritable Bowel Syndrome (C-Ibs) -Safety and Efficacy. Gastroenterology 146(5): S-357

Butt, S.; Leung, R.S.; Batla, A.; Bhatia, K.; Raeburn, A.J.; Zarate, N.; Emmanuel, A. 2014: Sa2024 Dysmotility in Parkinson's Disease Correlates to Gut Symptoms: Findings of a Wireless Motility Capsule Study. Gastroenterology 146(5): S-357

Erdogan, A.; Lee, Y.Y.; Sifuentes, H.; Rao, S.S. 2014: Sa2026 Small Intestinal Fungal Overgrowth (Sifo): A Cause of Gastrointestinal Symptoms. Gastroenterology 146(5): S-358

LoCasale, R.J.; Datto, C.; Sexton, C.C.; Coyne, K.; Yeomans, K.; Chavoshi, S.; King, F.R.; Tack, J.F. 2014: Sa2028 Symptom Burden and Treatment of Patients With Opioid-Induced Constipation (Oic) for Non-Cancer Pain. Gastroenterology 146(5): S-358

Bignell, M.; Hart, A.; Rhode, M. 2014: Sa2030 The Endogenous System Is Not Implicated in the Pathogenesis of Functional Constipation; Results of a Randomised, Double Blind, Study Investigating Naloxone Hydrochloride Sustained Release Capsules (Nalcol) As a Treatment for Functional Constipation. Gastroenterology 146(5): S-359

Dhanekula, R.; Malik, Z.A.; Parkman, H.P. 2014: Sa2031 Methane Levels on Lactulose Breath Hydrogen Testing Correlates to the Severity of Constipation. Gastroenterology 146(5): S-359

Gambaccini, D.; Racale, C.; Salvadori, S.; Bassotti, G.; Pucciani, F.; Battaglia, E.; Bocchini, R.; Bove, A.; Alduini, P.; Marchi, S.; Bellini, M. 2014: Sa2033 Chronic Constipation: Rome Iii Criteria and What Patients Think. Are We Talking the Same Language?. Gastroenterology 146(5): S-360

Burnett, B.J.; Setty, P.; Singh, S.B.; Breath, H.C.L. 2014: Sa2034 Accurate Interpretation of Breath Test Results Depends on Measuring Hydrogen Sulfide in Non-Methane Excretors. Gastroenterology 146(5): S-360

Spierings, E.L.; Drossman, D.A.; Cryer, B.L.; Losch-Beridon, T.; Ueno, R. 2014: Sa2036 A Pooled Analysis of Response to Lubiprostone in Patients With Opioid-Induced Constipation Receiving Non-Methadone Opioids Versus Methadone. Gastroenterology 146(5): S-360